rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCTGGGCCACTACTGGAAACACCATATATTTTGGAGAG	CASSPWATTGNTIYF	In	VDJ	5	264	0.0027885163825337473	0.0035003513610267697	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	4	8	0	2	4	5	23	35	43	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPWATTGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGGDSYNEQFF	In	VDJ	2	127	0.0013414453809916134	0.0016838811471606052	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	3	0	0	1	23	-1	45	39	46			01,02										Vb 1	CASSVGGDSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGGGGCGACAGGTAGAAACTATGGCTACACCTTCGGTTCG	CASSPGATGRNYGYTF	In	VDJ	2	104	0.0010985064537254157	0.0013789262937378183	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	2	8	4	23	35	49	43	53			01,02										Vb 1	CASSPGATGRNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAACAGCGCGCGAACACTGAAGCTTTCTTTGGACAA	CASSEQRANTEAFF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	5	3	5	1	3	5	23	34	41	37	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEQRANTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCAGACAGGGGTGCCCTACGAGCAGTACTTCGGGCCG	CASQTGVPYEQYF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	2	2	2	3	23	32	42	34	45			01,02										Vb 1	CASQTGVPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCACCTCAGACAGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSHLRQGGQETQYF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	1	1	8	1	23	34	51	42	52			01,02										Vb 1	CASSHLRQGGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAGAAGGGGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEGDSSYNEQFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	0	1	4	23	39	45	40	49			01,02										Vb 1	CASSLEGDSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTACCAACGGTAAAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	46	4.858778545323954E-4		50	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-06	01	7	3	6	5	13	5	23	32	48	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-06	TCRBV09-01		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGACAGTTTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	46	4.858778545323954E-4		43	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	2	0	4	23	-1	44	37	48			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGACGGACTAGCGGCTAGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	46	4.858778545323954E-4		49	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	5	3	3	4	23	36	49	39	53			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGAAGGGGGACAGGGGCCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	4.013773580919788E-4		49	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	4	9	3	23	34	53	43	56			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCGGCCGGAAAGCGTGCCGAGGGATGAGCAGTTCTTCGGGCCA	CASSPRPESVPRDEQFF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	0	8	20	0	23	35	-1	55	60			01,02										Vb 1	CASSPRPESVPRDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCTGGACAGGGCCCGTGAACACTGAAGCTTTCTTTGGACAA	CASSPWTGPVNTEAFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	0	4	4	23	35	47	39	51			01,02										Vb 1	CASSPWTGPVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGGGACAGCACATGAACAGCCCCAGCATTTTGGTGAT	CASSGTAHEQPQHF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	7	1	8	23	34	42	35	50			01,02										Vb 1	CASSGTAHEQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAAGGACAGCCGGAAACACCATATATTTTGGAGAG	CASSERTAGNTIYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	4	5	2	23	34	45	39	47			01,02										Vb 1	CASSERTAGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGGCCCACAGGGTGAAGCTTTCTTTGGACAA	CASSPGPQGEAFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	7	8	0	23	35	-1	43	49			01,02										Vb 1	CASSPGPQGEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACGAAGTTAACTACGAGCAGTACTTCGGGCCG	CASSVDEVNYEQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	0	2	8	3	2	6	23	39	43	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDEVNYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGACCCACAGGGTTCGGGAGGCTACACCTTCGGTTCG	CASSEDPQGSGGYTF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	8	9	7	23	34	49	43	56			01,02										Vb 1	CASSEDPQGSGGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCATGGGCATACGGGTCTATGGCTACACCTTCGGTTCG	CASMGIRVYGYTF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	6	8	0	4	1	8	23	33	38	34	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASMGIRVYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCAACAAACAGGGAATGAGCAGTTCTTCGGGCCA	CASSPQQTGNEQFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	7	9	0	23	35	-1	44	50			01,02										Vb 1	CASSPQQTGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGCGATCTAGCGGGATTTACAATGAGCAGTTCTTCGGGCCA	CASSPRSSGIYNEQFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	3	4	7	2	23	35	51	42	53			01,02										Vb 1	CASSPRSSGIYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCAGGACGGTGACTAGCGCGGGTTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.9012611699093733E-4		50	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	6	7	9	7	23	37	54	46	61			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAGGTCAGGGTGAGTACGAGCAGTACTTCGGGCCG	CASSLGQGEYEQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	4	2	4	23	39	46	41	50			01,02										Vb 1	CASSLGQGEYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGGGGATTATTGAGGGTGATACGCAGTATTTTGGCCCA	CASSLGIIEGDTQYF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	0	6	10	1	19	33	48	43	49														CASSLGIIEGDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGGCCGCGGGTCACGATTCACCCCTCCACTTTGGGAAC	CASSLAAGHDSPLHF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	7	4	8	4	5	19	33	42	37	47						01,02								CASSLAAGHDSPLHF+TCRBV11-01+TCRBJ01-06	TCRBV11-01*01	TCRBD02-01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGGATAGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	12	676	0.007140291949215201		46	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	1	8	0	2	4	29	46	51	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCTAAGTGGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	136	0.001436508439487082		47	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-04	01	1	6	2	1	6	0	29	45	-1	51	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01		TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTCAAATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPQISGANVLTF	In	VDJ	1	79	8.344424023491138E-4	0.0010474536269739197	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	4	4	6	0	2	3	29	42	46	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPQISGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATATTCCCCGAGCCCACCGTCGGATGAGCAGTTCTTCGGGCCA	CASSQYSPSPPSDEQFF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	7	8	9	10	29	44	56	53	66						01,02							Vb 16	CASSQYSPSPPSDEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGATGACAAGGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	6.231911612480723E-4		43	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	2	6	1	3	4	29	43	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAACCAAGATCCGACAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	57	6.020660371379682E-4		41	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	4	3	0	29	46	-1	49	54													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTACTTTAGAGGACCCAATCGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	55	5.809409130278641E-4		56	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	4	1	7	0	9	8	25	38	51	47	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGGGGATTCAGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSQEGGFRGMNTEAFF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	0	9	1	27	44	60	53	61													Vb 16	CASSQEGGFRGMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGACTAGCTTACGAGCAGTACTTCGGGCCG	CASSPGLAYEQYF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	7	4	1	1	29	42	52	43	53						01,02							Vb 16	CASSPGLAYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTAGGAGACAGGGGACACGGGTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	4.013773580919788E-4		58	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	2	7	9	16	33	48	40	57													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGGTGTAGGGGAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	25	2.640640513763018E-4		50	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	0	5	2	4	8	2	29	46	59	54	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGAGGGACAGGGCGGCGAGCAGTACTTCGGGCCG	CASSLEGQGGEQYF	In	VDJ	2	105	0.0011090690157804677	0.0013921852004083744	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	5	3	24	36	50	41	53														CASSLEGQGGEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAACGGGACATTGGAACACTGAAGCTTTCTTTGGACAA	CASRTGHWNTEAFF	In	VDJ	2	93	9.823182711198428E-4	0.001233078320361703	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	1	3	3	24	35	44	38	47														CASRTGHWNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATTAAGGGGGGCCATGAACACTGAAGCTTTCTTTGGACAA	CASRLRGAMNTEAFF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	5	1	0	4	4	24	35	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLRGAMNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGACAGGGGTTGAAGGCTACACCTTCGGTTCG	CASRTGVEGYTF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	8	0	5	24	-1	43	35	48														CASRTGVEGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAGTCAGCTACAATGAAAAACTGTTTTTTGGCAGT	CASRVSYNEKLFF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-04	01	6	4	5	5	3	4	24	35	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVSYNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGTGGTGGGACAGGGGCCATTGGGGAGCTGTTTTTTGGAGAA	CASGGGTGAIGELFF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	2	8	8	5	24	31	49	39	54														CASGGGTGAIGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCACGATGGGACAGACGGTCTATGGCTACACCTTCGGTTCG	CATMGQTVYGYTF	In	VDJ	1	58	6.126285991930202E-4	7.690165868922448E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	5	4	4	5	24	31	42	35	47														CATMGQTVYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAACGACATCCGTAACTTCTACAATGAGCAGTTCTTCGGGCCA	CANDIRNFYNEQFF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	6	3	0	10	24	-1	37	33	47														CANDIRNFYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGACAGGGGGCTGGCCCTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGGQGAGPSYNEQFF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	1	5	7	24	36	53	41	60														CASSVGGQGAGPSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGATCGGTCGAGTTCTGGCTACACCTTCGGTTCG	CASSLDRSSSGYTF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	8	7	1	13	24	36	40	37	53						01,02								CASSLDRSSSGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCGCTGGGGTGAATCGCTACACCTTCGGTTCG	CASSPAGVNRYTF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	6	2	9	6	6	24	36	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAGVNRYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGGGACTAGCTTAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	2.85189175486406E-4		40	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	7	1	3	24	36	46	37	49						01,02								X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAAGGGAGAATGAGCAGTTCTTCGGGCCA	CASSVRENEQFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	2	7	4	0	24	36	-1	40	45														CASSVRENEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGGAGGGCAGGCTATAACCGATACGCAGTATTTTGGCCCA	CASSVGGGQAITDTQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	6	6	12	24	36	48	42	60														CASSVGGGQAITDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGCGAAGTTCGGAGGACATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	2.2181380315609354E-4		56	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	1	6	4	12	12	24	35	52	47	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAGCAGAGAACTCCTACGAGCAGTACTTCGGGCCG	CASRAENSYEQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	6	4	5	0	2	4	24	35	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAENSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCCAACTCCTAACAGGCTTCTATGGCTACACCTTCGGTTCG	CASSAQLLTGFYGYTF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	4	4	12	3	24	36	53	48	56														CASSAQLLTGFYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAGTAGCAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRVAVNTGELFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	7	1	2	3	24	35	41	37	44						01,02								CASRVAVNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCTCCCCGGAAACGACTGAAGCTTTCTTTGGACAA	CASSPSPETTEAFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	1	8	5	8	4	24	36	47	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSPETTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCACCGGGACAGGAGGTTTTGGCTTTCTTTGGACAA		Out	VDJ	1	19	2.006886790459894E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	11	4	8	24	36	48	40	56														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCCCTGTATCCGCCGGAGGCACTGAAGCTTTCTTTGGACAA	CASSSPVSAGGTEAFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	4	15	0	24	36	-1	51	56														CASSSPVSAGGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCCGCGGGGGTTTTGGCAATGAGCAGTTCTTCGGGCCA	CASSSRGGFGNEQFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	2	6	4	6	24	36	47	40	53														CASSSRGGFGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGGGGATTACAGTCAGCCCCAGCATTTTGGTGAT	CASSEGDYSQPQHF	In	VDJ	1	50	5.281281027526036E-4	6.629453335277972E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-05	01	1	0	8	6	0	6	23	-1	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGDYSQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGTGGACAGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSEEWTGANEQFF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	2	6	3	1	23	39	51	42	52														CASSEEWTGANEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCCGGGACAGGGGTGGAAAAACTGTTTTTTGGCAGT	CASSEAPGTGVEKLFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	2	8	4	2	23	40	54	44	56														CASSEAPGTGVEKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGGAAGTGGGAACACTGAAGCTTTCTTTGGACAA	CASSEGGSGNTEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	0	8	1	1	5	23	39	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGGSGNTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCACGTTTGGTGAGGGGGACTMAGCTGTGTATCTCTGTGCCAGCAGCCCCGGGGGACGGGGGTGCCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	2.3237636521114563E-4		46	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	2	5	2	11	22	34	42	36	53														X+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCACCTTGACAGAGAAGCTTTCTTTGGACAA	CAWSHLDREAFF	In	VDJ	11	618	0.006527663350022182	0.008194004322403574	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	8	6	1	26	38	49	44	50			unresolved										Vb 20	CAWSHLDREAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCGGAGGCGAACATTCACCCCTCCACTTTGGGAAC	CAWGGGEHSPLHF	In	VDJ	5	259	0.002735703572258487	0.00343405682767399	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	10	1	8	3	5	26	35	43	38	48													Vb 20	CAWGGGEHSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCTACTAGGACCCTACGGCCGGAGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	180	0.0019012611699093733		52	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	3	8	6	3	16	26	38	46	41	62						01,02							Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCTAACTCGGGACTGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CAWSV*LGTGGQETQYF	Stop	VDJ	3	149	0.0015738217462027589		51	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	1	7	5	26	40	53	47	58			unresolved			01,02							Vb 20	CAWSV*LGTGGQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCAAACCGGGACAGGGTTTGAAAAACTGTTTTTTGGCAGT	CAWSQTGTGFEKLFF	In	VDJ	3	146	0.0015421340600376026	0.0019358003739011682	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	7	7	2	26	37	53	44	55													Vb 20	CAWSQTGTGFEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTGAGCATCGCGTTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	3	141	0.0014893212497623424		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	6	7	5	2	9	26	35	40	37	49						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD02-01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTACGACTAGCGGGAGCTGGAGAGCAGTACTTCGGGCCG	CALRLAGAGEQYF	In	VDJ	2	136	0.001436508439487082	0.0018032113071956087	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	2	2	7	3	5	26	33	48	36	53			unresolved										Vb 20	CALRLAGAGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAACGTAGTGAGAAACTGTTTTTTGGCAGT	CAWERSEKLFF	In	VDJ	2	125	0.0013203202568815092	0.0016573633338194933	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	5	8	11	5	4	26	35	43	40	47			unresolved			01,02							Vb 20	CAWERSEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCTCTGTAGGTAGCGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGSGAYNEQFF	In	VDJ	2	106	0.0011196315778355197	0.0014054441070789302	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	5	3	2	10	0	26	33	-1	43	51													Vb 20	CASSVGSGAYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATAAGGGCGGAGACCCAGTACTTCGGGCCA	CAWIRAETQYF	In	VDJ	2	100	0.0010562562055052072	0.0013258906670555945	33	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	4	5	3	5	2	2	26	36	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIRAETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAGACGCGGGAGGGCCGAACAATGAGCAGTTCTTCGGGCCA	CAWTDAGGPNNEQFF	In	VDJ	2	97	0.0010245685193400512	0.0012861139470439268	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	5	5	4	26	36	50	41	54			unresolved										Vb 20	CAWTDAGGPNNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACATGGGGGGTAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	84	8.872552126243742E-4		46	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	1	3	4	5	26	40	50	44	55			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGGACTTACTACGAGCAGTACTTCGGGCCG	CAWSPGTYYEQYF	In	VDJ	1	82	8.6613008851427E-4	0.0010872303469855876	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	10	3	3	2	26	38	47	41	49			unresolved			01,02							Vb 20	CAWSPGTYYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGGACTACTTGAACGAGCAGTACTTCGGGCCG	CALDYLNEQYF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	1	9	5	1	5	26	33	40	34	45			unresolved			01,02							Vb 20	CALDYLNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGGATTCCAACACCGGGGAGCTGTTTTTTGGAGAA	CAWSRDSNTGELFF	In	VDJ	1	70	7.393793438536452E-4	9.281234669389162E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	2	0	8	2	1	4	26	38	43	39	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSRDSNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGAGGGGCCGGGGAAAAACTGTTTTTTGGCAGT	CAWSVRGAGEKLFF	In	VDJ	1	63	6.654414094682806E-4	8.353111202450246E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	0	5	2	8	3	5	26	40	48	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVRGAGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTTACGATTCGGACAGCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	61	6.443162853581765E-4		46	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	4	10	2	26	38	54	48	56													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCCTAGGGCAGGGAGACCAAGAGACCCAGTACTTCGGGCCA	CALGQGDQETQYF	In	VDJ	1	58	6.126285991930202E-4	7.690165868922448E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	8	4	3	0	6	2	26	32	43	38	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CALGQGDQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTTGGGTCAGAAGAGACCCAGTACTTCGGGCCA	CAWSFGSEETQYF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	2	0	9	3	3	4	26	38	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFGSEETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGACAGGGTACTGAAGCTTTCTTTGGACAA	CAWSRQGTEAFF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	3	5	1	1	26	38	46	39	47			unresolved										Vb 20	CAWSRQGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGAACAGGGGGCTGGATCACCCCTCCACTTTGGGAAC	CAWREQGAGSPLHF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	0	10	3	4	26	37	49	40	53													Vb 20	CAWREQGAGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACAAAGGGGGCCCGGGGAGCTGTTTTTTGGAGAA	CAWRQRGPGELFF	In	VDJ	1	49	5.175655406975516E-4	6.496864268572413E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	0	6	4	0	26	37	-1	41	48			unresolved										Vb 20	CAWRQRGPGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGACAGGGCAGAAGGTACGAGCAGTACTTCGGGCCG	CAWGQGRRYEQYF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	4	0	7	26	-1	43	35	50													Vb 20	CAWGQGRRYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGTGTAATGAACACTGAAGCTTTCTTTGGACAA	CAWSVGVMNTEAFF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	0	9	0	0	5	26	-1	43	40	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGVMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGTCGGGTGGAGAGCAGTACTTCGGGCCG	CAWRSGGEQYF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	7	2	4	26	37	43	39	47						01,02							Vb 20	CAWRSGGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGGTAGCACTGAAGCTTTCTTTGGACAA	CAWSLGSTEAFF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	8	4	5	0	26	38	-1	43	46			unresolved			01,02							Vb 20	CAWSLGSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACGCGGTTGAAGCTTTCTTTGGACAA	CAWGDAVEAFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	5	0	7	7	1	5	26	35	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGDAVEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTTGGGTGGGGACAGGGGATCGCGCAGTATTTTGGCCCA	CAWSFGWGQGIAQYF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	10	8	4	26	38	56	46	60													Vb 20	CAWSFGWGQGIAQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCTTGGGGACACTGAAGCTTTCTTTGGACAA	CAWTLGDTEAFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	6	2	3	5	0	26	36	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTLGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCTCATAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVPHSNQPQHF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	3	7	0	0	4	26	-1	42	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPHSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACGACCCGACAGAGAGAACACTGAAGCTTTCTTTGGACAA	CAWRRPDRENTEAFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	1	7	3	26	37	49	44	52													Vb 20	CAWRRPDRENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGGGGCTATGAACACTGAAGCTTTCTTTGGACAA	CAWSLGAMNTEAFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	2	7	0	0	3	2	26	38	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLGAMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGCGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSERGSSYNEQFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	2	0	0	2	26	-1	47	39	49													Vb 20	CAWSERGSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCCAGGGGGCAAGTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	29	3.063142995965101E-4		46	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	0	3	2	3	26	37	47	39	50													Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCCGGACAGGGTCATCAGCCCCAGCATTTTGGTGAT	CAWSPGQGHQPQHF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	3	5	4	2	26	37	49	41	51			unresolved										Vb 20	CAWSPGQGHQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCCCAAGCGACCTGTACAATGAGCAGTTCTTCGGGCCA	CAWSTPSDLYNEQFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	4	6	5	26	38	48	44	53						01,02							Vb 20	CAWSTPSDLYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACGTGGGATACGCAGTATTTTGGCCCA	CAWSVTWDTQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	0	0	10	6	5	0	26	40	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVTWDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGATTGGCAGGGGTTTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	2.006886790459894E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	3	7	4	26	40	53	47	57													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACGGGACAGGGGCGGAGGCATGGCTACACCTTCGGTTCG	CAWSVTGQGRRHGYTF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	6	3	7	26	40	53	43	60			unresolved										Vb 20	CAWSVTGQGRRHGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGCAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSWQSSYNEQFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	0	1	4	26	38	42	39	46													Vb 20	CAWSWQSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGACAGGGGGCCGGTCAGCCCCAGCATTTTGGTGAT	CAWSVGQGAGQPQHF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	0	6	1	3	26	40	52	41	55													Vb 20	CAWSVGQGAGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGGACACTACTACGAGCAGTACTTCGGGCCG	CAWSPGHYYEQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	3	2	3	26	38	46	40	49													Vb 20	CAWSPGHYYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGTGGGACAGTGAGCACCTTCGGTTCG	CAWRGGTVSTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	13	4	4	26	37	48	41	52			unresolved										Vb 20	CAWRGGTVSTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGGGGAACGGCGGTGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASRGTAVDSYNEQFF	In	VDJ	2	89	9.400680228996345E-4	0.0011800426936794792	48	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-01	01	6	0	8	0	0	11	18	-1	33	29	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGTAVDSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCCAAAAATCGACAGGGGCATACGGAAACACCATATATTTTGGAGAG	CASSPQKSTGAYGNTIYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	2	4	11	5	18	30	49	41	54														CASSPQKSTGAYGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTTCGGACATAGCCGGGGAGCTGTTTTTTGGAGAA	CASSSSDIAGELFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	6	6	4	3	18	31	40	35	43														CASSSSDIAGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATGGGGACAGGTCGGTCCTAACACTGAAGCTTTCTTTGGACAA	CASSLWGQVGPNTEAFF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	4	2	2	8	18	33	43	35	51														CASSLWGQVGPNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTGGACAGGGGGTGGCACTGAAGCTTTCTTTGGACAA	CASSWTGGGTEAFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	4	0	3	18	-1	41	31	44														CASSWTGGGTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGACCGGTTCTCAGGGTCAACACTGAAGCTTTCTTTGGACAA	CASRPVLRVNTEAFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	2	9	2	18	29	43	38	45														CASRPVLRVNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCATAGCGGGGGCAACAACGAGCAGTACTTCGGGCCG	CASSHSGGNNEQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	5	2	5	18	30	41	32	46														CASSHSGGNNEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGGGCGACTAGCGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASSGRLAGVTDTQYF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	2	4	1	18	30	46	34	47														CASSGRLAGVTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAACGCTTGGGCTAGAGACCCAGTACTTCGGGCCA	CASSLTLGLETQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	8	0	4	6	1	18	33	43	39	44														CASSLTLGLETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGGGCAGGGAGACCGGGGAGCTGTTTTTTGGAGAA	CASSSGRETGELFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-02	01	4	4	3	5	4	2	18	31	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRETGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCGCGGGGACTGGAGGGGCGACATGAGCAGTTCTTCGGGCCA	CASSPRGLEGRHEQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	8	5	11	18	30	41	35	52						01,02								CASSPRGLEGRHEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAGAGGGTGAGGAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	337	0.003559583412552549		40	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	11	0	8	2	6	19	31	38	33	44														X+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGTTTGGCGGGAGGCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	2.5350148932124975E-4		49	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	1	0	4	2	19	35	47	39	49														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCAGGACCGGCACAGATACGCAGTATTTTGGCCCA	CASSSRTGTDTQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	3	1	7	1	3	2	19	32	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRTGTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGACCAACTAGCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLDQLAGGELFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	3	4	7	4	0	19	35	-1	39	48						01,02								CASSLDQLAGGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCTCCGGAGGGACAGGGGGTAACTGAAGCTTTCTTTGGACAA	CASSSPEGQGVTEAFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	5	7	2	19	32	50	39	52														CASSSPEGQGVTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGAGGACAACTACGAGCAGTACTTCGGGCCG	CASSQEEDNYEQYF	In	VDJ	3	166	0.0017533853011386443	0.002200978507312287	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	0	1	6	3	3	1	23	40	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEEDNYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGGCCAGAATCTCTATGGCTACACCTTCGGTTCG	CASSQGGQNLYGYTF	In	VDJ	2	106	0.0011196315778355197	0.0014054441070789302	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	7	0	4	0	8	23	-1	44	39	52														CASSQGGQNLYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCCCGTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDPVSSYNEQFF	In	VDJ	2	100	0.0010562562055052072	0.0013258906670555945	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	2	0	6	0	23	40	-1	46	49														CASSQDPVSSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTTACTAGCGGGGGGCCCCGGGGTGAGCAATTCTTCGGGCCA	CASSLTSGGPRGEQFF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	1	16	2	15	23	36	50	38	65														CASSLTSGGPRGEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCCGGGACTAGCGGGCCTTGCCTACGAGCAGTACTTCGGGCCG	CASSQDPGLAGLAYEQYF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	4	2	3	5	23	40	55	43	60						01,02								CASSQDPGLAGLAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAAGTGGTTGCGGGAGGGACAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	46	4.858778545323954E-4		58	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	0	1	7	3	23	40	56	47	59														X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCCATCGCGGTTCTGGAGGGGGACTGAAGCTTTCTTTGGACAA	CASSPSRFWRGTEAFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	6	5	1	5	16	0	23	34	-1	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSRFWRGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGAGCGGGGGGGCCATGAGCAGTTCTTCGGGCCA	CASSQEERGGHEQFF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	0	8	2	2	23	40	52	42	54														CASSQEERGGHEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGGGGACAATACCTACGAGCAGTACTTCGGGCCG	CASSQEGDNTYEQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	2	2	3	23	40	48	42	51														CASSQEGDNTYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCTACCGACCCAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTDPTNTGELFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	4	2	7	0	5	4	23	36	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTDPTNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTGGGGAGCGGCTCTAACTATGGCTACACCTTCGGTTCG	CASSLGSGSNYGYTF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	5	0	5	2	23	36	46	41	48						01,02								CASSLGSGSNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGTCACAGGGAATGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	2.3237636521114563E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	1	3	5	23	36	45	39	50														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGCTCGGGGGAGAGGGGGCTACACCTTCGGTTCG	CASSQDARGRGGYTF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	2	8	4	6	23	40	50	44	56														CASSQDARGRGGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGCGGGTGGAGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	1.7956355493588524E-4		40	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	4	6	0	5	23	-1	44	39	49						01,02								X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCCGGGGCCAAGGTAGCGGGGGTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	128	0.0013520079430466654		56	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	2	12	2	19	33	54	45	56													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACAGGGGGCAACACTGAAGCTTTCTTTGGACAA	CASSWTGGNTEAFF	In	VDJ	1	77	8.133172782390097E-4	0.0010209358136328078	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	0	2	0	0	19	-1	-1	32	43													Vb 5.1	CASSWTGGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGAATTGGGACTAGCGGGAGGGCTAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSLAELGLAGGLGAYEQYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	63	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	0	0	2	7	7	18	34	57	41	64													Vb 5.1	CASSLAELGLAGGLGAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTAGTGGGGCGTACAATGAGCAGTTCTTCGGGCCA	CASSFSGAYNEQFF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	7	0	4	4	1	19	33	42	37	43													Vb 5.1	CASSFSGAYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCTCAACTACAGGGTCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	2.5350148932124975E-4		49	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	3	9	4	19	32	47	41	51													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGCAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSAGGYNEQFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	3	3	0	19	32	-1	35	42													Vb 5.1	CASSSAGGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGGGGGATACACTGAAGCTTTCTTTGGACAA	CASSLAGGYTEAFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	3	0	2	19	-1	42	35	44													Vb 5.1	CASSLAGGYTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGAATCCCGGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSWNPGTANTEAFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	1	8	1	19	32	47	40	48													Vb 5.1	CASSWNPGTANTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGACTAGCGGGAGAGATACGCAGTATTTTGGCCCA	CASSPGTSGRDTQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	2	5	3	0	19	31	-1	34	48													Vb 5.1	CASSPGTSGRDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGGGACTCAGCCGTGTATCTCTACACCAGCAGTGAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	1.7956355493588524E-4		37	TCRBV17	TCRBV17-01	01				TCRBJ01	TCRBJ01-02	01	10	2	7	4	14	0	22	26	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGGGGTGAGGGCCCTGAAGCTTTCTTTGGACAA	CASWGEGPEAFF	In	VDJ	46	2574	0.027188034729704037	0.034128425770011	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	0	6	6	2	25	34	45	40	47													Vb 3	CASWGEGPEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGACAGCCGGAGACAATCAGCCCCAGCATTTTGGTGAT	CASSLWTAGDNQPQHF	In	VDJ	16	875	0.009242241798170564	0.011601543336736454	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	5	3	0	7	25	-1	47	42	54													Vb 3	CASSLWTAGDNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCCCAGACGCACCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	10	571	0.006031222933434734		41	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	8	2	7	2	4	5	25	34	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCGGACAGATCCTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	9	483	0.0051017174725901514		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	5	5	3	5	25	38	47	41	52													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGGCACGGCGGGGGATGAAAAACTGTTTTTTGGCAGT	CASTGTAGDEKLFF	In	VDJ	7	393	0.004151086887635465	0.005210750321528487	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	7	2	6	8	0	25	35	-1	43	50													Vb 3	CASTGTAGDEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGACTAGCGGGAGGTTTGGGGAGACCCAGTACTTCGGGCCA	CASSLWTSGRFGETQYF	In	VDJ	5	259	0.002735703572258487	0.00343405682767399	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	2	1	5	0	6	25	-1	55	42	61													Vb 3	CASSLWTSGRFGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGGGAGGGGTACCCTATGGCTACACCTTCGGTTCG	CASGGGVPYGYTF	In	VDJ	4	237	0.0025033272070473416	0.003142360880921759	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	9	0	4	2	5	25	34	43	36	48													Vb 3	CASGGGVPYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCGGGACAAATAATGAAAAACTGTTTTTTGGCAGT	CASSTGTNNEKLFF	In	VDJ	4	229	0.0024188267106069247	0.0030362896275573114	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	6	4	4	2	25	36	46	40	48													Vb 3	CASSTGTNNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGGAGGGGACCCACGGGTAGTACTTCGGGCCG	CASSGEGTHG*YF	Stop	VDJ	4	198	0.0020913872869003105		39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	11	1	11	25	37	45	38	56													Vb 3	CASSGEGTHG*YF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACGGGAGACTTGAACACTGAAGCTTTCTTTGGACAA	CASRTGDLNTEAFF	In	VDJ	3	156	0.0016477596805881236	0.0020683894406067277	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	2	0	2	3	25	36	44	38	47													Vb 3	CASRTGDLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTACACGGACGGAAGGGCTGAAGCTTTCTTTGGACAA	CASSLYTDGRAEAFF	In	VDJ	2	112	0.0011830069501658322	0.0014849975471022659	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	6	6	7	25	39	49	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLYTDGRAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGATACCCCAGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSLDTPGGNEQFF	In	VDJ	2	102	0.0010773813296153115	0.0013524084803967064	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	7	7	1	25	40	54	47	55													Vb 3	CASSLDTPGGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGGGGTAGCGGGGCGACCGGGGAGCTGTTTTTTGGAGAA	CASWGSGATGELFF	In	VDJ	2	90	9.506305849546866E-4	0.0011933016003500352	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	5	3	5	5	2	25	34	47	39	49													Vb 3	CASWGSGATGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCGACTCTAGCGGCTCAAGAGACCCAGTACTTCGGGCCA	CASSTLAAQETQYF	In	VDJ	1	82	8.6613008851427E-4	0.0010872303469855876	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	4	5	2	6	2	25	34	47	40	49						01,02							Vb 3	CASSTLAAQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTGGGGGAACTGAAGCTTTCTTTGGACAA	CASSLSGGTEAFF	In	VDJ	1	80	8.450049644041659E-4	0.0010607125336444757	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	1	6	1	5	2	1	25	41	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSGGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGGACTTCCCTATACAATGAGCAGTTCTTCGGGCCA	CASSPGTSLYNEQFF	In	VDJ	1	80	8.450049644041659E-4	0.0010607125336444757	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	4	3	6	25	37	46	40	52						01,02							Vb 3	CASSPGTSLYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCCCCGTAGGGGACTATTTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	79	8.344424023491138E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	9	2	9	4	25	35	51	44	55						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTAAAGGGCTGACAGGGTACGATGAGCAGTTCTTCGGGCCA	CASKGLTGYDEQFF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	2	3	8	9	4	25	33	49	42	53													Vb 3	CASKGLTGYDEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCATCAGGGGGGTGAATCAGCCCCAGCATTTTGGTGAT	CASTIRGVNQPQHF	In	VDJ	1	77	8.133172782390097E-4	0.0010209358136328078	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	1	4	4	3	25	35	46	39	49													Vb 3	CASTIRGVNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTATTTAGGGACAGGGTCACACCGACGGACCGGGGAGCTGTTTTTTGGAGAA	CASSYLGTGSHRRTGELFF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	5	5	12	24	37	51	42	63													Vb 3	CASSYLGTGSHRRTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTCAGTTGGGGGAGTTCTCTATGGCTACACCTTCGGTTCG	CASSSSVGGVLYGYTF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	4	6	1	4	8	6	25	38	51	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSSVGGVLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTAGACAGCACTGAAGCTTTCTTTGGACAA	CASSLDSTEAFF	In	VDJ	1	72	7.605044679637493E-4	9.546412802800281E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	4	4	0	25	36	-1	40	45													Vb 3	CASSLDSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGAATCCAGGGCAATGAGCAGTTCTTCGGGCCA	CASRIQGNEQFF	In	VDJ	1	71	7.499419059086972E-4	9.413823736094722E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	3	6	6	0	25	34	-1	40	45													Vb 3	CASRIQGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATCGGGGATACGCAGTATTTTGGCCCA	CASSFIGDTQYF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	6	3	0	25	39	-1	42	46						01,02							Vb 3	CASSFIGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGTCATTGGCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLSSLAATNEKLFF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	5	0	9	0	25	41	-1	50	53													Vb 3	CASSLSSLAATNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGTTGGCGAAACACAATGAGCAGTTCTTCGGGCCA	CASSGLAKHNEQFF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	5	0	9	5	0	10	25	-1	40	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGLAKHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGCGGGGCGGGGGTAACACCATATATTTTGGAGAG	CASSRRGGGNTIYF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	7	2	7	8	1	25	36	51	44	52													Vb 3	CASSRRGGGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGTCACGCCCGGACACACGAGGAAAAACTGTTTTTTGGCAGT	CASGHARTHEEKLFF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	6	8	10	6	25	34	49	44	55													Vb 3	CASGHARTHEEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCCTGGGGGGTGGAGCAGGAAACACCATATATTTTGGAGAG	CASSPPLGGGAGNTIYF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	9	1	4	8	7	25	37	51	45	58													Vb 3	CASSPPLGGGAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGGTCTCCCCGCGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTGLPASGANVLTF	In	VDJ	1	61	6.443162853581765E-4	8.087933069039127E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	7	6	1	11	0	25	35	-1	46	49						01,02							Vb 3	CASTGLPASGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCAGACTGGCTCTTAGCTCTGGAAACACCATATATTTTGGAGAG	CATRLALSSGNTIYF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	6	9	0	0	3	6	25	36	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATRLALSSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGGGACAGGGGGGCTTCAATCAGCCCCAGCATTTTGGTGAT	CASSLLGQGGFNQPQHF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	1	3	1	4	25	41	53	42	57													Vb 3	CASSLLGQGGFNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGATATCCCCGAATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	50	5.281281027526036E-4		50	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	5	2	8	0	1	12	25	37	40	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGAGGACTGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	49	5.175655406975516E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	10	5	4	4	25	41	50	45	54						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCTCCGGGATAATCGAAGAGACCCAGTACTTCGGGCCA	CASSLGSGIIEETQYF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	3	3	5	6	25	40	50	45	56													Vb 3	CASSLGSGIIEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAACCCCGGGACAGGGCTAGAAAAACTGTTTTTTGGCAGT	CASRNPGTGLEKLFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	8	7	3	25	36	52	43	55													Vb 3	CASRNPGTGLEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCATGAGGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSSMREMNTEAFF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	2	0	6	1	25	38	49	44	50													Vb 3	CASSSMREMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCACAGGGGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSTGEGNTEAFF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	3	2	1	2	4	25	38	47	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSTGEGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAACAGGGGGTAGGGGGGACCCAGTACTTCGGGCCA	CASKQGVGGTQYF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	1	7	1	7	25	35	44	36	51													Vb 3	CASKQGVGGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTAGCGGGAGGGCCGCCAGATATGCAGTATTTTGGCCCA	CASSLVAGGPPDMQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	5	0	11	1	11	25	40	52	41	63													Vb 3	CASSLVAGGPPDMQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGAGCGGGAACCTACGAGCAGTACTTCGGGCCG	CASSLWGAGTYEQYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	3	2	3	1	25	42	52	45	53													Vb 3	CASSLWGAGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCAATCTCAGGGGCGAAGACGTGGAGACCCAGTACTTCGGGCCA	CASSFNLRGEDVETQYF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	5	6	10	25	39	51	45	61													Vb 3	CASSFNLRGEDVETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGCAGGGCCTGATCGATGGCTACACCTTCGGTTCG	CASSFGQGLIDGYTF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	6	4	8	25	39	48	43	56													Vb 3	CASSFGQGLIDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCAGTTTGGGAGATACGCAGTATTTTGGCCCA	CASSLSSLGDTQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	1	0	9	5	7	0	25	41	-1	48	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSSLGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGCAGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSLGQGDTDTQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	2	3	1	25	40	50	43	51													Vb 3	CASSLGQGDTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGTGGTGGCGGGAAGATACGAGCAGTACTTCGGGCCG	CASSSVVAGRYEQYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	3	4	8	3	25	38	52	46	55													Vb 3	CASSSVVAGRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTAACTAAGGGGAACTATGGCTACACCTTCGGTTCG	CASSLTKGNYGYTF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	2	2	8	0	25	36	-1	44	49													Vb 3	CASSLTKGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTCCCTTCGGTCCTCCTGACTTCGGGCCG	CASSPPFGPPDF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	5	14	9	8	25	36	48	45	56						01,02							Vb 3	CASSPPFGPPDF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACAGCAAGTTGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CATASWGRTDTQYF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	6	0	1	9	0	25	32	-1	41	47													Vb 3	CATASWGRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTGAGACAGGGGGCGGCCAGAAGGCTACACCTTCGGTTCG		Out	VDJ	1	29	3.063142995965101E-4		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	0	8	4	8	25	40	54	44	62													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATTTCGGACAGGGGCAAAGGCTACACCTTCGGTTCG	CASSLISDRGKGYTF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	2	8	5	4	25	40	54	45	58													Vb 3	CASSLISDRGKGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCCCATGGGGTAGGGGGCGGGAAAAACTGTTTTTTGGCAGT	CASSLPWGRGREKLFF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	0	8	12	2	25	37	56	49	58													Vb 3	CASSLPWGRGREKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGCCGGGTCCGATGGCTATACCTTTGGTTCG	CASSFAGSDGYTF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	20	3	18	25	39	46	42	64						01,02							Vb 3	CASSFAGSDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACAGGGACAGAGACCCAGTACTTCGGGCCA	CASSLGTGTETQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	3	4	0	2	25	-1	49	40	51													Vb 3	CASSLGTGTETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGCCGAGGGGGCCCCAGCATTTTGGTGAT	CASSLPRGPQHF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	5	2	9	6	0	25	37	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLPRGPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACAGGGGAGACAGGTGAAAAACTGTTTTTTGGCAGT	CASSLGTGETGEKLFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	7	0	7	25	-1	50	40	57													Vb 3	CASSLGTGETGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCATGGGGGCGACGGCGATGGAAACAATCAGCCCCAGCATTTTGGTGAT	CASTHGGDGDGNNQPQHF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	6	0	3	5	14	25	35	46	40	60													Vb 3	CASTHGGDGDGNNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGTTTAGCGGGAGAAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSRLAGEGYNEQFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	3	4	4	25	37	50	41	54													Vb 3	CASSRLAGEGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAAAGACAGGGCCACTGAAGCTTTCTTTGGACAA	CASSKDRATEAFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	3	1	25	37	47	40	48													Vb 3	CASSKDRATEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCATATGGGTCCGACAGGGTTTTTGCATTTTGGTGAT	CASSHMGPTGFLHF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	15	12	5	25	36	55	48	60													Vb 3	CASSHMGPTGFLHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAGGGAAACTACCAAAACATTCAGTACTTCGGCGCC	CASSLEGNYQNIQYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	10	0	5	0	8	25	-1	45	39	53													Vb 3	CASSLEGNYQNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACATGGGTACGAGCAGTACTTCGGGCCG	CASSLHGYEQYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	0	9	4	3	0	25	40	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLHGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCAAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPKMNTEAFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	2	8	0	5	0	25	37	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPKMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTCCGACAGGGGATTAATTCACCCCTCCACTTTGGGAAC	CASSVRQGINSPLHF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	2	6	4	2	25	37	49	41	51													Vb 3	CASSVRQGINSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCAGAGACAGGGGTGGCACTGAAGCTTTCTTTGGACAA	CASTRDRGGTEAFF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	2	4	5	3	25	35	48	40	51													Vb 3	CASTRDRGGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGAGTCGCGGGGCGAGCAGTACTTCGGGCCG	CASSFESRGEQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	6	6	0	25	39	-1	45	51													Vb 3	CASSFESRGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCGTACGACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASSSVRQGNTEAFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	2	8	1	25	36	51	44	52													Vb 3	CASSSVRQGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGACTATACAATGAGCAGTTCTTCGGGCCA	CASSLGLYNEQFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	9	4	0	0	25	-1	-1	40	46						01,02							Vb 3	CASSLGLYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTCGACAAATTCTATGGCTACACCTTCGGTTCG	CASSFFDKFYGYTF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	4	4	4	25	39	47	43	51													Vb 3	CASSFFDKFYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGACATCGAACACTGAAGCTTTCTTTGGACAA	CASSLWTSNTEAFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	6	1	0	2	25	-1	46	42	48													Vb 3	CASSLWTSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGCCTACAGGGTGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPAYRVVNTEAFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	0	8	3	25	36	50	44	53													Vb 3	CASSPAYRVVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAAGGGAAGGGGGCACTGGAAACACCATATATTTTGGAGAG	CASKREGGTGNTIYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	5	0	2	7	1	25	35	49	42	50													Vb 3	CASKREGGTGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGAGGTGGAGGGAGCAGTTCTTCGGGCCA	CASSLRWREQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	1	10	7	0	25	37	-1	44	49													Vb 3	CASSLRWREQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCAAGTTGCTTAGAGTCGGGGGGCGAAGAGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	3.1687686165156223E-4		50	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	1	5	3	7	18	34	44	37	51														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGAGGGCGGGATCGCAGACAATGAGCAGTTCTTCGGGCCA	CASRLEGGIADNEQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	3	5	3	6	18	34	43	37	49														CASRLEGGIADNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTGGGACTAGCGGTCCGCACAGACGAGCAGTACTTCGGGCCG	CASSLGLAVRTDEQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	48	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	5	5	0	9	23	-1	48	37	57						01,02							Vb 14	CASSLGLAVRTDEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCCATATTAGCGGGGGCACCAACACTGGGGAGCTGTTTTTTGGAGAA	CAHISGGTNTGELFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	11	5	2	8	5	10	23	29	43	34	53													Vb 14	CAHISGGTNTGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCACGGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASTAGGPDTQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	0	4	2	1	23	33	44	35	45													Vb 14	CASTAGGPDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGASYNEQFF	In	VDJ	30	1681	0.017755666814542534	0.022288222113204546	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	7	7	0	0	2	0	25	32	-1	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAGASYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGGGACAGCCTGAATGAAAAACTGTTTTTTGGCAGT	CSARDSLNEKLFF	In	VDJ	9	523	0.005524219954792234	0.006934408188700759	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	5	3	4	25	32	42	35	46													Vb 4	CSARDSLNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTGGGCGGACCGTGGAAACACCATATATTTTGGAGAG	CSAWADRGNTIYF	In	VDJ	8	436	0.004605277056002704	0.005780883308362393	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	7	1	7	3	7	2	25	32	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAWADRGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGAGCTTCGTACAATGAGCAGTTCTTCGGGCCA	CSVGASYNEQFF	In	VDJ	6	341	0.003601833660772757	0.004521287174659577	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	2	4	1	5	25	33	38	34	43													Vb 4	CSVGASYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCGCACTTACAAGAGACCCAGTACTTCGGGCCA	CSVEPHLQETQYF	In	VDJ	4	195	0.0020596996007351542	0.0025854868007584094	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	3	10	2	4	2	25	37	44	41	46						01,02							Vb 4	CSVEPHLQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGAGTTAATAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVVELISSYNEQFF	In	VDJ	2	125	0.0013203202568815092	0.0016573633338194933	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	2	0	1	8	25	35	40	36	48													Vb 4	CSVVELISSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGGTCGAACGGTGGGCACTAAAGCTTTCTTTGGACAA	CSVEEGRTVGTKAFF	In	VDJ	1	73	7.710670300188013E-4	9.679001869505841E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	0	8	0	9	12	4	25	39	55	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEEGRTVGTKAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGATGAGCAAGCCTCGGGACAAATAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	66	6.971290956334368E-4		52	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	6	6	17	6	25	32	55	49	61													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGCGGACAGAACACTGAAGCTTTCTTTGGACAA	CSVGGQNTEAFF	In	VDJ	1	62	6.548788474132286E-4	8.220522135744686E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	1	4	0	25	33	-1	37	42													Vb 4	CSVGGQNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGAAGGCGGGATGGGGAATGAGCAGTTCTTCGGGCCA	CSEGGMGNEQFF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	7	3	7	3	5	25	32	41	35	46													Vb 4	CSEGGMGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGATTCTCGACAGGGCAGCTTACGAGCAGTACTTCGGGCCG	CSVILDRAAYEQYF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	4	7	5	25	33	47	40	52													Vb 4	CSVILDRAAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGACAGGGACGGCCGAGCAGTACTTCGGGCCG	CSAGTGTAEQYF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	6	2	5	25	32	43	34	48													Vb 4	CSAGTGTAEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCATACCGGGGCAGATACGCAGTATTTTGGCCCA	CSVEDHTGADTQYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	4	6	0	25	39	-1	45	50													Vb 4	CSVEDHTGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAACTAGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CSVEELAGGPDTQYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	0	4	0	1	25	-1	52	39	53													Vb 4	CSVEELAGGPDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATCTACAGGGTGGGAGCTATGGCTACACCTTCGGTTCG	CSVDLQGGSYGYTF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	4	3	6	25	36	45	39	51													Vb 4	CSVDLQGGSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGACTGTTTTTAGTAGGCACAGATACGCAGTATTTTGGCCCA	CSVEGLFLVGTDTQYF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	10	1	0	11	25	-1	42	38	53						01,02							Vb 4	CSVEGLFLVGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCGGGGGACAGGGGTCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	46	4.858778545323954E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	2	3	3	1	25	38	51	41	52													Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGGACAGGGTCTTGACTATGGCTACACCTTCGGTTCG	CSVEEGQGLDYGYTF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	3	1	5	25	39	48	40	53													Vb 4	CSVEEGQGLDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGACTAGCGGGAGGTGAAACTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVRLAGGETANTGELFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	2	1	0	1	8	25	34	48	35	56													Vb 4	CSVRLAGGETANTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCAATGGACAGGGGAAGGAAACACCATATATTTTGGAGAG	CSVQWTGEGNTIYF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	2	4	5	2	25	33	47	38	49													Vb 4	CSVQWTGEGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCCCTCTACCTACGAGCAGTACTTCGGGCCG	CSVAPSTYEQYF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	9	2	6	0	25	35	-1	41	44						01,02							Vb 4	CSVAPSTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCCGGGGGGGGCAGGAAAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	4.436276063121871E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	8	0	5	1	9	25	31	40	32	49													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACTAGGATCAGATACGCAGTATTTTGGCCCA	CSVGLGSDTQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	8	4	0	3	25	-1	41	35	44						01,02							Vb 4	CSVGLGSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGGGCTTGGAGGTTCGGTTTTGGCCACTGAAGCTTTCTTTGGACAA	CSVAGLGGSVLATEAFF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	51	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	4	3	4	0	20	25	-1	40	35	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAGLGGSVLATEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGAAAGGACCGGGACAGGGGCATCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	4.33065044257135E-4		56	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	2	0	6	6	25	37	53	43	59													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAAGGTGGGCCTATACAATGAGCAGTTCTTCGGGCCA	CSVEDKVGLYNEQFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	4	6	3	25	39	49	45	52													Vb 4	CSVEDKVGLYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTGGGGCGGAACACTGAAGCTTTCTTTGGACAA	CSVEVGRNTEAFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	1	1	1	25	38	44	39	45													Vb 4	CSVEVGRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCGGACAGGTTTCACGGGGCAGTACTTCGGGCCG		Out	VDJ	1	35	3.696896719268226E-4		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	9	4	9	25	32	43	36	52													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTCCAGGGTGTCTCTTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	3.591271098717705E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	6	3	8	25	34	42	37	50													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTCGGCGGGGCAGACGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	3.3800198576166635E-4		53	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	7	3	0	4	7	25	39	49	43	56													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTTGGAGAATCTTAGCACAGATACGCAGTATTTTGGCCCA	CSVLENLSTDTQYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	2	0	3	6	25	33	40	36	46													Vb 4	CSVLENLSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTATCCCTCCGGATTGGTACTGAAGCTTTCTTTGGACAA	CSVSLRIGTEAFF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	6	1	8	5	8	5	25	33	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSLRIGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAGGGCCGCTAACTATGGCTACACCTTCGGTTCG	CSVDRAANYGYTF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	0	0	3	25	-1	41	36	44													Vb 4	CSVDRAANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATCTGGCGGGGGGCGTCTATGAGCAGTTCTTCGGGCCA	CSVDLAGGVYEQFF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	1	8	4	5	25	36	48	40	53													Vb 4	CSVDLAGGVYEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCGACAGGGGGGTACACTGAAGCTTTCTTTGGACAA	CSVPTGGYTEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	3	3	2	25	33	45	36	47													Vb 4	CSVPTGGYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGTACTAGCTTCCAACAATGAGCAGTTCTTCGGGCCA	CSAVLASNNEQFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	3	7	5	4	5	25	32	42	36	47						01,02							Vb 4	CSAVLASNNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCTTCAGACAGGGGAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	2.640640513763018E-4		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	2	6	6	2	25	32	46	38	48													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGAGACTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CSETSGYNEQFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	5	4	1	1	25	32	42	33	43						01,02							Vb 4	CSETSGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCTCCAGAGGAGGGGTTGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	2.429389272661977E-4		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	0	8	7	25	34	48	42	55													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGTTGGGGCTAGCGGGACGGGAGAGCAGTTCTTCGGGCCA	CSVVGASGTGEQFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	3	10	8	5	25	33	50	41	55													Vb 4	CSVVGASGTGEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCCGACAGGGGGCCGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	2.429389272661977E-4		43	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	3	3	4	25	33	46	36	50													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTCTCGAGGAGGACTAACACTGAAGCTTTCTTTGGACAA	CSVLSRRTNTEAFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	10	2	11	0	25	33	-1	44	49						01,02							Vb 4	CSVLSRRTNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGAGTTGGAGCGGGATCTGACGAGCAGTACTTCGGGCCG	CSVRVGAGSDEQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	3	5	9	4	25	33	49	42	53													Vb 4	CSVRVGAGSDEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGTTCTCGCGCTGGCAAGGGTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	19	1072	0.011323066523015823		55	TCRBV07	unresolved					TCRBJ02	TCRBJ02-03	01	4	5	3	2	17	2	22	35	56	52	58		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGAAACCCGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSETRANVLTF	In	VDJ	4	247	0.002608952827597862	0.0032749499476273187	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-06	01	0	1	8	5	0	5	23	-1	43	40	48		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSETRANVLTF+TCRBV06-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACCACCCAGTCCCGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	212	0.0022392631556710394		44	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	5	6	5	5	23	37	45	42	50		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGAAGAGGGATCTGGAAACACCATATATTTTGGAGAG	CASSEEEGSGNTIYF	In	VDJ	3	187	0.0019751991042947377	0.0024794155473939618	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	11	0	1	2	1	23	39	46	41	47		TCRBV06-01,TCRBV06-07												CASSEEEGSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAAGGACTAGCGGGTTGAATGAGCAGTTCTTCGGGCCA	CASSERTSGLNEQFF	In	VDJ	2	115	0.0012146946363309884	0.0015247742671139338	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	4	7	4	3	26	38	53	42	56		TCRBV06-01,TCRBV06-07,TCRBV06-08				01,02								CASSERTSGLNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAAGAGGGACACATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	103	0.0010879438916703635		40	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	2	3	3	26	36	45	39	48		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCGTATCGTCGGTACTGAAGCTTTCTTTGGACAA	CASSRIVGTEAFF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	5	8	1	23	35	46	43	47		TCRBV06-07,TCRBV06-08				01,02								CASSRIVGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGGACTCSGCCRTGTATCKCTGTGCCAGCAGCTGGGGACAGGGGAGTTACGAGCAGTACTTCGGGCCG	CASSWGQGSYEQYF	In	VDJ	1	63	6.654414094682806E-4	8.353111202450246E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	4	1	3	18	31	42	32	45		TCRBV07-06,TCRBV07-08												CASSWGQGSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCGACGACAGGACGATTAACCAAACACTGAAGCTTTCTTTGGACAA	CASSRRQDD*PNTEAFF	Stop	VDJ	1	57	6.020660371379682E-4		51	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	2	4	11	26	38	48	42	59		TCRBV10-01,TCRBV10-02												CASSRRQDD*PNTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTTCCTGACTAGCGGGATTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSS*LAGFSSYNEQFF	Stop	VDJ	1	56	5.915034750829161E-4		54	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	3	0	4	5	26	38	53	42	58		TCRBV10-01,TCRBV10-02												CASSS*LAGFSSYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGACGCTCCAGGGATGACCAATCAGCCCCAGCATTTTGGTGAT	CASSYDAPGMTNQPQHF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	3	7	5	26	41	53	48	58		TCRBV06-07,TCRBV06-08												CASSYDAPGMTNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGACAGGACTCAATGAAAAACTGTTTTTTGGCAGT	CASSYSTGLNEKLFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	4	5	0	4	26	-1	49	43	53		TCRBV06-07,TCRBV06-08												CASSYSTGLNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGATTGTGGAAATCAACAACAATTCACCCCTCCACTTTGGGAAC	CASSYSIVEINNNSPLHF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	54	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	0	1	8	7	6	10	23	40	49	46	59		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSIVEINNNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCGGGCTGACGCAGGGGGTGAGAGACATTCAGTACTTCGGCGCC	CASGLTQGVRDIQYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	4	1	8	9	6	23	32	48	41	54		TCRBV06-04,TCRBV06-08												CASGLTQGVRDIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGGGAGGTCTACGAGCAGTACTTCGGGCCG	CASSYGEVYEQYF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	1	3	1	1	23	38	45	39	46		TCRBV06-04,TCRBV06-08												CASSYGEVYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCAGTCAGGAGCCTTCTTGAAGCTTTCTTTGGACAA	CASSYSVRSLLEAFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	0	4	4	7	3	8	23	40	47	43	55		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSVRSLLEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGGACTCSGCCRTGTATCKCTGTGCCAGCAGCTTAAACAGGGGACCCTCTCAGCCCCAGCATTTTGGTGAT	CASSLNRGPSQPQHF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	6	1	6	18	33	41	34	47		TCRBV07-06,TCRBV07-08												CASSLNRGPSQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCTGTGTACTTSTGTGCCAGCAGTTCCCCCTACCAGGGACAGGGGGTAGGATATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSPYQGQGVGYGANVLTF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	63	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	1	3	10	7	10	23	44	33	51		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSSPYQGQGVGYGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGTAGCCCCCGAGCGGGGTTGGGTGAAAAACTGTTTTTTGGCAGT	CASSPRAGLGEKLFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	9	6	3	7	9	5	28	36	52	45	57		TCRBV06-04,TCRBV06-07												CASSPRAGLGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCCCCGGATCTTTTTTGGAGCAGTACTTCGGGCCG	CASSPGSFLEQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	6	1	8	7	4	9	23	34	41	38	50		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGSFLEQYF+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTACACAGGGGGTTTGGGTCAGCCCCAGCATTTTGGTGAT	CASSYTGGLGQPQHF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	1	6	0	6	23	-1	46	38	52		TCRBV06-08,TCRBV06-09												CASSYTGGLGQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAAGGGCCGGGTCAGGGGATGACAGGGAGCTGTTTTTTGGAGAA	CASSLRAGSGDDRELFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	9	10	6	19	34	50	44	56		TCRBV07-05,TCRBV07-07												CASSLRAGSGDDRELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTACGCCTCAGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	2.9575173754145805E-4		40	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	4	6	7	0	23	36	-1	43	47		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTTTGGGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSFGGTNTEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	1	3	2	28	40	49	43	51		TCRBV06-04,TCRBV06-08												CASSFGGTNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCRGCCCTGTATCTCTGCGCCAGCAGCCAAGAAGGACTGGACGGGAGAGGTTGGGCTTTCTTTGGACAA	CASSQEGLDGRGWAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	48	TCRBV04	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	2	11	9	7	23	40	55	49	62		TCRBV04-01,TCRBV04-03												CASSQEGLDGRGWAFF+TCRBV04-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACAGGGGAAGTTTGGATTCACCCCTCCACTTTGGGAAC	CASSYRGSLDSPLHF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	5	2	8	0	8	23	-1	43	38	51		TCRBV06-07,TCRBV06-08												CASSYRGSLDSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCCCGGGACCCCCCGGGGACTAAAGCTTTCTTTGGACAA	CASSPRDPPGTKAFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	9	9	15	0	26	38	-1	53	60		TCRBV06-07,TCRBV06-08				01,02								CASSPRDPPGTKAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGGACTCSGCCRTGTATCKCTGTGCCAGCAGCTGGCGCACAGGGGCTGACACTGAAGCTTTCTTTGGACAA	CASSWRTGADTEAFF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	3	5	3	18	31	43	36	46		TCRBV07-06,TCRBV07-08												CASSWRTGADTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCCGGGACAGGGAGTAACCACCTACGAGCAGTACTTCGGGCCG	CASSPGQGVTTYEQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	2	3	8	28	39	51	42	59		TCRBV06-04,TCRBV06-08												CASSPGQGVTTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGGACAGGGCACTGAAGCTTTCTTTGGACAA	CASSLGQGTEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	4	2	0	22	35	-1	37	45		TCRBV07-01,TCRBV07-04												CASSLGQGTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGTTTTACCCCGTGGGTGGACACTGAAGCTTTCTTTGGACAA	CASSFTPWVDTEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	4	0	9	3	9	3	26	39	51	48	54		TCRBV06-07,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTPWVDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACAAGACTAGCGGTCTCAATGAGCAGTTCTTCGGGCCA	CASSYKTSGLNEQFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	5	6	2	3	23	38	49	40	52		TCRBV06-04,TCRBV06-08				01,02								CASSYKTSGLNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGGAGGGATTGGTCAACTCGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	19	2.006886790459894E-4		43	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	9	11	0	4	0	12	28	-1	41	36	53		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCATCAGCCTACCCCGGGTAGCGGGAGCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	2.006886790459894E-4		50	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	2	4	11	2	23	34	54	45	56		TCRBV10-02,TCRBV10-03												X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGGGACAGTTATGTACAATGAGCAGTTCTTCGGGCCA	CASGTVMYNEQFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	5	4	0	5	23	-1	39	32	44		TCRBV06-07,TCRBV06-08												CASGTVMYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGCTTCAGTCTCCGGGGACTGAAGCTTTCTTTGGACAA	CASSYSLQSPGTEAFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	5	11	0	23	40	-1	51	56		TCRBV06-04,TCRBV06-08												CASSYSLQSPGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCCTGCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSPAAGELFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	36	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	6	10	0	6	4	2	23	34	40	38	42		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAAGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACCGACCCGGGGGACAGGTAGGCACGAGCAGTACTTCGGGCCG	CASRPTRGTGRHEQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	5	10	5	23	34	52	44	57		TCRBV06-07,TCRBV06-08												CASRPTRGTGRHEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAGGTCGCCAGCCTCTATGCTAGGCTACACCTTCGGTTCG		Out	VDJ	1	18	1.9012611699093733E-4		47	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	1	4	5	8	5	11	18	34	42	39	53		TCRBV07-02,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTCGGAGGAAGCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	1.9012611699093733E-4		43	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	1	1	1	4	18	31	37	32	41		TCRBV07-06,TCRBV07-07												X+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCGCGGGGGGCGGTAACGGTCGTAGAGCAGTTCTTCGGGCCA	CASSEARGAVTVVEQFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	1	10	0	14	23	-1	48	40	62		TCRBV06-01,TCRBV06-07												CASSEARGAVTVVEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTTCGGACTAGCGACGGACCATCGACCCAGTACTTCGGGCCA	CASSYLRTSDGPSTQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	6	7	4	10	26	41	54	45	64		TCRBV06-07,TCRBV06-08				01,02								CASSYLRTSDGPSTQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCCGGGACAGGGGGCAACGTCCTGACTTTCGGGGCC	CASSSGTGGNVLTF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	1	9	2	0	26	39	-1	41	52		TCRBV06-07,TCRBV06-08												CASSSGTGGNVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGGACCAGGGGAGGTCGATGGCTACACCTTCGGTTCG	CASRGPGEVDGYTF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	6	4	2	6	5	6	26	37	48	42	54		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGPGEVDGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCCCGGGGGGCGCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPPGGAGNQPQHF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	48	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	1	2	4	5	22	34	45	38	50														CASSPPGGAGNQPQHF+TCRBV07-01+TCRBJ01-05	TCRBV07-01*01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGCCCGGGACTAGCTATCCCGCGAAGAGATACGAGCAGTACTTCGGGCCG	CASRPGTSYPAKRYEQYF	In	VDJ	4	203	0.0021442000971755707	0.002691558054122857	54	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	4	4	15	23	34	47	38	62						01,02							Vb 12	CASRPGTSYPAKRYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACGACGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSDDGMNTEAFF	In	VDJ	3	156	0.0016477596805881236	0.0020683894406067277	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	3	2	7	0	1	4	23	37	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDDGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAACGGACTAGCGGGATTCCAAGAGACCCAGTACTTCGGGCCA	CASSNGLAGFQETQYF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	3	1	3	2	23	35	50	38	52													Vb 12	CASSNGLAGFQETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCCCACTAGGAATAGTCGACACCGGGGAGCTGTTTTTTGGAGAA	CASTPLGIVDTGELFF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	3	8	3	4	9	23	33	42	37	51						01,02							Vb 12	CASTPLGIVDTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCGGGGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSRGQGEKLFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	7	3	0	23	34	-1	37	46													Vb 12	CASSRGQGEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTCCGAGGTCCTCGGCACTGAAGCTTTCTTTGGACAA	CASSSEVLGTEAFF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	4	3	7	23	35	42	38	49													Vb 12	CASSSEVLGTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACAGACTCACCTAGTGGAAATGAAAAACTGTTTTTTGGCAGT	CASTDSPSGNEKLFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	2	10	5	2	11	23	33	39	35	50						01,02							Vb 12	CASTDSPSGNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATGGGGACTAGCGGGCTCACCGGGGAGCTGTTTTTTGGAGAA	CASMGTSGLTGELFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	0	4	4	2	2	23	33	47	35	49						01,02							Vb 12	CASMGTSGLTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGCGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASRGGTSTDTQYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	0	4	0	23	34	-1	38	44						01,02							Vb 12	CASRGGTSTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTCTCGGACACTGAAGCTTTCTTTGGACAA	CASSEFSDTEAFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	3	3	0	23	39	-1	42	45						01,02							Vb 12	CASSEFSDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGAGGACAGGGGCAGGGAATCAGCCCCAGCATTTTGGTGAT	CASRRTGAGNQPQHF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	4	2	5	23	34	45	36	50													Vb 12	CASRRTGAGNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGAGGGTGAAGAGCAGTACTTCGGGCCG	CASSEEGEEQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	0	7	0	4	23	-1	43	38	47													Vb 12	CASSEEGEEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCACAGGGAAATCCTGATCAGCCCCAGCATTTTGGTGAT	CASSESQGNPDQPQHF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	3	5	0	8	23	-1	46	40	54													Vb 12	CASSESQGNPDQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAAGGGAGAGGCGGGTGAGCAGTACTTCGGGCCG	CASSEKGEAGEQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	7	4	7	9	1	23	38	52	47	53						01,02							Vb 12	CASSEKGEAGEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAATCTGTCTTTGGGTCAGATCTCTGAAGCTTTCTTTGGACAA	CAISESNLSLGQISEAFF	In	VDJ	3	139	0.0014681961256522381	0.0018429880272072764	54	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	0	0	9	6	12	8	23	40	55	52	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESNLSLGQISEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAACGACTCGCCAAGCTACGAGCAGTACTTCGGGCCG	CAISESNDSPSYEQYF	In	VDJ	2	97	0.0010245685193400512	0.0012861139470439268	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	10	3	4	7	23	40	48	44	55						01,02							Vb 12	CAISESNDSPSYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGACGTCGGGACCGGGGAGCTGTTTTTTGGAGAA	CAISDVGTGELFF	In	VDJ	1	62	6.548788474132286E-4	8.220522135744686E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	4	5	3	0	24	38	-1	41	45						01,02							Vb 12	CAISDVGTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGTAACAGGGGCGCCCAGTACTTCGGGCCG	CAISEGNRGAQYF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	10	4	4	23	38	49	42	53													Vb 12	CAISEGNRGAQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCCGGGGAAACGCACAGATACGCAGTATTTTGGCCCA	CAISESPGKRTDTQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	1	2	4	23	40	47	42	51													Vb 12	CAISESPGKRTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCGGGACAGGGGCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	4.2250248220208295E-4		47	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	3	2	2	23	40	52	42	54													Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCACAAGACTATGGCTACACCTTCGGTTCG	CAISESQDYGYTF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	6	3	0	2	23	-1	43	40	45													Vb 12	CAISESQDYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGCAGGGATCTTGGCTACACCTTCGGTTCG	CAISESGRDLGYTF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	7	3	4	23	40	48	43	52													Vb 12	CAISESGRDLGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGTATTCAGGTTTGGATGAGCAGTTCTTCGGGCCA	CASSEYSGLDEQFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	4	8	3	5	24	40	47	43	52													Vb 12	CASSEYSGLDEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGTGCACCCGTAGAACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	2.2181380315609354E-4		49	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	8	5	9	3	23	40	52	49	55						01,02							Vb 12	X+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD02-01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGATCCCTTCTGGCCGCGAGCAGTACTTCGGGCCG	CAISESIPSGREQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	6	10	2	23	40	53	50	55													Vb 12	CAISESIPSGREQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTCACAAAACTCCCGCTGAAGCTTTCTTTGGACAA	CASSIVHKTPAEAFF	In	VDJ	6	356	0.003760272091598538	0.004720170774717917	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	3	6	6	3	9	27	43	49	46	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVHKTPAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCCGACAGGGACGACTACGAGCAGTACTTCGGGCCG	CASRADRDDYEQYF	In	VDJ	5	261	0.002756828696368591	0.003460574641015102	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	3	4	4	27	38	49	42	53			01,02										Vb 17	CASRADRDDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGACGGACTTAAACACTGAAGCTTTCTTTGGACAA	CASSKGTDLNTEAFF	In	VDJ	4	244	0.002577265141432706	0.0032351732276156508	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	0	7	2	2	7	27	40	47	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKGTDLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGACGGGGGGAGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	192	0.002028011914569998		37	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	9	8	1	2	1	3	27	35	43	36	46			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCTATCTCTGTGCCAGTAGTCCCCTCTCCGGGACTCCTCCCAGCAGCCTCGGCACAGATACGCAGTATTTTGGCCCA	CASSPLSGTPPSSLGTDTQYF	In	VDJ	3	190	0.002006886790459894	0.0025191922674056297	63	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	1	9	16	8	20	35	29	51			01,02			01,02							Vb 17	CASSPLSGTPPSSLGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTACACTGAACACTGAAGCTTTCTTTGGACAA	CASSLTLNTEAFF	In	VDJ	3	187	0.0019751991042947377	0.0024794155473939618	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	6	0	3	1	27	39	45	42	46			01,02										Vb 17	CASSLTLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCCCTCGTGGGAGAAGCTTTCTTTGGACAA	CASSMALVGEAFF	In	VDJ	3	175	0.0018484483596341128	0.0023203086673472904	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	8	9	0	27	41	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMALVGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCTTGGACAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPLGQSGANVLTF	In	VDJ	3	146	0.0015421340600376026	0.0019358003739011682	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	5	1	6	0	27	39	-1	45	51			01,02										Vb 17	CASSPLGQSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCGTTCCGGTGCTATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	145	0.0015315714979825506		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	9	1	12	0	27	41	-1	53	56			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACTAGTTTTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	140	0.0014787586877072904		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	8	6	1	4	27	40	47	41	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDRGYSNQPQHF	In	VDJ	2	131	0.0013836956292118216	0.0017369167738428288	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	2	0	1	3	27	38	47	39	50			01,02										Vb 17	CASSDRGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTGCCTGGACACATGAGCAGTTCTTCGGGCCA	CASSIFAWTHEQFF	In	VDJ	2	121	0.001278070008661301	0.0016043277071372695	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	6	8	8	1	27	41	54	49	55			01,02										Vb 17	CASSIFAWTHEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGGAAACGGAGTCAAAATGAAAAACTGTTTTTTGGCAGT	CASSIEGKRSQNEKLFF	In	VDJ	2	121	0.001278070008661301	0.0016043277071372695	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	0	0	8	5	1	11	27	44	49	45	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGKRSQNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGTTAGCGGGGGCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGLAGASSYNEQFF	In	VDJ	2	118	0.0012463823224961447	0.0015645509871256016	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	0	4	4	27	39	52	43	56			01,02										Vb 17	CASSGLAGASSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTTAGGACAGGGCTACGCCTACGAGCAGTACTTCGGGCCG	CASTLGQGYAYEQYF	In	VDJ	2	104	0.0010985064537254157	0.0013789262937378183	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	2	5	5	27	37	50	42	55			01,02										Vb 17	CASTLGQGYAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCCAGGGACAGCTGAACACTGAAGCTTTCTTTGGACAA	CASRPQGQLNTEAFF	In	VDJ	2	102	0.0010773813296153115	0.0013524084803967064	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	6	1	27	38	51	44	52			01,02										Vb 17	CASRPQGQLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGCGGGGAGGGGTTACGAGCAGTACTTCGGGCCG	CASTAGRGYEQYF	In	VDJ	2	92	9.717557090647908E-4	0.0012198194136911471	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	9	0	4	5	2	27	37	49	42	51			01,02										Vb 17	CASTAGRGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGVNTEAFF	In	VDJ	2	91	9.611931470097386E-4	0.001206560507020591	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	2	0	0	0	27	-1	-1	43	46			01,02										Vb 17	CASSLGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCGGAGCACTGATACGCAGTATTTTGGCCCA	CASSGRSTDTQYF	In	VDJ	2	91	9.611931470097386E-4	0.001206560507020591	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	2	6	4	4	27	39	47	43	51			01,02										Vb 17	CASSGRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGATCGGGAATGAGCAGTTCTTCGGGCCA	CASSLGIGNEQFF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	3	7	2	5	27	39	46	41	51			01,02										Vb 17	CASSLGIGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGTAGCGGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSGGGNQPQHF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	7	2	2	0	2	27	-1	47	40	49			01,02										Vb 17	CASSSGGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGGGGAGTTTAATGTGGATACGCAGTATTTTGGCCCA	CASSWGEFNVDTQYF	In	VDJ	2	86	9.083803367344783E-4	0.0011402659736678114	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	1	6	1	11	27	39	46	40	57			01,02										Vb 17	CASSWGEFNVDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAAGACAATAACTATGGCTACACCTTCGGTTCG	CASQDNNYGYTF	In	VDJ	2	84	8.872552126243742E-4	0.0011137481603266995	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	6	1	3	1	27	36	43	39	44			01,02										Vb 17	CASQDNNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSIAGGTDTQYF	In	VDJ	1	82	8.6613008851427E-4	0.0010872303469855876	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	2	1	0	0	27	-1	-1	43	49			01,02										Vb 17	CASSIAGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGCGAGGGTTGGCCCGGGGAGAGACCCAGTACTTCGGGCCA	CASSSRGLARGETQYF	In	VDJ	1	80	8.450049644041659E-4	0.0010607125336444757	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	3	4	15	0	27	39	-1	54	59			01,02			01,02							Vb 17	CASSSRGLARGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTTCTGAAGCTTTCTTTGGACAA	CASSIVSEAFF	In	VJ	1	78	8.238798402940618E-4	0.0010341947203033638	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	0	0	6	0	3	27	-1	43	-1	46			01,02										Vb 17	CASSIVSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCAGCCTCTCCGGGGGCGAGCAGTACTTCGGGCCG	CASSGSLSGGEQYF	In	VDJ	1	76	8.027547161839575E-4	0.001007676906962252	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	6	11	0	27	39	-1	50	56			01,02										Vb 17	CASSGSLSGGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGTCGGGATCGGCGAGCAGTACTTCGGGCCG	CASSVGIGEQYF	In	VDJ	1	76	8.027547161839575E-4	0.001007676906962252	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	3	6	3	4	27	38	46	41	50			01,02										Vb 17	CASSVGIGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTCGGGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSIVRGGADTQYF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	0	4	2	2	27	43	53	45	55			01,02										Vb 17	CASSIVRGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAACAGGGGTTATGGCAATCAGCCCCAGCATTTTGGTGAT	CASSINRGYGNQPQHF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	2	1	5	27	42	50	43	55			01,02										Vb 17	CASSINRGYGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGAGTATATCAGGGGGCGACCACTAAAGCTTTCTTTGGACAA	CASSIRVYQGATTKAFF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	9	9	8	27	42	59	51	67			01,02										Vb 17	CASSIRVYQGATTKAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCGGACAGGAGGTAACACTGAAGCTTTCTTTGGACAA	CASSPRTGGNTEAFF	In	VDJ	1	72	7.605044679637493E-4	9.546412802800281E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	2	4	4	27	39	50	43	54			01,02										Vb 17	CASSPRTGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGGGACAACCAAGAGACCCAGTACTTCGGGCCA	CASSSRDNQETQYF	In	VDJ	1	70	7.393793438536452E-4	9.281234669389162E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	0	4	0	27	39	-1	43	49			01,02										Vb 17	CASSSRDNQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGACAGGGGTATACCCCTACGAGCAGTACTTCGGGCCG	CASSIETGVYPYEQYF	In	VDJ	1	69	7.288167817985931E-4	9.148645602683603E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	2	0	6	27	-1	52	44	58			01,02										Vb 17	CASSIETGVYPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGACTAGCGTCTAAAGAGACCCAGTACTTCGGGCCA	CASSLGLASKETQYF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	6	3	2	4	27	39	51	41	55			01,02			01,02							Vb 17	CASSLGLASKETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGATCTAGCTACGAGCAGTACTTCGGGCCG	CASSIRSSYEQYF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	8	3	4	0	27	42	-1	46	50			01,02			01,02							Vb 17	CASSIRSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCGACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASRATGGSYEQYF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	0	3	0	27	38	-1	41	50			01,02										Vb 17	CASRATGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTCCGGGACACCTTAAAATATAATTCACCCCTCCACTTTGGGAAC	CASSMFRDTLKYNSPLHF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	6	4	5	8	27	41	52	46	60			01,02										Vb 17	CASSMFRDTLKYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGACGCGGGACAGTGGGAAACACCATATATTTTGGAGAG	CASSIRRGTVGNTIYF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	4	7	2	27	41	55	48	57			01,02										Vb 17	CASSIRRGTVGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTAGCGGCCGGTCGGGAAACACCATATATTTTGGAGAG	CASISGRSGNTIYF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	5	5	4	1	7	27	37	44	38	51			01,02			01,02							Vb 17	CASISGRSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGGGGGACAGGCCATGGCTACACCTTCGGTTCG	CASSIGGGTGHGYTF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	4	6	5	2	27	43	56	48	58			01,02										Vb 17	CASSIGGGTGHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGGGACCCTCCCAAATGAGCAGTTCTTCGGGCCA	CASSIAGTLPNEQFF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	0	7	7	2	7	27	43	50	45	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAGTLPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGCCGGGACGGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSMGPGRSNEKLFF	In	VDJ	1	63	6.654414094682806E-4	8.353111202450246E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	0	7	3	6	3	27	41	52	47	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGPGRSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACAGGGGGAACGGCTACACCTTCGGTTCG	CASSNRGNGYTF	In	VDJ	1	63	6.654414094682806E-4	8.353111202450246E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	1	8	0	3	27	-1	48	40	51			01,02										Vb 17	CASSNRGNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGTAGGACAAGCCATACAATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	62	6.548788474132286E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	1	4	10	27	39	48	43	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTAAAGTTGGGGGATTTGGCTATGGCTACACCTTCGGTTCG	CASSPKVGGFGYGYTF	In	VDJ	1	61	6.443162853581765E-4	8.087933069039127E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	6	1	4	9	6	27	39	53	48	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPKVGGFGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCGAACCGGTGGGGCTATGGCTACACCTTCGGTTCG	CASSMANRWGYGYTF	In	VDJ	1	61	6.443162853581765E-4	8.087933069039127E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	6	2	4	11	0	27	41	-1	52	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMANRWGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACAGGGTATCGACCGGGGAGCTGTTTTTTGGAGAA	CASRDRVSTGELFF	In	VDJ	1	61	6.443162853581765E-4	8.087933069039127E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	5	0	5	27	-1	46	38	51			01,02										Vb 17	CASRDRVSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSIVANQPQHF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	9	0	3	1	0	27	43	-1	44	47			01,02										Vb 17	CASSIVANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCGGTCAGGCATAGAGCAGTATTTCGGGCCG	CASSFRSGIEQYF	In	VDJ	1	56	5.915034750829161E-4	7.424987735511329E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	4	16	7	13	27	39	50	46	63			01,02										Vb 17	CASSFRSGIEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTTCGGGGGCAGGTGGGAATGAGCAGTTCTTCGGGCCA	CASISGAGGNEQFF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	6	0	7	4	7	27	37	47	41	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASISGAGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCCGGGACAGGGCGTTTTGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	54	5.70378350972812E-4		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	4	4	7	27	43	56	47	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGATTCTTGTGGGATCAGGAAACACTGAAGCTTTCTTTGGACAA	CASSPRILVGSGNTEAFF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	0	8	2	14	6	27	39	57	53	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRILVGSGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAATAGTCAGGACAGGGGGCACTACGAGCAGTACTTCGGGCCG	CANSQDRGHYEQYF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	3	2	1	27	39	52	41	53			01,02										Vb 17	CANSQDRGHYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAGGGGCGGGCTGGCGAGCAGTACTTCGGGCCG	CASQGRAGEQYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	2	6	0	8	27	-1	42	36	50			01,02										Vb 17	CASQGRAGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTAGGAACAATGAGCAGTTCTTCGGGCCA	CASSIGRNNEQFF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	1	8	5	5	0	27	41	-1	46	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGRNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGATCCATGGCTACACCTTCGGTTCG	CASSIGIHGYTF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	1	8	6	0	3	27	-1	46	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGIHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCGACAGCCTACCGCATGAAGCTTTCTTTGGACAA	CASSPDSLPHEAFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	7	4	9	27	38	47	42	56			01,02										Vb 17	CASSPDSLPHEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGCAGAACACCTTCGGTTCG	CASSIGQQNTF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	12	1	4	27	41	48	42	52			01,02										Vb 17	CASSIGQQNTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGACAGGGGCATCAGCCCCAGCATTTTGGTGAT	CASSIGGQGHQPQHF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	2	5	2	1	27	43	54	45	55			01,02										Vb 17	CASSIGGQGHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATACGCAGGGGGCGCGAGGACTGAAGCTTTCTTTGGACAA	CASSIYAGGARTEAFF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	5	4	6	27	42	54	46	60			01,02										Vb 17	CASSIYAGGARTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGTTTGACCAGGGACTACACCTTCGGTTCG	CASGLTRDYTF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	3	10	8	1	27	36	49	44	50			01,02										Vb 17	CASGLTRDYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSGGTGGYEQYF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	3	3	0	27	39	-1	42	53			01,02										Vb 17	CASSGGTGGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTGGGACAGGGTACGAGCAGTACTTTGGGCCG	CASSPGTGYEQYF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	19	3	15	27	39	51	42	66			01,02										Vb 17	CASSPGTGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGNTEAFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	1	1	0	27	39	-1	40	44			01,02										Vb 17	CASSPGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTACACCCACCGACAGGCGGCGTGGCTACACCTTCGGTTCG	CATTPTDRRRGYTF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	4	7	11	5	27	34	51	45	56			01,02										Vb 17	CATTPTDRRRGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTAAGAGGGCCCGGAGGTGAAAAACTGTTTTTTGGCAGT	CASLRGPGGEKLFF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	10	1	7	12	0	27	36	-1	48	53			01,02										Vb 17	CASLRGPGGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGTTGGCGCGGGGGGGCAGTTCTTCGGGCCA	CASSIVGAGGQFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	1	12	7	0	27	41	-1	48	56			01,02										Vb 17	CASSIVGAGGQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGCGGGACTAGCGGGAGGAACTCCTACGAGCAGTACTTCGGGCCG	CASGGTSGRNSYEQYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	0	1	0	3	2	27	36	54	39	56			01,02										Vb 17	CASGGTSGRNSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGACGGATGGGGCCTCTGGAAACACCATATATTTTGGAGAG	CASSMWTDGASGNTIYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	7	0	0	10	0	27	41	-1	51	56			01,02										Vb 17	CASSMWTDGASGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACTCCGACGGACCGCTCTGGCCCCATGGCTACACCTTCGGTTCG	CASSYSDGPLWPHGYTF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	1	7	6	9	12	27	39	52	48	64			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYSDGPLWPHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGAGACGCGGGGTCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIGRRGVSNQPQHF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	3	1	8	2	27	41	55	49	57			01,02			01,02							Vb 17	CASSIGRRGVSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGGACAGGGTAAACTATGGCTACACCTTCGGTTCG	CASSRDRVNYGYTF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	2	2	2	27	38	49	40	51			01,02										Vb 17	CASSRDRVNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGATTACAGGGACGGAGTCAGCCCCAGCATTTTGGTGAT	CASRLQGRSQPQHF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	6	3	6	27	38	47	41	53			01,02										Vb 17	CASRLQGRSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGGCTTACGAGATTTTTGAACACTGAAGCTTTCTTTGGACAA	CASTRLTRFLNTEAFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	9	0	0	3	12	27	37	43	40	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTRLTRFLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCTTGGGACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSILGTSGQETQYF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	5	1	4	0	27	41	-1	45	56			01,02			01,02							Vb 17	CASSILGTSGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCGAGCGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSMASGSYNEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	1	4	1	27	41	50	45	51			01,02			01,02							Vb 17	CASSMASGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGTTGAAGCCGGAGGACCCTACGAGCAGTACTTCGGGCCG	CASSLVEAGGPYEQYF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	2	12	2	27	39	56	51	58			01,02										Vb 17	CASSLVEAGGPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCGGGCCAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSISGQNTGELFF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	8	0	2	3	3	27	41	48	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISGQNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGAACTCAGCCCCAGCATTTTGGTGAT	CASSIGGTQPQHF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	0	8	6	1	2	27	43	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGTQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGCTTTCTATCTCTGTGCCAGTAGTCGATCCGGGGCTACTAGCGGGACGAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSRSGATSGTRGQETQYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	60	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	3	2	12	8	14	26	48	38	56			01,02										Vb 17	CASSRSGATSGTRGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGTCCAGGATGGGGAGCAGTACTTCGGGCCG	CASSIVQDGEQYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	7	4	5	27	41	49	45	54			01,02										Vb 17	CASSIVQDGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGACAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIDDSSGANVLTF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	2	5	0	1	0	27	44	-1	45	50			01,02										Vb 17	CASSIDDSSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTCCTTTGACAGGGTCGGTGGCTATGGCTACACCTTCGGTTCG	CASSPSFDRVGGYGYTF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	4	9	7	27	39	55	48	62			01,02										Vb 17	CASSPSFDRVGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAATCTATGGCTACACCTTCGGTTCG	CASSIGIYGYTF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	2	8	4	0	2	27	-1	45	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGIYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTTTCAGGGGGACTGAAGCTTTCTTTGGACAA	CASSIGFRGTEAFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	5	6	0	27	41	-1	47	54			01,02										Vb 17	CASSIGFRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGGACTAATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.3237636521114563E-4		37	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	9	4	2	2	27	39	47	41	49			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCGGGACAGGGGCTTACGAGCAGTACTTCGGGCCG	CASSIAGTGAYEQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	4	2	2	27	43	55	45	57			01,02										Vb 17	CASSIAGTGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACTAGCGGATACTTCCAAGAGACCCAGTACTTCGGGCCA	CASSRTSGYFQETQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	5	1	0	6	27	-1	50	40	56			01,02			01,02							Vb 17	CASSRTSGYFQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCATGGGACTAGCGGGAGTCCTAAACAATGAGCAGTTCTTCGGGCCA	CASMGLAGVLNNEQFF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	0	2	5	3	6	27	35	52	38	58			01,02										Vb 17	CASMGLAGVLNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACTACCGGACGGATGAACACTGAAGCTTTCTTTGGACAA	CASTTGRMNTEAFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	9	1	7	0	7	3	27	35	46	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTTGRMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAATGGAAAACCGGGGAGCTGTTTTTTGGAGAA	CASSIEWKTGELFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	0	1	8	5	2	2	27	44	49	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEWKTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCGGGGAGGTGGCTGAAGCTTTCTTTGGACAA	CASSIVGEVAEAFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	1	6	3	3	27	43	52	46	55			01,02										Vb 17	CASSIVGEVAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGATATAAGGGGGCGGCACTGAAGCTTTCTTTGGACAA	CARI*GGGTEAFF	Stop	VDJ	1	18	1.9012611699093733E-4		39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	5	0	4	6	2	27	35	48	41	50			01,02										Vb 17	CARI*GGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGCCCGGGAATGAGCAGTTCTTCGGGCCA	CASSMGPGNEQFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	7	0	7	0	5	27	-1	46	41	51			01,02										Vb 17	CASSMGPGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCAAAGACAGGTCTACAGTTTACAATCAGCCCCAGCATTTTGGTGAT	CASSTKDRSTVYNQPQHF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	4	3	5	11	27	40	51	45	62			01,02										Vb 17	CASSTKDRSTVYNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCAGACAGTGGGGCAGGGGGGCGAGCAGTACTTCGGGCCG	CASSQTVGQGGEQYF	In	VDJ	4	211	0.0022287005936159877	0.0027976293074873045	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	6	12	1	23	35	54	47	55													Vb 11	CASSQTVGQGGEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTGTATTTCAGACTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	65	6.865665335783848E-4		50	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	13	5	23	35	52	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGAACGGGACTAGCGGGTTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGTGLAGYSYNEQFF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	4	0	4	3	23	36	52	40	55						01,02							Vb 11	CASSGTGLAGYSYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAATAGCGGGAGGGGTAGAAGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	53	5.598157889177599E-4		50	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	0	8	1	9	23	38	50	39	59													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTGGGGCACGGCGGATACAATGAGCAGTTCTTCGGGCCA	CASSVGHGGYNEQFF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	7	0	4	1	8	23	36	42	37	50													Vb 11	CASSVGHGGYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCCATTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPIDTGELFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	6	3	2	3	23	35	39	37	42													Vb 11	CASSPIDTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGAGTGGAGGGAGGTACTATGGCTACACCTTCGGTTCG	CASRSGGRYYGYTF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	3	7	1	23	34	47	41	48													Vb 11	CASRSGGRYYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGCGACTAGCGGGAAGGGGGACAATGAGCAGTTCTTCGGGCCA	CASSEATSGKGDNEQFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	2	3	5	3	6	23	37	51	40	57													Vb 11	CASSEATSGKGDNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCGATCCGGGACAGGGGCGTCTAATGAGCAGTTCTTCGGGCCA	CASRSGTGASNEQFF	In	VDJ	2	106	0.0011196315778355197	0.0014054441070789302	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	7	6	5	23	32	48	38	53													Vb 22	CASRSGTGASNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACCGGCAAGGGCCGACTACGAGCAGTACTTCGGGCCG	CASSEPARADYEQYF	In	VDJ	1	60	6.337537233031245E-4	7.955344002333567E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	2	5	3	3	6	4	23	38	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEPARADYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACTAGCGGGGCCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	54	5.70378350972812E-4		46	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	2	0	2	23	-1	46	37	48													Vb 22	X+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGTGGAATTGGCTAACTATGGCTACACCTTCGGTTCG	CASRVELANYGYTF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	6	1	8	0	3	5	23	34	40	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRVELANYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTAGGACCGGGACAGGGGGAGATACGCAGTATTTTGGCCCA	CASSRTGTGGDTQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	1	5	6	0	23	35	-1	41	52													Vb 22	CASSRTGTGGDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTGGCGGGGGTTAGCACAGATACGCAGTATTTTGGCCCA	CASSVAGVSTDTQYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	2	0	2	2	23	36	45	38	47													Vb 22	CASSVAGVSTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACTCGGGCAGGGGGCCTCCACAGATACGCAGTATTTTGGCCCA	CASSELGQGASTDTQYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	0	2	6	3	23	38	52	44	55													Vb 22	CASSELGQGASTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCTCCCTGGGGGTAATCCTGGGTGGCTACACCTTCGGTTCG	CASSLGVILGGYTF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	8	6	1	7	5	10	23	32	42	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSLGVILGGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTACCCCGGGACAGGGATCCGGGACCCAGTACTTCGGGCCA	CASTPGQGSGTQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	0	3	7	6	6	23	31	46	37	52													Vb 22	CASTPGQGSGTQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAATCGGGACAGGGGCATTGGCTACACCTTCGGTTCG	CASNRDRGIGYTF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	7	3	3	23	33	46	36	49													Vb 22	CASNRDRGIGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCCTACAGGGGGCCCACCTCTGGAAACACCATATATTTTGGAGAG	CASSSYRGPTSGNTIYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	0	0	4	4	23	35	48	39	52													Vb 22	CASSSYRGPTSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCATCGGTCAGGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	2.1125124110104148E-4		44	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	2	9	0	23	34	-1	43	49													Vb 22	X+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACTCTTCCAGGGTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTLPGSGTGELFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	3	4	6	5	23	33	44	39	49													Vb 22	CASTLPGSGTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAATCCGACAACTAACTATGGCTACACCTTCGGTTCG	CASSENPTTNYGYTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	6	0	5	1	23	38	47	43	48													Vb 22	CASSENPTTNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGTGAGTTTGACCTACAATGAGCAGTTCTTCGGGCCA	CASSEVSLTYNEQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	2	2	1	5	23	39	43	40	48													Vb 22	CASSEVSLTYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAACTCCTGCCTCCTACGAGCAGTACTTCGGGCCG	CASSETPASYEQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	10	0	0	5	23	-1	41	38	46						01,02							Vb 22	CASSETPASYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCCGCTTAGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSRLGANEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	6	6	1	28	39	50	45	51			01,02											CASSRLGANEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCCCTAAACTAGCGGGACTTCTCGAGCAGTACTTCGGGCCG	CASSPKLAGLLEQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	3	6	6	5	28	39	55	45	60			01,02											CASSPKLAGLLEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACAAGGGGGACAGGGGGCTTTAGTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.5843843082578111E-4		52	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	0	5	4	6	28	43	59	47	65			01,02											X+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACACTAGCGGGGGTATCTACGAGCAGTACTTCGGGCCG	CASSYTSGGIYEQYF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	3	0	3	26	-1	52	41	55														CASSYTSGGIYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGTTCGGGACAGGGGAATTCTCTGGAAACACCATATATTTTGGAGAG	CASRFGTGEFSGNTIYF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	2	0	4	4	26	37	51	41	55														CASRFGTGEFSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACAAGCGGGGAAGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	4.753152924773433E-4		44	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	3	5	1	4	26	41	49	42	53														X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCTGGGGGTTCGGACCGGGGAGCTGTTTTTTGGAGAA	CASLGVRTGELFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	39	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-02	01	8	6	1	5	2	5	26	35	42	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLGVRTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCCCTCTTTTGGGTGAAGCTTTCTTTGGACAA	CASTPLLGEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	36	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	7	0	9	7	10	0	26	36	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPLLGEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAGTCCGCAGGACAGCCTCCGGTTCTTCGGGCCA		Out	VDJ	1	24	2.5350148932124975E-4		40	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	15	7	6	26	40	53	47	59														X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCCCGGCCGGGGGCTCTTGACACTGAAGCTTTCTTTGGACAA	CASSPRPGALDTEAFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	48	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	5	6	0	3	8	5	26	38	52	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRPGALDTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATTATCCAGGGGAGCGCGCTTTCTTTGGACAA		Out	VDJ	1	17	1.7956355493588524E-4		35	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	2	11	5	5	26	36	47	41	52														X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAAGGACTAGCGGTTTAGTTGAGCAGTTCTTCGGGCCA	CASSERTSGLVEQFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	9	4	6	26	38	52	42	58						01,02								CASSERTSGLVEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTATGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSYGQGTDTQYF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	4	1	2	0	19	32	-1	34	41														CASSYGQGTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCGATACGGACAGATTTGAACACTGAAGCTTTCTTTGGACAA	CASSSIRTDLNTEAFF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	0	6	3	19	32	44	38	47														CASSSIRTDLNTEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGTCACACCCCCACGGGGGCTGAAGCTTTCTTTGGACAA	CASSHTPTGAEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	6	11	0	19	30	-1	41	47														CASSHTPTGAEAFF+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGGACCCCTACAGGGTGTATCGGGTGGCTACACCTTCGGTTCG	CASSLGPLQGVSGGYTF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	51	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	7	9	9	19	33	48	42	57														CASSLGPLQGVSGGYTF+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGACGGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSQSTVMNTEAFF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	45	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-01	01	0	2	7	0	0	5	29	-1	49	46	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSTVMNTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCACCACCTCTGGTGTGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	2.2181380315609354E-4		43	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-01	01	3	0	10	6	8	5	29	43	53	51	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV16-01+TCRBJ01-01	TCRBV16-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGGCATCTAGAAGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	63	6.654414094682806E-4		53	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	4	8	5	4	14	25	36	44	40	58						01,02								X+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01	TCRBD02-01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAACAAAGGGCCAAAAACATTCAGTACTTCGGCGCC	CSA*QRAKNIQYF	Stop	VDJ	26	1450	0.015315714979825507		39	TCRBV20						TCRBJ02	TCRBJ02-04	01	5	3	6	1	2	4	26	35	40	37	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSA*QRAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCCGGACAGGGAGCAGTTCTTCGGGCCA		Out	VDJ	26	1448	0.015294589855715402		35	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	4	10	4	0	26	38	-1	42	49		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGACCGGGACTCCCAGGCTCGGCTACACCTTCGGTTCG	CASSPTGTPRLGYTF	In	VDJ	24	1322	0.013963707036778841	0.017528274618474962	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	0	10	8	5	9	23	36	47	41	56	TCRBV01,TCRBV04					01,02								CASSPTGTPRLGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAGTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSQDSSGSYEQYF	In	VDJ	18	992	0.010478061558611657	0.013152835417191498	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	2	3	3	0	23	40	-1	43	52	TCRBV01,TCRBV04													CASSQDSSGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTCCACCCGGCGGGGGGGCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	15	859	0.00907324080528973		53	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	4	10	2	26	43	62	53	64		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCACCGACCCGGGGGGGACAGGGGATGCCGGGGAGCTGTTTTTTGGAGAA	CASTDPGGTGDAGELFF	In	VDJ	15	831	0.008777489067748273	0.011018151443231991	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	2	6	11	3	18	28	49	39	52	TCRBV07,TCRBV11													CASTDPGGTGDAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATACGGGACTGCGTCGTACCAAGAGACCCAGTACTTCGGGCCA	CSAREYGTASYQETQYF	In	VDJ	14	790	0.008344424023491137	0.010474536269739198	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	0	4	7	26	40	50	44	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREYGTASYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGTCCGAGGCTAGCGGCCCCTCGGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	12	654	0.006907915584004056		58	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	5	6	11	9	23	37	55	48	64		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTAGGGGTGAGGTCGAAAAACTGTTTTTTGGCAGT	CASSLGRGEVEKLFF	In	VDJ	8	458	0.004837653421213849	0.006072579255114623	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	2	8	4	7	26	40	49	44	56		TCRBV12-03,TCRBV12-04												CASSLGRGEVEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATACAGGGGTGAAAAACTGTTTTTTGGCAGT	CASSLYRGEKLFF	In	VDJ	8	438	0.004626402180112808	0.005807401121703504	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	2	7	1	0	26	41	-1	42	49		TCRBV12-03,TCRBV12-04												CASSLYRGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCATAGTCGCAATGAGCAGTTCTTCGGGCCA	CASSHSRNEQFF	In	VDJ	8	433	0.004573589369837548	0.005741106588350724	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	5	8	6	3	3	24	35	41	38	44		TCRBV24-01,TCRBV24-or09_02				01,02								CASSHSRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGCTGGGGAAAAGAACACTGAAGCTTTCTTTGGACAA	CASSQDAGEKNTEAFF	In	VDJ	7	399	0.004214462259965778	0.005290303761551822	48	unresolved						TCRBJ01	TCRBJ01-01	01	0	0	8	1	5	3	23	40	49	45	52	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDAGEKNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTAATCCGGGACAGGGGTTTGCCACTGAAGCTTTCTTTGGACAA	CASSNPGQGFATEAFF	In	VDJ	7	396	0.004182774573800621	0.005250527041540155	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	4	5	5	23	35	50	40	55	TCRBV02,TCRBV09													CASSNPGQGFATEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTGGGACAGGGCACCCTACGAGCAGTACTTCGGGCCG	CASWDRAPYEQYF	In	VDJ	6	317	0.0033483321714515074	0.0042030734145662345	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	3	2	1	3	23	32	42	33	45	TCRBV06,TCRBV10													CASWDRAPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGCGGGGGCCCAGGACACTGAAGCTTTCTTTGGACAA	CASSAGAQDTEAFF	In	VDJ	5	265	0.0027990789445887995	0.0035136102676973256	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	2	3	1	6	23	34	42	35	48	TCRBV09,TCRBV12													CASSAGAQDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCCCCCGACAGGGAGTGGTGAAGCTTTCTTTGGACAA		Out	VDJ	4	247	0.002608952827597862		43				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	7	5	5	18	31	43	36	48	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCGCAGGGAGGTTGAGACCCAGTACTTCGGGCCA	CASSQERREVETQYF	In	VDJ	4	241	0.0025455774552675496	0.003195396507603983	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	1	5	5	2	26	43	54	48	56		TCRBV03-01,TCRBV03-02												CASSQERREVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGTCGGAGAGTCACACTGAAGCTTTCTTTGGACAA	CSARESESHTEAFF	In	VDJ	4	227	0.0023977015864968206	0.0030097718142161997	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	3	0	10	26	-1	41	37	51		TCRBV20-01,TCRBV20-or09_02												CSARESESHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGCACCCCAGGGGGCGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	225	0.0023765764623867166		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	3	6	3	23	37	51	43	54	TCRBV01,TCRBV04,TCRBV07,TCRBV17													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGGTCAGGGAGCGGACAACTACGAGCAGTACTTCGGGCCG	CSARGGQGADNYEQYF	In	VDJ	4	211	0.0022287005936159877	0.0027976293074873045	48	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	1	6	3	13	1	26	39	57	52	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGQGADNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCGGGGTGAACTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	202	0.002133637535120519		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	8	3	1	1	7	24	33	39	34	46		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCTACAGGGAAGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQPTGKGSNQPQHF	In	VDJ	3	193	0.0020385744766250502	0.0025589689874172977	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	1	3	6	26	41	50	44	56		TCRBV03-01,TCRBV03-02												CASSQPTGKGSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGTCTCCGGAAGTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQVSGSGANVLTF	In	VDJ	3	189	0.0019963242284048418	0.002505933360735074	48	unresolved						TCRBJ02	TCRBJ02-06	01	1	1	8	3	5	2	22	38	46	43	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQVSGSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGACGAGGGATACACTGAAGCTTTCTTTGGACAA	CASSQDEGYTEAFF	In	VDJ	3	167	0.0017639478631936963	0.0022142374139828428	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	3	3	2	20	35	43	38	45	TCRBV04,TCRBV23													CASSQDEGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGACAGGTATGGCAATCAGCCCCAGCATTTTGGTGAT	CSAEDRYGNQPQHF	In	VDJ	3	165	0.001742822739083592	0.002187719600641731	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	2	3	4	26	35	44	38	48		TCRBV20-01,TCRBV20-or09_02												CSAEDRYGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGCCTATGGCTACACCTTCGGTTCG	CASSQGQAYGYTF	In	VDJ	3	161	0.0017005724908633838	0.0021346839739595073	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	4	4	0	1	26	-1	48	42	49		TCRBV03-01,TCRBV03-02												CASSQGQAYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGGGACCCTTCACAGATACGCAGTATTTTGGCCCA	CASSSGPFTDTQYF	In	VDJ	3	159	0.0016794473667532796	0.0021081661606183956	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	0	7	2	2	4	26	38	45	40	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPFTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGAGGGGACTAGCGGGAGATAGTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPEGTSGR*SYNEQFF	Stop	VDJ	3	153	0.0016160719944229673		54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	1	7	4	26	34	55	41	59		TCRBV20-01,TCRBV20-or09_02												CSAPEGTSGR*SYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGAGGAGTTTGGAGCTTTCTTTGGACAA	CATSDLEEFGAFF	In	VDJ	3	149	0.0015738217462027589	0.001975577093912836	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	10	2	5	24	42	48	44	53		TCRBV24-01,TCRBV24-or09_02												CATSDLEEFGAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTGGATGGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDWMENTGELFF	In	VDJ	3	147	0.0015526966220926548	0.001949059280571724	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	1	8	2	2	5	26	43	48	45	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWMENTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCAGGGGGGCTGGAACGGGCACCATATATTTTGGAGAG		Out	VDJ	3	144	0.0015210089359274986		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	1	9	0	11	24	-1	49	42	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGACCAGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSLGPGASYEQYF	In	VDJ	3	141	0.0014893212497623424	0.0018695058405483883	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	2	0	3	1	18	34	43	37	44	TCRBV07,TCRBV11													CASSLGPGASYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGGGGGCGGGAAAGGAAGAGACCCAGTACTTCGGGCCA	CASSLGGAGKEETQYF	In	VDJ	3	141	0.0014893212497623424	0.0018695058405483883	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	9	0	3	2	10	24	36	45	38	55		TCRBV24-01,TCRBV24-or09_02												CASSLGGAGKEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACCTCGGACCCGCTAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	141	0.0014893212497623424		44	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	1	7	2	7	8	26	34	45	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGAGACAGAGTACGAGCAGTACTTCGGGCCG	CSAQETEYEQYF	In	VDJ	3	140	0.0014787586877072904	0.0018562469338778325	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	4	5	2	26	35	45	40	47		TCRBV20-01,TCRBV20-or09_02												CSAQETEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCCGGGACAGGGAGTAGATGGCTACACCTTCGGTTCG	CASSSPGQGVDGYTF	In	VDJ	3	139	0.0014681961256522381	0.0018429880272072764	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	6	5	5	24	36	50	41	55		TCRBV24-01,TCRBV24-or09_02												CASSSPGQGVDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGACCCCTGGAGTAGAACTGAAGCTTTCTTTGGACAA	CASSRDPWSRTEAFF	In	VDJ	2	138	0.0014576335635971861	0.0018297291205367206	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	5	5	4	26	43	52	48	56		TCRBV03-01,TCRBV03-02												CASSRDPWSRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCTATTGGGGCGGGATTTATACGCAGTATTTTGGCCCA	CSARDSYWGGIYTQYF	In	VDJ	2	132	0.0013942581912668736	0.0017501756805133849	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	3	7	11	3	26	40	57	51	60		TCRBV20-01,TCRBV20-or09_02												CSARDSYWGGIYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATGCCCCGGGACAGACTAATGAAAAACTGTTTTTTGGCAGT	CSADAPGQTNEKLFF	In	VDJ	2	130	0.0013731330671567696	0.001723657867172273	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	2	8	0	26	35	-1	43	50		TCRBV20-01,TCRBV20-or09_02												CSADAPGQTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGCACAGGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	127	0.0013414453809916134		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	4	0	4	2	26	43	52	47	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCCTCCCGGACAGGGGGCAAGTGAAGCTTTCTTTGGACAA	CASSPPGQGASEAFF	In	VDJ	2	124	0.0013097576948264572	0.0016441044271489373	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	0	7	7	3	23	34	52	41	55	TCRBV09,TCRBV12													CASSPPGQGASEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATCGGACAGGGCCTCCAATGAGCAGTTCTTCGGGCCA	CSARESDRASNEQFF	In	VDJ	2	124	0.0013097576948264572	0.0016441044271489373	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	6	3	4	26	40	51	43	55		TCRBV20-01,TCRBV20-or09_02												CSARESDRASNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCCCTCGGTGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPSVGSSYNSPLHF	In	VDJ	2	123	0.001299195132771405	0.0016308455204783814	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	9	2	0	10	0	23	34	-1	44	49	TCRBV02,TCRBV09													CASSPSVGSSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCCACCGACAGGGCCACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	122	0.001288632570716353		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	3	2	5	3	22	34	46	39	49	TCRBV07,TCRBV11													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACATATGGAGACCAACTAATGAAAAACTGTTTTTTGGCAGT	CSARDIWRPTNEKLFF	In	VDJ	2	121	0.001278070008661301	0.0016043277071372695	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	6	0	0	9	26	-1	42	37	51		TCRBV20-01,TCRBV20-or09_02												CSARDIWRPTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCTCATTGTTTGTTGCGCGCATTCGAAGCTTTCTTTGGACAA		Out	VDJ	2	116	0.0012252571983860404		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	6	8	12	7	26	38	53	50	60	TCRBV03,TCRBV09					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGGCGAGAGGCGGGACACACTGAAGCTTTCTTTGGACAA	CASRREAGHTEAFF	In	VDJ	2	112	0.0011830069501658322	0.0014849975471022659	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	7	3	3	7	1	18	29	42	36	43	TCRBV05,TCRBV11													CASRREAGHTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGTGGGGACAGCGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSRGDSGSGANVLTF	In	VDJ	2	111	0.0011724443881107802	0.00147173864043171	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	0	4	3	22	34	45	38	48	TCRBV04,TCRBV07,TCRBV17													XASSRGDSGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCTGGGGAGGGGATCTAACTATGGCTACACCTTCGGTTCG	CASSLGRGSNYGYTF	In	VDJ	2	109	0.001151319264000676	0.0014452208270905981	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	0	2	3	23	36	45	38	48	TCRBV01,TCRBV23													CASSLGRGSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATACTTCAGGAATTTCCACAGATACGCAGTATTTTGGCCCA	CASSQDTSGISTDTQYF	In	VDJ	2	109	0.001151319264000676	0.0014452208270905981	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	2	5	6	23	40	49	45	55	TCRBV01,TCRBV04													CASSQDTSGISTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCACTCTAGCGGGGTCCCAGCGAGAGACCCAGTACTTCGGGCCA	CASTLAGSQRETQYF	In	VDJ	2	109	0.001151319264000676	0.0014452208270905981	45	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	0	6	2	4	0	8	26	-1	47	43	55	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASTLAGSQRETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGATGAAACAGGGGACGCAGAAGCTTTCTTTGGACAA	CASSDETGDAEAFF	In	VDJ	2	106	0.0011196315778355197	0.0014054441070789302	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	8	7	5	22	33	47	40	52	TCRBV09,TCRBV12													CASSDETGDAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCTCGGGGGGCGGGGAGCTGTTTTTTGGAGAA	CSARPSGGGELFF	In	VDJ	2	105	0.0011090690157804677	0.0013921852004083744	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	1	7	4	0	26	38	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARPSGGGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCAGGATTAAACACTGAAGCTTTCTTTGGACAA	CASSLAGLNTEAFF	In	VDJ	2	105	0.0011090690157804677	0.0013921852004083744	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	0	1	8	2	1	3	26	43	47	44	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGACTAGCTATAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	104	0.0010985064537254157		40	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	7	3	0	5	26	-1	43	38	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATCGGTTCGGTGGGGGACTGAAGCTTTCTTTGGACAA	CASSESVRWGTEAFF	In	VDJ	2	102	0.0010773813296153115	0.0013524084803967064	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	6	1	5	13	0	22	34	-1	47	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESVRWGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCTCACCAGGGGGACTAACTATGGCTACACCTTCGGTTCG	CASSLTRGTNYGYTF	In	VDJ	2	101	0.0010668187675602595	0.0013391495737261506	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	1	0	6	1	20	31	44	37	45	TCRBV04,TCRBV23													CASSLTRGTNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCGGGGCCAGACACAGATACGCAGTATTTTGGCCCA	CSAREAGPDTDTQYF	In	VDJ	2	100	0.0010562562055052072	0.0013258906670555945	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	2	1	5	26	40	47	41	52		TCRBV20-01,TCRBV20-or09_02												CSAREAGPDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGCGTTAGGGGGCGGCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	98	0.0010351310813951032		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	0	4	5	5	24	35	47	40	52	TCRBV06,TCRBV10													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSGGSSYEQYF	In	VDJ	2	97	0.0010245685193400512	0.0012861139470439268	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	2	0	0	0	24	-1	-1	37	44		TCRBV24-01,TCRBV24-or09_02												CASSGGSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCTCCCGGGGGGGGACGGAAAACTACGAGCAGTACTTCGGGCCG	CASSRGGTENYEQYF	In	VDJ	2	96	0.001014005957284999	0.001272855040373371	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	8	0	3	3	9	23	32	43	35	52	TCRBV02,TCRBV12													CASSRGGTENYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTCCGGGGACCTAATGAAAAACTGTTTTTTGGCAGT	CASSLVRGPNEKLFF	In	VDJ	2	96	0.001014005957284999	0.001272855040373371	45	unresolved						TCRBJ01	TCRBJ01-04	01	1	0	7	3	4	0	18	34	-1	38	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRGPNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGGGGGGGACATCCACCCGCTGAACACTGAAGCTTTCTTTGGACAA	CASSGGDIHPLNTEAFF	In	VDJ	2	95	0.001003443395229947	0.0012595961337028149	51	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	6	8	0	0	0	12	22	-1	41	33	53	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASSGGDIHPLNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCACATGTGTTAGACGAGCAGTACTTCGGGCCG	CASSHPHVLDEQYF	In	VDJ	2	94	9.92880833174895E-4	0.001246337227032259	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	3	6	5	3	8	26	40	46	43	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPHVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACTAGCGAATACAATGAGCAGTTCTTCGGGCCA	CSARDTSEYNEQFF	In	VDJ	2	93	9.823182711198428E-4	0.001233078320361703	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	6	4	1	2	26	40	48	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDTSEYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRGYTGELFF	In	VDJ	2	92	9.717557090647908E-4	0.0012198194136911471	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	1	3	1	1	26	39	47	40	48		TCRBV03-01,TCRBV03-02												CASSPRGYTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCTGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSARGLGQGNTEAFF	In	VDJ	2	91	9.611931470097386E-4	0.001206560507020591	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	3	1	4	0	26	39	-1	43	52		TCRBV20-01,TCRBV20-or09_02												CSARGLGQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCAGACCCGGACCTGGGGAGACCCAGTACTTCGGGCCA	CASSPRPGPGETQYF	In	VDJ	2	90	9.506305849546866E-4	0.0011933016003500352	45	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	1	7	5	9	5	24	36	49	45	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRPGPGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCACTCAAGAAATGAGCAGTTCTTCGGGCCA	CASSHSRNEQFF	In	VDJ	2	89	9.400680228996345E-4	0.0011800426936794792	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	3	10	7	2	5	24	35	40	37	45	TCRBV24,TCRBV27					01,02								CASSHSRNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTAGGGGACTAGCGGGGTATACGCAGTATTTTGGCCCA	CASSRGLAGYTQYF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	7	2	1	22	34	49	36	50	TCRBV02,TCRBV12													CASSRGLAGYTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAGGGGGCTCCGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	88	9.295054608445825E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	0	7	2	5	26	35	45	37	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACACCTTTAATGAAAAACTGTTTTTTGGCAGT	CSARDTFNEKLFF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	3	7	4	1	3	26	40	43	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTFNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCTACCGGGACAGCCTGACAATGAGCAGTTCTTCGGGCCA	CASSSLPGQPDNEQFF	In	VDJ	2	87	9.189428987895304E-4	0.0011535248803383673	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	5	7	4	18	31	45	38	49	TCRBV07,TCRBV11													CASSSLPGQPDNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCCGGGACGGCGAACACTGAAGCTTTCTTTGGACAA	CASSAGTANTEAFF	In	VDJ	2	85	8.978177746794263E-4	0.0011270070669972554	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	0	7	1	2	3	24	37	44	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGTANTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGTTGGGGCGGGAGGGGGAGATACGCAGTATTTTGGCCCA	CSARVVGAGGGDTQYF	In	VDJ	2	85	8.978177746794263E-4	0.0011270070669972554	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	0	5	8	2	26	39	56	47	58		TCRBV20-01,TCRBV20-or09_02												CSARVVGAGGGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTCCTATCCGGGGCAGGGGGCGATTCTAACTATGGCTACACCTTCGGTTCG	CSALLSGAGGDSNYGYTF	In	VDJ	2	85	8.978177746794263E-4	0.0011270070669972554	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	0	14	4	26	34	56	48	60		TCRBV20-01,TCRBV20-or09_02												CSALLSGAGGDSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGTCGGGGGGCGAGAGTTCACCCCTCCACTTTGGGAAC	CSARASGGESSPLHF	In	VDJ	1	83	8.766926505693221E-4	0.0011004892536561435	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	1	8	1	9	3	6	26	39	49	42	55		TCRBV20-01,TCRBV20-or09_02												CSARASGGESSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTACAGGGTGGTGTGTTCACTGAAGCTTTCTTTGGACAA	CSARDLQGGVFTEAFF	In	VDJ	1	83	8.766926505693221E-4	0.0011004892536561435	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	4	3	9	26	40	49	43	58		TCRBV20-01,TCRBV20-or09_02												CSARDLQGGVFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCTTAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLGQETQYF	In	VDJ	1	82	8.6613008851427E-4	0.0010872303469855876	36	unresolved						TCRBJ02	TCRBJ02-05	01	5	5	3	2	2	0	26	38	-1	40	44	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCCATCGGGGTGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	82	8.6613008851427E-4		43	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	8	3	5	5	2	26	40	50	45	52		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTAGGGACTGATGGGATTACACCGGGGAGCTGTTTTTTGGAGAA	CATRD*WDYTGELFF	Stop	VDJ	1	81	8.555675264592179E-4		45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	10	3	2	9	24	32	40	34	49		TCRBV24-01,TCRBV24-or09_02				01,02								CATRD*WDYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATAAGGTCGGCGGCTATGAGCAGTTCTTCGGGCCA	CSAYKVGGYEQFF	In	VDJ	1	81	8.555675264592179E-4	0.0010739714403150316	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	8	10	2	26	35	49	45	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYKVGGYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCCGCGGGAGCTTTTAATGAGCAGTTCTTCGGGCCA	CASSLAAGAFNEQFF	In	VDJ	1	80	8.450049644041659E-4	0.0010607125336444757	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	7	1	5	18	35	43	36	48	TCRBV07,TCRBV11													CASSLAAGAFNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAAACTGACTGGAAACACCATATATTTTGGAGAG	CASKLTGNTIYF	In	VDJ	1	79	8.344424023491138E-4	0.0010474536269739197	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	3	10	2	1	2	23	33	37	34	39	TCRBV02,TCRBV09					01,02								CASKLTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGCGGGGACAGTTTACCCCCAGAGGCTTTCTTTGGACAA		Out	VDJ	1	78	8.238798402940618E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	11	3	13	24	36	46	39	59	TCRBV12,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTGGGACAGGTCACCGGGGAGCTGTTTTTTGGAGAA	CSASLGQVTGELFF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	4	4	3	1	26	37	48	40	49		TCRBV20-01,TCRBV20-or09_02												CSASLGQVTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGGGGACCGACGGTATTTTATGGCTACACCTTCGGTTCG	CASRGPTVFYGYTF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	7	5	0	11	24	-1	40	35	51	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGPTVFYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTAGCCGGGACGGGGACAGGGGGGAGCAGTACTTCGGGCCG	CSSRDGDRGEQYF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	1	7	10	0	26	32	-1	42	53		TCRBV20-01,TCRBV20-or09_02												CSSRDGDRGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACGTACAGTTAACACTGAAGCTTTCTTTGGACAA	CASRRTVNTEAFF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	2	4	2	26	37	45	41	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRTVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGACTCGGGACATCCTGGAAACACCATATATTTTGGAGAG	CASSQDSGHPGNTIYF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	6	2	5	2	20	35	46	40	48	TCRBV04,TCRBV23													CASSQDSGHPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGACTAGCGGGAGTGGTCCCTTTAGGCAGTTCTTCGGGCCA	CASSPGTSGSGPFRQFF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	12	3	12	24	36	53	39	65		TCRBV24-01,TCRBV24-or09_02												CASSPGTSGSGPFRQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCAGGGGGCGGAGAGCACAGATACGCAGTATTTTGGCCCA	CSAIQGAESTDTQYF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	0	2	4	26	36	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSAIQGAESTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGGAGGACGGCCGGGGAGCTGTTTTTTGGAGAA	CSARAGRTAGELFF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	9	1	6	2	4	26	39	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSARAGRTAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGGTCGGGAGGGCCAGATGAGCAGTTCTTCGGGCCA	CASGSGGPDEQFF	In	VDJ	1	74	7.816295920738534E-4	9.8115909362114E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	8	0	8	4	4	26	35	47	39	51		TCRBV03-01,TCRBV03-02												CASGSGGPDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCAGACGGGTTTGTTTGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	73	7.710670300188013E-4		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	9	8	4	6	4	9	24	33	41	37	50		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCGGGGGGGTTAATGAATGAGCAGTTCTTCGGGCCA	CSARDAGGLMNEQFF	In	VDJ	1	73	7.710670300188013E-4	9.679001869505841E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	7	1	6	26	40	50	41	56		TCRBV20-01,TCRBV20-or09_02												CSARDAGGLMNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCTAGCGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGLAGSYNEQFF	In	VDJ	1	73	7.710670300188013E-4	9.679001869505841E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	3	1	2	0	26	42	-1	44	53		TCRBV03-01,TCRBV03-02												CASSQGLAGSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTCCCGTACTAGCGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSSRTSGSYNEQFF	In	VDJ	1	71	7.499419059086972E-4	9.413823736094722E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	3	7	0	18	29	-1	36	47	TCRBV07,TCRBV11													CASSSRTSGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCACCACCCACCGGGCCGGGGGAAACACCATATATTTTGGAGAG	CASSTTHRAGGNTIYF	In	VDJ	1	71	7.499419059086972E-4	9.413823736094722E-4	48	TCRBV24						TCRBJ01	TCRBJ01-03	01	7	8	0	4	11	4	24	35	50	46	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTTHRAGGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGTAAGGGGGCAAGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	71	7.499419059086972E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	5	5	5	26	43	55	48	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQMYTGELFF	In	VJ	1	71	7.499419059086972E-4	9.413823736094722E-4	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	2	0	0	3	0	4	26	-1	41	-1	45		TCRBV03-01,TCRBV03-02												CASSQMYTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACGGGGACTAGCGGGGGGCTTAGCACAGATACGCAGTATTTTGGCCCA	CSATGTGTSGGLSTDTQYF	In	VDJ	1	70	7.393793438536452E-4	9.281234669389162E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	0	8	3	24	34	57	42	60		TCRBV20-01,TCRBV20-or09_02												CSATGTGTSGGLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGTGGCTACGAGCAGTACTTCGGGCCG	CASSFGGYEQYF	In	VDJ	1	70	7.393793438536452E-4	9.281234669389162E-4	36	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	0	10	3	1	3	26	40	43	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCAGAGCCGGGACGGCCCTTTACGAGCAGTACTTCGGGCCG	CASSRAGTALYEQYF	In	VDJ	1	69	7.288167817985931E-4	9.148645602683603E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	7	4	6	7	18	30	41	36	48	TCRBV03,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAGTALYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCTACCGGGACTAGCGGGAGCGCTGAGCAGTTCTTCGGGCCA	CSASATGTSGSAEQFF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	2	9	7	3	26	37	58	44	61		TCRBV20-01,TCRBV20-or09_02												CSASATGTSGSAEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTCGTCCTATGGCTACACCTTCGGTTCG	CASSQVSSYGYTF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	6	4	3	2	26	42	47	45	49		TCRBV03-01,TCRBV03-02				01,02								CASSQVSSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGCCCCAGGGCTAGCGGGATACTACAATGAGCAGTTCTTCGGGCCA	CASSEAPGLAGYYNEQFF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	3	3	13	2	24	35	57	48	59	TCRBV09,TCRBV21													CASSEAPGLAGYYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTCCTACACTGCGGGCTACGAGCAGTACTTCGGGCCG	CASSSYTAGYEQYF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	4	3	8	0	18	31	-1	39	44	TCRBV05,TCRBV07					01,02								CASSSYTAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACTAGCGGGAAGCACAGATACGCAGTATTTTGGCCCA	CSAGLAGSTDTQYF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	3	0	1	0	26	34	-1	35	47		TCRBV20-01,TCRBV20-or09_02												CSAGLAGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGATCTAGCGGGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	66	6.971290956334368E-4		49	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	8	4	2	1	4	1	24	34	48	38	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTACAGCACAGATACGCAGTATTTTGGCCCA	CSARYSTDTQYF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	3	7	0	2	0	26	37	-1	39	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARYSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGCTAGCGGGGCCAGGCAACTACGAGCAGTACTTCGGGCCG	CASSQDGLAGPGNYEQYF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	4	8	26	43	56	47	64		TCRBV03-01,TCRBV03-02												CASSQDGLAGPGNYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTCGCGGGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	66	6.971290956334368E-4		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	5	8	4	0	26	43	-1	47	51		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCGGCGGGACAGGTTAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	65	6.865665335783848E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	3	3	3	18	30	41	33	44	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGACAGGGACTAATCAGCCCCAGCATTTTGGTGAT	CASSQGTGTNQPQHF	In	VDJ	1	65	6.865665335783848E-4	8.618289335861365E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	4	1	3	26	40	50	41	53		TCRBV03-01,TCRBV03-02												CASSQGTGTNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGACAGGCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	65	6.865665335783848E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	4	3	1	2	26	43	51	44	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GCTGTGCCAGCAGCTAAACACAAACTTCACAAAGCCACTCAGTCCTACAAGCCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	64	6.760039715233327E-4		70	TCRBV07						TCRBJ02	TCRBJ02-03	01	4	3	6	3	2	34	-1	11	16	13	50		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-03	TCRBV07		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCTATGAACACTGAAGCTTTCTTTGGACAA	CSASMNTEAFF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	9	0	2	0	26	34	-1	36	39		TCRBV20-01,TCRBV20-or09_02				01,02								CSASMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCAGGACAGGCGAGGGTATGGCTACACCTTCGGTTCG	CSATQDRRGYGYTF	In	VDJ	1	63	6.654414094682806E-4	8.353111202450246E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	5	4	6	26	36	47	40	53		TCRBV20-01,TCRBV20-or09_02												CSATQDRRGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAAGAGGGGCGAGCAGTACTTCGGGCCG	CASSFKRGEQYF	In	VDJ	1	63	6.654414094682806E-4	8.353111202450246E-4	36	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	5	2	6	4	0	26	40	-1	44	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFKRGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAATGGAGGGGGCGACGCAGATACGCAGTATTTTGGCCCA	CSANGGGDADTQYF	In	VDJ	1	62	6.548788474132286E-4	8.220522135744686E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	4	6	4	26	34	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSANGGGDADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCTCAGGGGTTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	62	6.548788474132286E-4		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	2	0	5	2	26	37	48	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTTGGCTGATACGGGACAGTGAAATTCACCCCTCCACTTTGGGAAC	CATSDLADTGQ*NSPLHF	Stop	VDJ	1	61	6.443162853581765E-4		54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	7	8	3	24	42	57	50	60		TCRBV24-01,TCRBV24-or09_02												CATSDLADTGQ*NSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAAAGGGTGGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	61	6.443162853581765E-4		41	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	5	3	3	4	5	26	37	45	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTTTCCGGGAACCAGCTARACCCAGTACTTCGGGCCA	CASRFPGTS*TQYF	Stop	VDJ	1	61	6.443162853581765E-4		42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	3	6	5	7	26	37	47	42	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRFPGTS*TQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAACGGGGGAAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CSVTGEGGSYEQYF	In	VDJ	1	60	6.337537233031245E-4	7.955344002333567E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	7	5	1	0	10	0	26	33	-1	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVTGEGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGACAGGGATAAGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	60	6.337537233031245E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	6	0	6	26	-1	43	38	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTATACACGACCGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSVYTTGTGNYGYTF	In	VDJ	1	59	6.231911612480723E-4	7.822754935628008E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	2	9	0	23	38	-1	47	56	TCRBV09,TCRBV21													CASSVYTTGTGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGNTGELFF	In	VDJ	1	59	6.231911612480723E-4	7.822754935628008E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	5	1	2	0	24	36	-1	38	41		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGAAAGGGACCTTCTTGGAGAGCAGTACTTCGGGCCG	CSARDGERDLLGEQYF	In	VDJ	1	59	6.231911612480723E-4	7.822754935628008E-4	48	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	0	7	7	8	9	26	40	53	48	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGERDLLGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAAGTGGGTGAAAAACTGTTTTTTGGCAGT	CASSQVGEKLFF	In	VDJ	1	59	6.231911612480723E-4	7.822754935628008E-4	36	TCRBV03						TCRBJ01	TCRBJ01-04	01	1	0	9	7	1	0	26	42	-1	43	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACAGGACTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	59	6.231911612480723E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	4	0	0	2	26	-1	46	40	48		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGGGGACAGGCGGACAGATACGCAGTATTTTGGCCCA	CASSGDRRTDTQYF	In	VDJ	1	58	6.126285991930202E-4	7.690165868922448E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	4	3	2	3	24	35	45	37	48		TCRBV24-01,TCRBV24-or09_02												CASSGDRRTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCACGGAAGGGACAGGCTCACAAGAGACCCAGTACTTCGGGCCA	CASSPTEGTGSQETQYF	In	VDJ	1	58	6.126285991930202E-4	7.690165868922448E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	4	2	10	4	26	37	55	47	59		TCRBV03-01,TCRBV03-02												CASSPTEGTGSQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCTAGCGGAATCTACAATGAGCAGTTCTTCGGGCCA	CSSSGIYNEQFF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	1	8	3	1	2	26	37	41	38	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSSSGIYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGACAAAGGGGGGGACTATAATTCACCCCTCCACTTTGGGAAC	CSARDWDKGGDYNSPLHF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	9	0	3	10	1	26	40	57	50	58		TCRBV20-01,TCRBV20-or09_02												CSARDWDKGGDYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGACATTACTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	57	6.020660371379682E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	5	0	19	26	-1	42	38	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGGATTGGCACTGAAGCTTTCTTTGGACAA	CASSQGRIGTEAFF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	1	4	0	5	26	-1	47	42	52		TCRBV03-01,TCRBV03-02												CASSQGRIGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCATCTATCTTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	57	6.020660371379682E-4		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	9	5	5	9	26	38	46	43	55		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAACAGGGGGCTAGTATCACCGGGGAGCTGTTTTTTGGAGAA	CSAEQGASITGELFF	In	VDJ	1	56	5.915034750829161E-4	7.424987735511329E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	4	2	6	26	35	46	37	52		TCRBV20-01,TCRBV20-or09_02												CSAEQGASITGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAGGGGCTCCCATTAGAAAAAACATTCAGTACTTCGGCGCC	CASSSGAPIRKNIQYF	In	VDJ	1	56	5.915034750829161E-4	7.424987735511329E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	2	4	1	11	26	38	45	39	56		TCRBV03-01,TCRBV03-02												CASSSGAPIRKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGCCGGGACCGAACACTGAAGCTTTCTTTGGACAA	CASSRPGPNTEAFF	In	VDJ	1	56	5.915034750829161E-4	7.424987735511329E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	0	7	1	4	1	26	39	48	43	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPGPNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAGCAGGGGGAGGTCACCCCTCCACTTTGGGAAC	CASSFSRGRSPLHF	In	VDJ	1	56	5.915034750829161E-4	7.424987735511329E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	1	10	3	3	26	40	50	43	53		TCRBV12-03,TCRBV12-04												CASSFSRGRSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGTGACTTGGAATCGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	55	5.809409130278641E-4		41	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	10	3	9	26	39	46	42	55		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGCTAGCGGGAGTAATCCATGAGCAGTTCTTCGGGCCA	CASSQGLAGVIHEQFF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	8	4	6	26	40	54	44	60		TCRBV03-01,TCRBV03-02												CASSQGLAGVIHEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCGCCGGGACAGGGGGCAAACTCTTAGAACACTGAAGCTTTCTTTGGACAA	CSANPPGQGANS*NTEAFF	Stop	VDJ	1	54	5.70378350972812E-4		57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	1	7	9	24	34	53	41	62		TCRBV20-01,TCRBV20-or09_02												CSANPPGQGANS*NTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCCGAGACTAGCGGGAGGTCACAGATACGCAGTATTTTGGCCCA	CASSLRD*REVTDTQYF	Stop	VDJ	1	54	5.70378350972812E-4		51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	1	2	6	1	24	36	55	42	56		TCRBV24-01,TCRBV24-or09_02												CASSLRD*REVTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGACAAGGCCCCTGAAGCTTTCTTTGGACAA	CASSQADKAPEAFF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	6	1	6	26	42	48	43	54		TCRBV03-01,TCRBV03-02												CASSQADKAPEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGGAAATGAGCAGTTCTTCGGGCCA	CASSQDRGNEQFF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	7	1	1	26	43	49	44	50		TCRBV03-01,TCRBV03-02												CASSQDRGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAGGACTAGCGGGAGAGTTTGGGAGCAGTTCTTTGGGCCA	CASSQERTSGRVWEQFF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02			0	1	2	22	2	19	26	43	58	45	77		TCRBV03-01,TCRBV03-02						TCRBJ02-01,TCRBJ02-05						CASSQERTSGRVWEQFF+TCRBV03-X+TCRBJ02-X	TCRBV03	TCRBD02-01*02	TCRBJ02	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGTTGGAGCGGGGTTGACAATGAGCAGTTCTTCGGGCCA	CSAPSWSGVDNEQFF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	5	9	3	26	35	51	44	54		TCRBV20-01,TCRBV20-or09_02												CSAPSWSGVDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAACAGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARNRASYNEQFF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	3	0	1	1	26	38	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSARNRASYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCGGAGCAGACTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGADYSNQPQHF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	2	9	0	9	0	24	36	-1	45	50	TCRBV09,TCRBV21					01,02								CASSPGADYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTAGCGGAGCAGCTGGGAAACAAGAGACCCAGTACTTCGGGCCA	CSAASGAAGKQETQYF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	5	2	1	13	26	35	43	36	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAASGAAGKQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGGATAGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSPG*GRTEAFF	Stop	VDJ	1	51	5.386906648076557E-4		42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	1	5	10	0	24	35	-1	45	51		TCRBV24-01,TCRBV24-or09_02												CASSPG*GRTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGCAAGGGCGGGGGGCCAATGAGCAGTTCTTCGGGCCA	CATQGRGANEQFF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	7	1	6	6	1	24	32	46	38	47		TCRBV24-01,TCRBV24-or09_02												CATQGRGANEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCCCCACAGGGGGGTATTTGCGGCTACACCTTCGGTTCG		Out	VDJ	1	50	5.281281027526036E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	1	8	7	8	24	38	53	45	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTTTGGACAGGGGGTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	5.281281027526036E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	1	4	5	2	23	40	55	45	57	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGACAGTGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSHGQ*SNQPQHF	Stop	VDJ	1	50	5.281281027526036E-4		45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	5	1	1	3	26	40	47	41	50		TCRBV03-01,TCRBV03-02												CASSHGQ*SNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCACCCCAGGGGACAGGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASTPGDRGGTDTQYF	In	VDJ	1	49	5.175655406975516E-4	6.496864268572413E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	13	0	2	3	13	4	25	28	51	41	55	TCRBV22,TCRBV24													CASTPGDRGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGCGGGTTGGAAACACCATATATTTTGGAGAG	CASSQARVGNTIYF	In	VDJ	1	49	5.175655406975516E-4	6.496864268572413E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	4	3	1	1	26	42	48	43	49		TCRBV03-01,TCRBV03-02				01,02								CASSQARVGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGAGGGAACAGGGGATAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	49	5.175655406975516E-4		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	2	7	4	26	43	57	50	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGGGGGGATCCCACTGAAGCTTTCTTTGGACAA	CASSLRGDPTEAFF	In	VDJ	1	49	5.175655406975516E-4	6.496864268572413E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	4	0	4	26	-1	48	41	52		TCRBV12-03,TCRBV12-04												CASSLRGDPTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCGGACTATATCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPDYIAYNEQFF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	9	2	2	5	18	30	38	32	43	TCRBV07,TCRBV11					01,02								CASSPDYIAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGCCCGGCGCGGGACGGTGAATTCACCCCTCCACTTTGGGAAC	CASSFARRGTVNSPLHF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	7	3	7	10	5	24	36	52	46	57		TCRBV24-01,TCRBV24-or09_02												CASSFARRGTVNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGTTTTAGGGCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSFSFRAGDTEAFF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	3	13	0	24	36	-1	49	55		TCRBV24-01,TCRBV24-or09_02												CASSFSFRAGDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCGGGAGGAGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CATSDFREEGGNQPQHF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	1	2	1	6	24	41	49	42	55		TCRBV24-01,TCRBV24-or09_02												CATSDFREEGGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*02	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGCAGCCCCGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	48	5.070029786424995E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	4	4	10	0	26	40	-1	50	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCCTACAGGGTAACACTGAAGCTTTCTTTGGACAA	CASLQGNTEAFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	2	2	1	23	32	40	34	41	TCRBV02,TCRBV09													CASLQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGACAGGGTCAGGAAACACCATATATTTTGGAGAG	CASSLATGSGNTIYF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	3	4	0	3	18	-1	42	35	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLATGSGNTIYF+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCCGCATTGGATTGGACAGGGCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	4.964404165874475E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	1	3	0	13	1	24	30	51	43	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTGGACCAGCCCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAAGPAPSYNEQFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	1	7	0	3	7	26	35	42	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAGPAPSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAAATACAGGGCAAAGGACTGAAAAACTGTTTTTTGGCAGT	CSAINTGQRTEKLFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	7	5	8	26	36	47	41	55		TCRBV20-01,TCRBV20-or09_02												CSAINTGQRTEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCGGGACACCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSATGTPATNEKLFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	6	0	4	4	26	34	44	38	48		TCRBV20-01,TCRBV20-or09_02												CSATGTPATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGGACAGGGAAGGTTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTGKVHTGELFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	3	1	7	26	37	47	38	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSGTGKVHTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCCGGGACCAAGGGGGAGCAGTACTTCGGGCCG	CSASAGTKGEQYF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	0	7	7	4	7	26	37	46	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASAGTKGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCTTAGGGTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.858778545323954E-4		49	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	5	3	5	4	15	26	38	46	42	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGTGCAGGGGCCAAACACTGAAGCTTTCTTTGGACAA	CASSLVQGPNTEAFF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	2	5	3	22	35	46	40	49	TCRBV07,TCRBV11													CASSLVQGPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGGGAGGCGCCTACGAGCAGTACTTCGGGCCG	CASSPGGGAYEQYF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	2	2	2	5	24	36	44	38	49		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGGGAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGGGGGGTTAACTATGGCTACACCTTCGGTTCG	CSARDRGVNYGYTF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	1	0	2	26	-1	47	40	49		TCRBV20-01,TCRBV20-or09_02												CSARDRGVNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGAGGGCGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLEGGAGELFF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	7	3	6	6	0	26	39	-1	45	51		TCRBV03-01,TCRBV03-02												CASSLEGGAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCACTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	44	4.6475273042229125E-4		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	3	10	3	0	0	23	-1	-1	40	43	TCRBV24,TCRBV27					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTCCGGGAGAATCAAATGAGCAGTTCTTCGGGCCA	CSAGPGESNEQFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	7	4	5	26	35	45	39	50		TCRBV20-01,TCRBV20-or09_02												CSAGPGESNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGCAGAGAATGAAAAACTGTTTTTTGGCAGT	CASSLGAENEKLFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	6	0	5	0	4	26	-1	46	40	50		TCRBV12-03,TCRBV12-04												CASSLGAENEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGCCGGAGGCTAGCGGGAGAGCCGAGGTCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	4.5419016836723914E-4		53				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	2	6	8	10	18	30	48	38	58	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGGGGACAGGACCAGGAGATACGCAGTATTTTGGCCCA	CSAQGTGPGDTQYF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	5	3	6	26	35	46	38	52		TCRBV20-01,TCRBV20-or09_02												CSAQGTGPGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCAAGGAGGACGGACTAACTATGGCTACACCTTCGGTTCG	CASSQGGRTNYGYTF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	4	10	1	0	3	5	19	31	39	34	44	TCRBV01,TCRBV05			TCRBD01,TCRBD02										CASSQGGRTNYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGGCCTGGGGGAGGGTGTCAGATACGCAGTATTTTGGCCCA	CASSLAWGRVSDTQYF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	4	7	3	18	32	46	39	49	TCRBV11,TCRBV23													CASSLAWGRVSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGATTCCTCCGGGACTTTTCCGGGGATGAGCAGTTCTTCGGGCCA	CASRFLRDFSGDEQFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	8	8	9	23	34	48	42	57	TCRBV06,TCRBV10					01,02								CASRFLRDFSGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGGCAGGGGGACGATGAACACTGAAGCTTTCTTTGGACAA	CASSLLGRGTMNTEAFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	0	8	4	24	36	51	44	55		TCRBV24-01,TCRBV24-or09_02												CASSLLGRGTMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAGGGGTATTAACTATGGCTACACCTTCGGTTCG	CASSLSRGINYGYTF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45							TCRBJ01	TCRBJ01-02	01	6	5	2	1	6	3	24	36	47	42	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRGINYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGACAGGGTACCTCCAAGAGACCCAGTACTTCGGGCCA	CSASGTGYLQETQYF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	1	1	5	26	37	47	38	52		TCRBV20-01,TCRBV20-or09_02												CSASGTGYLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTGAGGGGGCGACCACTGAAGCTTTCTTTGGACAA	CSARDGEGATTEAFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	4	5	3	26	40	52	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDGEGATTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGCAAAGCCTACGAGCAGTACTTCGGGCCG	CSARDEGKAYEQYF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	2	1	5	26	40	46	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDEGKAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACCCGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CSAREPGQGNYGYTF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	2	2	4	0	26	40	-1	44	53		TCRBV20-01,TCRBV20-or09_02												CSAREPGQGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGGGACTTCGGGCGGGTATGAGCAGTACTTCGGGCCG	CASSHGTSGGYEQYF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	7	1	12	26	40	47	41	59		TCRBV03-01,TCRBV03-02				01,02								CASSHGTSGGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCATCCCGACTAGCGGGGGGGTAGACTACAATGAGCAGTTCTTCGGGCCA	CAIPTSGGVDYNEQFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	2	0	3	6	4	26	31	51	37	55	TCRBV09,TCRBV12													CAIPTSGGVDYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGACGGTGGGACAGTTAATTCACCCCTCCACTTTGGGAAC	CASSDGGTVNSPLHF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	5	6	6	1	26	38	51	44	52		TCRBV12-03,TCRBV12-04												CASSDGGTVNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGGGGTAAAATAAGATATCTTTCGCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	4.33065044257135E-4		61	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	1	5	1	22	13	30	38	31	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCGGTCTTTATCAAGGAAGCACAGATACGCAGTATTTTGGCCCA	CASGLYQGSTDTQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	7	5	0	0	13	24	-1	35	31	48	TCRBV22,TCRBV24					01,02								CASGLYQGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCGCAGACAGCTACGAGCAGTACTTCGGGCCG	CSASSADSYEQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	3	7	0	26	37	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSASSADSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAAGACAGGGCAAATCAGCCCCAGCATTTTGGTGAT	CSAQDRANQPQHF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	4	4	2	26	34	45	38	47		TCRBV20-01,TCRBV20-or09_02												CSAQDRANQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGCGGGAGGACACCTACGAGCAGTACTTCGGGCCG	CASSQDRREDTYEQYF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	1	2	3	3	26	43	54	46	57		TCRBV03-01,TCRBV03-02												CASSQDRREDTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGCGGGAGGTCCGCCCAGCAGTACTTCGGGCCG	CASSSGRSAQQYF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	1	8	0	7	24	-1	45	36	52		TCRBV24-01,TCRBV24-or09_02												CASSSGRSAQQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAGTGCCATCGACTCGGCTTTCTTTGGACAA	CSARDSAIDSAFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	11	0	13	26	-1	43	37	56		TCRBV20-01,TCRBV20-or09_02												CSARDSAIDSAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCTGTATCTTCCGGCTACACCTTCGGTTCG	CSARPVSSGYTF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	10	0	8	0	11	26	-1	39	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPVSSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGACTTAACGAGCAGTACTTCGGGCCG	CSASGLNEQYF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	10	5	1	2	26	37	43	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGLNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACAGGGACACTGAAGCTTTCTTTGGACAA	CSASDRDTEAFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	3	1	0	26	37	-1	38	45		TCRBV20-01,TCRBV20-or09_02												CSASDRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGACAGGGGGCGCGACTATGAAAAACTGTTTTTTGGCAGT	CSANDRGRDYEKLFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	0	6	2	6	26	36	48	38	54		TCRBV20-01,TCRBV20-or09_02												CSANDRGRDYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCGGGGGGATCGGGAGATATACGAGCAGTACTTCGGGCCG	CSANRGDREIYEQYF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	1	4	2	11	26	36	45	38	56		TCRBV20-01,TCRBV20-or09_02												CSANRGDREIYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAACGACAGGGGGAAACTGAAGCTTTCTTTGGACAA	CASSQRQGETEAFF	In	VDJ	1	40	4.2250248220208295E-4	5.303562668222379E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	5	1	2	26	41	51	42	53		TCRBV03-01,TCRBV03-02												CASSQRQGETEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGGGCGCTCCATTTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	40	4.2250248220208295E-4		55	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	5	3	5	1	18	26	38	43	39	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ACCAGACAGCTCTTTACTTCTGTGCCACCAGTCAACCAGAGGGGGGGACACCCCTGGGGCTTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	4.2250248220208295E-4		61	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	9	0	1	8	15	20	32	47	40	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGAAACACCCCTTGGGGCCCTGGAAACACCATATATTTTGGAGAG	CASRNTPWGPGNTIYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	7	0	2	11	1	19	30	46	41	47	TCRBV07,TCRBV11													CASRNTPWGPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCTCGGATCGGGGGCGGGTGGCTACACCTTCGGTTCG	CASSPLGSGAGGYTF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	45	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	6	0	7	11	3	24	36	53	47	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGSGAGGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGACAGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSARGGQATNEKLFF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	4	0	3	0	26	37	-1	40	48		TCRBV20-01,TCRBV20-or09_02												CSARGGQATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCTATCCCGCTAGCGGGGCTCTCGAGCAGTACTTCGGGCCG	CSARPYPASGALEQYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	6	10	4	26	38	57	48	61		TCRBV20-01,TCRBV20-or09_02												CSARPYPASGALEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACTAGCGGGAGTTTGGTGAGTAGTTCTTCGGGCCA		Out	VDJ	1	39	4.119399201470309E-4		46	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	2	14	1	10	26	42	54	43	64		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCYGTGTATSTCTGTGCCAGTTCGGGCCAACAGGGCGAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSGQQGEGSYEQYF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	3	1	9	7	19	27	42	36	49	TCRBV07,TCRBV12													CASSGQQGEGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCGGGAGGGCATCGGGGAGCTGTTTTTTGGAGAA	CASSPREGIGELFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	0	7	3	3	24	36	47	39	50		TCRBV24-01,TCRBV24-or09_02												CASSPREGIGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGTAGTTTATCGGGACAGGGGTTCTACGAGCAGTACTTCGGGCCG	CASSLSGQGFYEQYF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	3	0	2	23	-1	50	40	52	TCRBV24,TCRBV27													CASSLSGQGFYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACAGGGTATACGGGTCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSARATGYTGRSNQPQHF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	3	1	3	12	26	37	47	40	59		TCRBV20-01,TCRBV20-or09_02												CSARATGYTGRSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGGGGAATACGCAGTATTTTGGCCCA	CSARKGNTQYF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	7	2	1	26	37	44	39	45		TCRBV20-01,TCRBV20-or09_02												CSARKGNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGCTAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CSARVLGVNTEAFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	0	4	0	26	39	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSARVLGVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACATTCCGGCAGGGTAGAGCTGTTTTTTGGAGAA	CSARHSGRVELFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	11	8	2	26	38	51	46	53		TCRBV20-01,TCRBV20-or09_02												CSARHSGRVELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCGGGGTAGCGAGACAGATACGCAGTATTTTGGCCCA	CSATRGSETDTQYF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	6	3	9	2	26	34	48	43	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSATRGSETDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGTCCGGGGGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSPGGPYNEQFF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	4	2	3	19	30	40	32	43	TCRBV05,TCRBV11													CASSPGGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCATGGGACTCGGCTATGGCTACACCTTCGGTTCG	CASMGLGYGYTF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	0	10	4	1	3	23	33	40	34	43	TCRBV06,TCRBV24					01,02								CASMGLGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTTCTGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	37	3.908147960369267E-4		41	TCRBV24						TCRBJ01	TCRBJ01-02	01	1	0	9	3	4	0	24	41	-1	45	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGACGGCAGGGAGTTAAGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	37	3.908147960369267E-4		46	TCRBV24						TCRBJ02	TCRBJ02-02	01	7	4	3	5	4	8	24	35	44	39	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGATGCCGGGACAGGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CSATDAGTGFTGELFF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	4	8	2	26	36	53	44	55		TCRBV20-01,TCRBV20-or09_02												CSATDAGTGFTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTCGGGGGCCCAACTATGGCTACACCTTCGGTTCG	CSASRGPNYGYTF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	6	0	2	5	2	26	34	45	39	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRGPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGGGACGCCGGAGGGGAGACCCAGTACTTCGGGCCA	CASSSRDAGGETQYF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	0	5	11	0	26	39	-1	50	56		TCRBV12-03,TCRBV12-04												CASSSRDAGGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGGACCGGGACGGACTCCTACGAGCAGTACTTCGGGCCG	CASRTGTDSYEQYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	6	0	7	0	4	3	20	31	40	35	43	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGTDSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACGTGAGCGCAGATACGCAGTATTTTGGCCCA	CAISDVSADTQYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	39				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	6	4	6	0	23	35	-1	41	45	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDVSADTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CACCAACCAGACMTCTMTGTACYTCTGTGCCAGCAGTTTAGTGGGGAATTTGTTCGAGCAGTACTTCGGGCCG	CASSLVGNLFEQYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	2	0	8	6	3	7	23	38	45	41	52	TCRBV27,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGNLFEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGACAGGGGTGGGACAGCCCCAGCATTTTGGTGAT	CSAATGVGQPQHF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	7	2	5	26	35	45	37	50		TCRBV20-01,TCRBV20-or09_02												CSAATGVGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTCCGCCGGGGCCTACGAGCAGTACTTCGGGCCG	CSAPSAGAYEQYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	2	8	0	26	35	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAPSAGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCCCCTTGAAGTGGGGGAGACCACTGAAGCTTTCTTTGGACAA	CSATPLEVGETTEAFF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	6	1	4	13	4	26	36	54	49	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPLEVGETTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGACAGGGTGACTATGGCTACACCTTCGGTTCG	CSARQGDYGYTF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	3	2	2	26	34	43	36	45		TCRBV20-01,TCRBV20-or09_02												CSARQGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTCTTTACTTCTGTGCCAGCAACCCGGGACTAGCGGGAGGGCCCAATCTCGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	36	3.8025223398187465E-4		62	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	0	0	0	7	10	13	20	43	27	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAGGACATATTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSLGHILSGNTIYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	6	0	0	6	26	-1	46	42	52	TCRBV12,TCRBV21													CASSLGHILSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCGACAGGGAGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSRQGEAGELFF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	6	2	5	26	37	46	39	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRQGEAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACCGGGACGGGACCTACGAGCAGTACTTCGGGCCG	CSAYRDGTYEQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	0	7	2	4	4	26	35	44	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYRDGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARDPVSGANVLTF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	8	5	1	2	2	26	40	45	42	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPVSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGAAGAATGAGCAGTTCTTCGGGCCA	CSARDKKNEQFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	2	8	7	3	2	26	40	45	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDKKNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCGGGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSQDSGGYNEQFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	45	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	8	0	3	3	2	26	43	50	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSGGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAACAGCCAAGTTGGACACCCCACAGATACGCAGTATTTTGGCCCA	CANSQVGHPTDTQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	6	2	2	3	26	42	49	44	52		TCRBV03-01,TCRBV03-02												CANSQVGHPTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGGGAAACAGGGGTATCTATGGCTACACCTTCGGTTCG	CASRGNRGIYGYTF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	4	5	3	24	35	47	40	50	TCRBV06,TCRBV10													CASRGNRGIYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGTGAACACTGAAGCTTTCTTTGGACAA	CASSVNTEAFF	In	VJ	1	35	3.696896719268226E-4	4.640617334694581E-4	33	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	0	0	0	0	1	26	-1	38	-1	39		TCRBV12-03,TCRBV12-04												CASSVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAAGCCCCAGACAGGGAGCCTGAAGCTTTCTTTGGACAA	CASSEAPDREPEAFF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	6	8	3	23	36	51	44	54	TCRBV09,TCRBV21													CASSEAPDREPEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCTCTGGAAGCCATTGGGCCAACGTCCTGACTTTCGGGGCC	CASSPSGSHWANVLTF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	48	unresolved						TCRBJ02	TCRBJ02-06	01	5	1	8	5	6	7	24	36	45	42	52	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSGSHWANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTAACGGGTTCACAGATACGCAGTATTTTGGCCCA	CASSFNGFTDTQYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	2	3	2	19	33	40	36	42		TCRBV05-06,TCRBV05-07				01,02								CASSFNGFTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGGGGGGGATTCGGTGAAGCTTTCTTTGGACAA	XASSRGGFGEAFF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	7	0	6	22	-1	42	34	48	TCRBV04,TCRBV07,TCRBV17													XASSRGGFGEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACCCCTCGACAGGGAAACACCATATATTTTGGAGAG	CASSLTPRQGNTIYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	5	4	10	0	24	36	-1	46	51		TCRBV24-01,TCRBV24-or09_02												CASSLTPRQGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGTGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSGSSYNEQFF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	1	8	0	3	2	24	36	42	39	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACGGGATTTTCTCCCCGGGCACAGATACGCAGTATTTTGGCCCA	CSADGIFSPGTDTQYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	3	1	2	12	26	35	42	37	54		TCRBV20-01,TCRBV20-or09_02												CSADGIFSPGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGCAGGGAAAATTCACCCCTCCATTTTGGGAAC	CSARPGRENSPLHF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	3	22	5	17	26	38	48	43	65		TCRBV20-01,TCRBV20-or09_02												CSARPGRENSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCAGGGGGCGGGGGTAACGCAGTATTTTGGCCCA	CASSPQGAGVTQYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	9	2	7	26	39	49	41	56		TCRBV03-01,TCRBV03-02												CASSPQGAGVTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAATTTCTGGGGGGGTGAAAAACTGTTTTTTGGCAGT	CASNFWGGEKLFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	9	0	7	6	0	23	33	-1	39	46	TCRBV02,TCRBV12													CASNFWGGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACGTAGCGGGCTCTCCTACGAGCAGTACTTCGGGCCG	CASSLRSGLSYEQYF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	4	0	5	2	24	36	48	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLRSGLSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAACCGTTCCCGGAGGGACAGGGACCCCAGGTACGCAGTATTTTGGCCCA	CASSSTVPGGTGTPGTQYF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	57	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	8	15	8	24	36	60	51	68		TCRBV24-01,TCRBV24-or09_02												CASSSTVPGGTGTPGTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTACTAGCGGCGAGCAGTACTTCGGGCCG	CATSDSTSGEQYF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	5	6	2	0	24	40	-1	42	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSTSGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACGAGGGATACCGGGGAGCTGTTTTTTGGAGAA	CATSDTRDTGELFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	0	5	2	2	24	39	46	41	48		TCRBV24-01,TCRBV24-or09_02												CATSDTRDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGACAGCCCCAATGAGCAGTTCTTCGGGCCA	CSASGDSPNEQFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	6	2	3	26	37	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSASGDSPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACCACAGGGTTATCACGGGGGGATAAGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	33	3.485645478167184E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	7	16	6	26	34	57	50	63		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCCCTCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSPSGGELFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	4	7	3	0	26	39	-1	42	46	TCRBV03,TCRBV12					01,02								CASSPSGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTATTTGGGAATGAGCAGTTCTTCGGGCCA	CASSLFGNEQFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	36	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	0	9	7	7	0	26	37	-1	44	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGAGAGGGGATAGGGGGAGAAGCTTTCTTTGGACAA	CASSREGIGGEAFF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	8	12	1	26	37	55	49	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSREGIGGEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCAACCAGGGACAGGGCTATGGCTACACCTTCGGTTCG	CASSNQGQGYGYTF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	5	0	19	31	-1	36	45	TCRBV07,TCRBV11													CASSNQGQGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGGGAAATCGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSREIGNTGELFF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	45	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	0	8	2	1	7	24	36	41	37	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSREIGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGTCAGGGTTAACTATGGCTACACCTTCGGTTCG	CATSDLVRVNYGYTF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	1	3	1	24	41	49	44	50		TCRBV24-01,TCRBV24-or09_02												CATSDLVRVNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCCATCGACCGTAAGGGGGGAGACCCAGTACTTCGGGCCA	CASSPSTVRGETQYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	13	0	23	34	-1	47	53	TCRBV24,TCRBV27													CASSPSTVRGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGCCAAAAACATTCAGTACTTCGGCGCC	CSARGTAKNIQYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	39	TCRBV20						TCRBJ02	TCRBJ02-04	01	3	0	7	0	1	0	26	37	-1	38	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGTAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGAAATATTCACCCCTCCACTTTGGGAAC	CSASGKYSPLHF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	8	3	8	0	3	26	-1	42	37	45		TCRBV20-01,TCRBV20-or09_02												CSASGKYSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGACAGGGCAAGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDGQGKSYNEQFF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	1	1	4	26	40	49	41	53		TCRBV20-01,TCRBV20-or09_02												CSARDGQGKSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATTGGGCTCGGTAGCGGGGAATACTTCGGGCCA	CSARIGLGSGEYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	5	3	14	11	2	26	38	57	49	59		TCRBV20-01,TCRBV20-or09_02												CSARIGLGSGEYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTGCTTGGACGGTTTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	3.3800198576166635E-4		41	unresolved						TCRBJ01	TCRBJ01-02	01	4	1	7	5	4	5	20	33	41	37	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACTAACCAGGGGATCGGGAATGAAAAACTGTTTTTTGGCAGT	CASSPTNQGIGNEKLFF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	2	5	8	6	26	39	53	47	59		TCRBV03-01,TCRBV03-02												CASSPTNQGIGNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACCGGGACAGGGGGTGGGTACAATGAGCAGTTCTTCGGGCCA	CASSTGTGGGYNEQFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	4	3	4	23	35	49	38	53	TCRBV09,TCRBV21													CASSTGTGGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAAACGACCCAGGACACCTAACTCCTACGAGCAGTACTTCGGGCCG	CASSKRPRTPNSYEQYF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	0	10	5	23	35	50	45	55	TCRBV06,TCRBV10													CASSKRPRTPNSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACGGGACTAGCGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSLTGLAGSYEQYF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	4	1	5	1	24	36	53	41	54		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLTGLAGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAGGACGGGACTAGCGGTTACAATGAGCAGTTCTTCGGGCCA	CSARKDGTSGYNEQFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	5	4	6	1	26	38	55	44	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARKDGTSGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCCGGGCAGGGGCTCGAGCAGTACTTCGGGCCG	CASSHPGQGLEQYF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	6	7	2	26	40	53	47	55		TCRBV03-01,TCRBV03-02												CASSHPGQGLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACAGGGGTATAATGAAAAACTGTTTTTTGGCAGT	CASSLGQGYNEKLFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	2	4	0	2	26	-1	50	42	52		TCRBV12-03,TCRBV12-04												CASSLGQGYNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGGGACAGGGGGCGGCACTGAAGCTTTCTTTGGACAA	CASSGTGGGTEAFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	4	0	2	18	-1	42	30	44	TCRBV07,TCRBV11													CASSGTGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCAAGAAGCGGGAGCCCTCAAGAGACCCAGTACTTCGGGCCA	CSSRSGSPQETQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	6	2	2	6	4	26	32	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSSRSGSPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTCCGGGGCGGGGCTACGAGCAGTACTTCGGGCCG	CSVPGRGYEQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	3	3	7	0	26	33	-1	40	46		TCRBV20-01,TCRBV20-or09_02												CSVPGRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGACAGGTGGAAACTGAAGCTTTCTTTGGACAA	CSAPGQVETEAFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	5	3	5	26	35	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSAPGQVETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACTAGCGGGGGGTACGAGACCCAGTACTTCGGGCCA	CSARTSGGYETQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	2	1	5	0	3	26	-1	50	37	53		TCRBV20-01,TCRBV20-or09_02												CSARTSGGYETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTACCCTAGCGGGAGGTTCCTACGAGCAGTACTTCGGGCCG	CSARATLAGGSYEQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	1	1	5	1	26	39	55	44	56		TCRBV20-01,TCRBV20-or09_02												CSARATLAGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTGGGGCAGGGGCCAACGAAGCTTTCTTTGGACAA	CSARDLGAGANEAFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	8	8	5	26	40	54	48	59		TCRBV20-01,TCRBV20-or09_02												CSARDLGAGANEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGTAGCTAGCGGTGTGTACAATGAGCAGTTCTTCGGGCCA	CASSVASGVYNEQFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	5	4	4	4	26	38	49	42	53	TCRBV03,TCRBV09					01,02								CASSVASGVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCCTGGCAGGCGGGACGATATACTGAAGCTTTCTTTGGACAA	CASSQDSWQAGRYTEAFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	7	3	5	10	6	26	43	59	53	65		TCRBV03-01,TCRBV03-02												CASSQDSWQAGRYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCCTCAAAACCGGGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CAILKTGTGDTGELFF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	2	3	9	0	24	33	-1	42	52	TCRBV06,TCRBV10													CAILKTGTGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGTGACACAGATACGCAGTATTTTGGCCCA	CASSLRDTDTQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	39	TCRBV12						TCRBJ02	TCRBJ02-03	01	2	2	8	2	3	0	26	41	-1	44	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRDTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGACACACTTGAACACTGAAGTTTTCTTTGGACAA	CASSLTHLNTEVFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	1	3	6	13	0	17	19	-1	37	34	54	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLTHLNTEVFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAGGGGACAGACGCAATCAGCCCCAGCATTTTGGTGAT	CATRGDRRNQPQHF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	5	2	2	2	24	35	44	37	46		TCRBV24-01,TCRBV24-or09_02												CATRGDRRNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAACAGGAGAAAACTATGGCTACACCTTCGGTTCG	CSVTGENYGYTF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	4	2	2	4	26	33	40	35	44		TCRBV20-01,TCRBV20-or09_02												CSVTGENYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGGCTTTCCGGAGGGAATGAGCAGTTCTTCGGGCCA	CSAPGLSGGNEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	0	7	12	0	26	35	-1	47	53		TCRBV20-01,TCRBV20-or09_02												CSAPGLSGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGCATCTGAGCAGTTCTTCGGGCCA	CSARVASEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	7	9	0	3	26	-1	43	39	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVASEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGCTCTACCTACGAGCAGTACTTCGGGCCG	CSAREGSTYEQYF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	2	0	4	26	-1	44	40	48		TCRBV20-01,TCRBV20-or09_02												CSAREGSTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCGACGGGACGGGGCACTGAAGCTTTCTTTGGACAA	CASRSTGRGTEAFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	0	7	4	6	4	26	37	48	43	52		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSTGRGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCATTGACAAAGACGGGGGAGCATAGCCAAAAACATTCAGTACTTCGGCGCC	CATSDH*QRRGSIAKNIQYF	Stop	VDJ	1	29	3.063142995965101E-4		60	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	8	2	0	12	5	21	36	54	48	59		TCRBV24-01,TCRBV24-or09_02												CATSDH*QRRGSIAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGCGCCGGTTGAGGAGACCCAGTACTTCGGGCCA	CASSLAPVEETQYF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	5	5	2	5	18	35	40	37	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAPVEETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCACGATGGAACAGGGGCAACTGAAGCTTTCTTTGGACAA	CASSHDGTGATEAFF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	5	9	2	18	30	46	39	48	TCRBV07,TCRBV11													CASSHDGTGATEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCTAGGCACAGATACGCAGTATTTTGGCCCA	CATSGLGTDTQYF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	8	1	2	0	24	37	-1	39	43		TCRBV24-01,TCRBV24-or09_02				01,02								CATSGLGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAGCCTAACTGGAAGAGTGAGCAGTTCTTCGGGCCA	CSAQPNWKSEQFF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	5	9	0	14	26	-1	38	34	52		TCRBV20-01,TCRBV20-or09_02												CSAQPNWKSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGGGTGGACTGAAGCTTTCTTTGGACAA	CASSLGWTEAFF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	3	5	1	3	26	39	44	40	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGACTAGTCGAAATACGCAGTATTTTGGCCCA	CASSGTSRNTQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	8	7	0	5	23	-1	43	36	48	TCRBV09,TCRBV21					01,02								CASSGTSRNTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTGGGTTTGGGCAGGGACGGCACTGAAGCTTTCTTTGGACAA	CASSLGLGRDGTEAFF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	48	TCRBV05						TCRBJ01	TCRBJ01-01	01	0	0	7	4	9	2	19	35	49	44	51		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGRDGTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCGTCCCAAGTCTCCGGTGGACGAACACTGAAGCTTTCTTTGGACAA	CASVPSLRWTNTEAFF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	8	1	7	1	16	0	20	29	-1	45	49	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVPSLRWTNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGGATGCCTCTGGAAACACCATATATTTTGGAGAG	CASSSDASGNTIYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	4	1	8	0	1	3	18	31	35	32	38	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDASGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTAGCTATAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSSYSGSTDTQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	4	0	5	0	24	36	-1	41	48	TCRBV24,TCRBV28					01,02								CASSSYSGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGCGAGACGTAGACGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	2.85189175486406E-4		55	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	2	7	4	4	21	22	33	40	37	61		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTTCGCAGGGGGCTGGGGACACTGAAGCTTTCTTTGGACAA	CSARDPSQGAGDTEAFF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	0	3	7	5	26	40	55	47	60		TCRBV20-01,TCRBV20-or09_02												CSARDPSQGAGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAACGGTCAGCTGGCTACACCTTCGGTTCG	CSAREERSAGYTF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	1	8	7	0	9	26	-1	43	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREERSAGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGTCCAGGAGCCGCTTTATGGCTACACCTTCGGTTCG	CASSLVQEPLYGYTF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	4	4	5	5	8	26	39	48	44	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVQEPLYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCTCCAAGGGCGACGGTGGAACACCATATATTTTGGAGAG	CASSLLQGRRWNTIYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	48	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	5	3	7	7	9	26	39	50	46	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLQGRRWNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGATAGACCAACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	2.85189175486406E-4		43	unresolved						TCRBJ02	TCRBJ02-07	01	0	2	7	3	2	5	23	40	45	42	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCTTTCGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASSFRTGDYEQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	3	5	1	26	37	51	42	52	TCRBV12,TCRBV21													CASSFRTGDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTCCGCGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPRTSGSTDTQYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	4	0	5	0	24	35	-1	40	51	TCRBV02,TCRBV21					01,02								CASSPRTSGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCGTCACAGGACAGAACACTGAAGCTTTCTTTGGACAA	CASSFVTGQNTEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	6	1	7	0	19	33	-1	40	45		TCRBV05-06,TCRBV05-07												CASSFVTGQNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCGTGGGGACACACTCTGGAAACACCATATATTTTGGAGAG	CASVGTHSGNTIYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	0	6	0	3	2	20	29	38	32	40	TCRBV11,TCRBV23													CASVGTHSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTACACTAGCGGGAACCCGGGAGCTGTTTTTTGGAGAA	CASSTLAGTRELFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	3	3	9	2	4	24	36	48	38	52	TCRBV24,TCRBV27													CASSTLAGTRELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTCTAGCCTCTCTTAGGGGACTAGCGGGTTCTCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	2.746266134313539E-4		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	15	0	4	6	14	5	24	27	53	41	58		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGACAGGGCTGGAAACACCATATATTTTGGAGAG	CASSLDRAGNTIYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	3	2	0	0	22	-1	-1	38	44		TCRBV12-03,TCRBV12-04												CASSLDRAGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCGGCTGAGCAGTTCTTCGGGCCA	CSAREAAEQFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	9	1	1	26	40	45	41	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREAAEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAAAATGTGGGAGATCAGCCCCAGCATTTTGGTGAT	CSAQNVGDQPQHF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	2	5	9	0	26	34	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAQNVGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACGCCGGGGTGGGCACTGAAGCTTTCTTTGGACAA	CSADAGVGTEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	4	6	4	26	34	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSADAGVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASRGAYEQYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	33	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	8	1	2	0	0	26	-1	-1	35	42		TCRBV03-01,TCRBV03-02												CASRGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGTTCTGGCTTGAACACTGAAGCTTTCTTTGGACAA	XASSSGLNTEAFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	11	4	5	0	2	11	22	25	30	27	41	TCRBV04,TCRBV17			TCRBD01,TCRBD02										XASSSGLNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCAGTGACGCGTCTAGCGGGAGTAATGAGCAGTTCTTCGGGCCA	CASSDASSGSNEQFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	7	7	1	26	38	55	45	56	TCRBV06,TCRBV10													CASSDASSGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCCTAAGGGTTTACGGGATCACCCCTTCACTTTGGGAAC		Out	VDJ	1	25	2.640640513763018E-4		43	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	11	8	3	19	16	9	24	31	52	47	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCCCGTTGAACACTGAAGCTTTCTTTGGACAA	CASSLSPLNTEAFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	42				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	5	9	0	1	7	24	36	39	37	46	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSPLNTEAFF+X+TCRBJ01-01		TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACGCTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLRLNTGELFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	3	7	1	2	4	24	36	40	38	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRLNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACTTGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	25	2.640640513763018E-4		44	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	0	8	0	5	0	24	36	-1	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGGCCACAACTAATGAAAAACTGTTTTTTGGCAGT	CASRATTNEKLFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	9	0	0	0	2	23	-1	37	34	39	TCRBV24,TCRBV27													CASRATTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGACTCCCCTTGGGACCCTTTTGGCTACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	25	2.640640513763018E-4		58	TCRBV24						TCRBJ01	TCRBJ01-04	01	4	0	7	2	8	10	23	37	50	45	60		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCAGGAATCAGCCCCAGCATTTTGGTGAT	CSASPRNQPQHF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	4	3	0	26	37	-1	40	44		TCRBV20-01,TCRBV20-or09_02												CSASPRNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCTCTGGAAACACCATATATTTTGGAGAG	CASSSSGNTIYF	In	VJ	1	25	2.640640513763018E-4	3.314726667638986E-4	36	TCRBV03						TCRBJ01	TCRBJ01-03	01	5	0	0	0	0	2	26	-1	38	-1	40		TCRBV03-01,TCRBV03-02												CASSSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTATGGATGGGCCCCAGCATTTTGGTGAT	CASSLMDGPQHF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	36	TCRBV03						TCRBJ01	TCRBJ01-05	01	4	1	8	9	4	3	26	39	46	43	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMDGPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATGTCCGGGACTGGCTTCTCCGAGCAGTACTTCGGGCCG	CASSQMSGTGFSEQYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	10	6	6	8	26	41	53	47	61		TCRBV03-01,TCRBV03-02				01,02								CASSQMSGTGFSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACGGGACAGATATGAAAAACTGTTTTTTGGCAGT	CASRRDRYEKLFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	6	2	2	24	35	44	37	46	TCRBV06,TCRBV10													CASRRDRYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACTAGCGGGACCTACTACGAGCAGTACTTCGGGCCG	CASSLTSGTYYEQYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	2	3	3	0	4	26	-1	51	40	55		TCRBV12-03,TCRBV12-04												CASSLTSGTYYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCATAAGCGGGAGGGCCCTGAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	2.5350148932124975E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	0	5	2	6	23	33	45	35	51	TCRBV09,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGTAGGGGAGGGAGCGAGACCCAGTACTTCGGGCCA	CASRGGSETQYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	9	0	5	3	3	23	31	41	34	44	TCRBV02,TCRBV12													CASRGGSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGGTAGCGGGCTAACCTACGAGCAGTACTTCGGGCCG	CASSQGSGLTYEQYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	4	2	5	4	18	30	42	35	46	TCRBV05,TCRBV11					01,02								CASSQGSGLTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCMTSTATCKCTGTGCAAGTCGCTCACCCGCTGCGGGACACCCCAGGGTTGTCTATGGCTACACCTTCGGTTCG	CASRSPAAGHPRVVYGYTF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	57	unresolved						TCRBJ01	TCRBJ01-02	01	12	0	6	4	18	12	18	23	47	41	59	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSPAAGHPRVVYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTACCCWMYCAGACAKCTSTKTACTTCTGTGCCAGCAGTTTAGGGACTACTAACAATGAGCAGTTCTTCGGGCCA	CASSLGTTNNEQFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	9	5	3	3	24	36	46	39	49	TCRBV06,TCRBV24					01,02								CASSLGTTNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCCAGGGGGCTCGGGGACTGAAGCTTTCTTTGGACAA	CASSSPGGSGTEAFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	5	4	6	24	36	48	40	54		TCRBV24-01,TCRBV24-or09_02												CASSSPGGSGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAAATGAGTTAGCTAACTATGGCTACACCTTCGGTTCG	CSARVNELANYGYTF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	5	8	0	9	0	26	39	-1	48	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVNELANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACAGAGGAATTAACTATGGCTACACCTTCGGTTCG	CSARGDRGINYGYTF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	1	0	6	26	-1	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSARGDRGINYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCTGGACGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	2.5350148932124975E-4		37	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	1	7	1	5	1	26	34	43	39	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGGGGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTGGGTCTAGCGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGAGELFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	4	2	6	3	0	22	37	-1	40	50	TCRBV05,TCRBV07													CASSLGLAGAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGGGGATACAGATACGCAGTATTTTGGCCCA	CASSQGQGDTDTQYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	1	3	0	2	26	-1	51	42	53		TCRBV03-01,TCRBV03-02												CASSQGQGDTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCCTCTGGAAACACCATATATTTTGGAGAG	CASSFSSGNTIYF	In	VJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	39	TCRBV12						TCRBJ01	TCRBJ01-03	01	3	0	0	0	0	3	26	-1	40	-1	43		TCRBV12-03,TCRBV12-04												CASSFSSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCWSSSASWCAKCTGTGTAYTTKTGTGCCAGCAGTTTGATGGGGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLMGTSNQPQHF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	45	unresolved						TCRBJ01	TCRBJ01-05	01	3	0	7	0	4	0	26	40	-1	44	49	TCRBV06,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMGTSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTGGACAGGGGGATGTTAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGQGDVRNTGELFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	1	1	1	7	23	31	42	32	49	TCRBV02,TCRBV09													CASGQGDVRNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCCCTCAACACCTGGTGGGGCCCCTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	2.429389272661977E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	7	0	4	14	4	23	32	51	46	55	TCRBV09,TCRBV12													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAGGGAGCAGATACGCAGTATTTTGGCCCA	CASSEGADTQYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	4	0	0	23	-1	-1	37	42	TCRBV02,TCRBV21													CASSEGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAATAATAGACAGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	2.429389272661977E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	3	6	0	24	38	-1	44	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGCCTGGTGGCTACACCTTCGGTTCG	CSASRPGGYTF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	9	0	7	2	4	26	37	42	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRPGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGTAGAAGAGACCCAGTACTTCGGGCCA	CSARGLVEETQYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	2	8	3	0	3	26	-1	45	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLVEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCAAGGACTAGCGATTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	2.429389272661977E-4		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	6	1	7	3	26	34	50	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTAGCCCCAATTAGGGGGCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPN*GAYSNQPQHF	Stop	VDJ	1	23	2.429389272661977E-4		51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	0	0	6	3	26	39	52	45	55		TCRBV03-01,TCRBV03-02												CASSPN*GAYSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCACAGGGAAGCAGTACTTCGGGCCG	CASSLTGKQYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	8	2	1	26	39	47	41	48		TCRBV03-01,TCRBV03-02												CASSLTGKQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACCTAGAGGTGGGGGAAACACCATATATTTTGGAGAG	CASSQGPRGGGNTIYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	4	8	4	3	7	26	42	49	45	56		TCRBV03-01,TCRBV03-02				01,02								CASSQGPRGGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAAGGTCGGGGAGTGTCACCTTCGGTTCG	CASSQGRSGSVTF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	3	13	6	5	26	42	53	48	58		TCRBV03-01,TCRBV03-02				01,02								CASSQGRSGSVTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACCCGACAGCACGGGAAAACTGTTTTTTGGCAGT	CASRPDSTGKLFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	5	10	4	6	26	37	46	41	52		TCRBV03-01,TCRBV03-02												CASRPDSTGKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAATGGGACTATGGGACTGTCAATGAAAAACTGTTTTTTGGCAGT	CASSEWDYGTVNEKLFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	9	5	4	10	26	38	49	42	59		TCRBV12-03,TCRBV12-04				01,02								CASSEWDYGTVNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGCAGGGTGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGGTGELFF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	5	2	4	18	34	41	36	45	TCRBV07,TCRBV11													CASSLGQGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATTCCCGGGGGCGACAGATACGCAGTATTTTGGCCCA	CASSLFPGATDTQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	6	0	3	7	1	23	36	49	43	50	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFPGATDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGTACGGGACACTGAAGCTTTCTTTGGACAA	CASSLVRDTEAFF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	3	6	0	24	36	-1	42	46	TCRBV24,TCRBV27					01,02								CASSLVRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTAGGGGCTAACTATGGCTACACCTTCGGTTCG	CATSVGANYGYTF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	2	0	1	0	24	37	-1	38	43		TCRBV24-01,TCRBV24-or09_02												CATSVGANYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGAGGACAGGGACTATGGCTACACCTTCGGTTCG	CSARVEDRDYGYTF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	3	4	0	26	39	-1	43	51		TCRBV20-01,TCRBV20-or09_02												CSARVEDRDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGGGAATTCCCTCTATGGCTACACCTTCGGTTCG	CASSRGNSLYGYTF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	0	4	0	8	26	-1	44	39	52		TCRBV03-01,TCRBV03-02												CASSRGNSLYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGCCTCGGATTAGCGGGAGGAATAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	2.2181380315609354E-4		58	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	1	0	11	3	23	36	57	47	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCAGTCCGACAGGGAGCCGGTCTCACTGAAGCTTTCTTTGGACAA	YASSPVRQGAGLTEAFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	7	9	22	34	48	41	57	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPVRQGAGLTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACTCCCAGCGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTPSGPSYNEQFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	4	0	5	2	23	33	44	38	46	TCRBV06,TCRBV10					01,02								CASTPSGPSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTCCTGGACAGACTCTCCTACGAGCAGTACTTCGGGCCG	CASSFLDRLSYEQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	0	3	3	23	37	46	40	49	TCRBV24,TCRBV27													CASSFLDRLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGACTAGCGATTACGAGCAGTACTTCGGGCCG	CSASGTSDYEQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	6	4	1	2	26	37	48	38	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGTSDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCGGACCAACACCTACGAGCAGTACTTCGGGCCG	CASSSRTNTYEQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	1	7	2	4	5	26	38	46	42	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRTNTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGGACAGGGGTTCGATGAGCAGTTCTTCGGGCCA	CASSLGQGFDEQFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	8	1	4	19	33	43	34	47	TCRBV05,TCRBV07													CASSLGQGFDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCACCAGACGGGACCTCCCTTATGGCTACACCTTCGGTTCG	CASTRRDLPYGYTF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	7	5	6	6	19	29	40	35	46	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRRDLPYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCCGAGGCGGGGGGTGGACTGAAGCTTTCTTTGGACAA	CASSRGGGWTEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	1	5	4	3	19	31	43	35	46	TCRBV07,TCRBV23													CASSRGGGWTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCCCGTGTGAATGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	2.1125124110104148E-4		44	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	7	4	13	0	18	30	-1	43	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCGGACAGGGGGGGTCGCTTAACTATGGCTACACCTTCGGTTCG	CASSFGQGGSLNYGYTF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	1	1	1	7	18	32	43	33	50	TCRBV07,TCRBV11													CASSFGQGGSLNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGTCCTTTGTGGACAGGGGAAAACACTGAAGCTTTCTTTGGACAA	CASRPLWTGENTEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	1	2	2	12	2	24	31	52	43	54		TCRBV24-01,TCRBV24-or09_02												CASRPLWTGENTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATGGGCAGGAGTTGACGAGCAGTACTTCGGGCCG	CASSLWAGVDEQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	6	4	4	5	7	5	24	36	47	43	52	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWAGVDEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGACCGGGACACCCACCCTGGGAGAGACCCAGTACTTCGGGCCA	CATSETGTPTLGETQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	6	4	4	11	24	38	48	42	59		TCRBV24-01,TCRBV24-or09_02												CATSETGTPTLGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACATAGCGGTGTCCAAAAACATTCAGTACTTCGGCGCC	CASSDIAVSKNIQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	5	5	2	4	3	22	34	44	38	47		TCRBV12-03,TCRBV12-04				01,02								CASSDIAVSKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGGGGAAACTGAAGCTTTCTTTGGACAA	CSARDQGETEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	5	3	2	26	40	48	43	50		TCRBV20-01,TCRBV20-or09_02												CSARDQGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGCCCAGGCGGCAGTGCCTGAAGCTTTCTTTGGACAA	CSAAQAAVPEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	4	4	6	4	9	26	34	42	38	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAQAAVPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGACCCGAGGGGTGGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	2.1125124110104148E-4		34	TCRBV20						TCRBJ01	TCRBJ01-05	01	9	5	2	7	5	4	26	31	41	36	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGTCCTCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	2.1125124110104148E-4		38	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	0	10	5	0	6	26	-1	41	39	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGCCCGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	2.1125124110104148E-4		41	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	6	0	26	39	-1	45	48		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGTTTTACTAGCGGGACCTTCTACGAGCAGTACTTCGGGCCG	CASSRFTSGTFYEQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	3	3	6	4	26	38	54	44	58		TCRBV12-03,TCRBV12-04												CASSRFTSGTFYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTTTTACCCGGCTACGAGCAGTACTTCGGGCCG	CASSVLPGYEQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	5	3	9	0	26	37	-1	46	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVLPGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCGTAGGAGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSVGAGGSTDTQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	0	6	0	26	37	-1	43	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVGAGGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCCTAGAGGGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLEGSGANVLTF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	5	11	0	1	3	1	22	34	42	37	43	TCRBV07,TCRBV09			TCRBD01,TCRBD02										CASSLEGSGANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCCGGAGCCGTATCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPEPYLNTGELFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	2	1	2	8	19	31	37	33	45	TCRBV04,TCRBV05													CASSPEPYLNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTCCTCAGGGATGGGCAATGAGCAGTTCTTCGGGCCA	CASSSSGMGNEQFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	6	3	5	19	32	40	35	45	TCRBV05,TCRBV07													CASSSSGMGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCAGCGGGGCATATCGATTACGAGCAGTACTTCGGGCCG	YASSPAGHIDYEQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	3	4	2	9	22	34	43	36	52	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPAGHIDYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGCAGGCGGGTACGAGCAGTACTTCGGGCCG	CASSLAAGGYEQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	4	4	5	0	18	35	-1	40	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAAGGYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASGACTCGGCYSTGTATCTCTGTGCCAGCAGCCCCGTCGTAGCAAACTCTGGAAACACCATATATTTTGGAGAG	CASSPVVANSGNTIYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	5	7	0	7	3	19	31	42	38	45	TCRBV05,TCRBV07					01,02								CASSPVVANSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCCCCTTTCGGGAATCTCTGGAAACACCATATATTTTGGAGAG	CASSPLSGISGNTIYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	8	3	0	6	2	23	36	47	42	49	TCRBV04,TCRBV23													CASSPLSGISGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAAGGGGGCGGATCCCAAGAGACCCAGTACTTCGGGCCA	CSARDEGGGSQETQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	1	3	5	26	40	50	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDEGGGSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGAAGGGGGCTGATGCTTTCTTTGGACAA	CSAEKGADAFF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	11	5	4	26	34	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSAEKGADAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGAGAGGGTACCCCTACGAGCAGTACTTCGGGCCG	CASSPRGYPYEQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	2	3	4	26	39	47	42	51		TCRBV03-01,TCRBV03-02												CASSPRGYPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCATTAGTGGGATCCTACGARCAGTACTTCGGGCCG		Out	VDJ	1	19	2.006886790459894E-4		46	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	0	8	1	8	0	26	42	-1	50	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CASCWSCCARACAKCTKTGTACTTCTGTGCCAGCAGTTCGGGACTAAACTCCGGCTATGGCTACACCTTCGGTTCG	CASSSGLNSGYGYTF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	0	9	4	1	8	24	37	45	38	53	TCRBV06,TCRBV22					01,02								CASSSGLNSGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGAGTGAGGGAGGGAAGCTACGAGCAGTACTTCGGGCCG	CASSPGVREGSYEQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	3	10	3	26	38	55	48	58		TCRBV12-03,TCRBV12-04												CASSPGVREGSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCGGGACGGTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSGRSSNQPQHF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	45	TCRBV12						TCRBJ01	TCRBJ01-05	01	6	0	7	0	3	4	26	37	45	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRSSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGACCCAAACCCTAATTCACCCCTCCACTTTGGGAAC	CASSLDPNPNSPLHF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	4	2	7	6	2	8	22	35	40	37	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPNPNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCCCCACAGTAAATGAAAAACTGTTTTTTGGCAGT	CASSPTVNEKLFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	5	3	2	22	34	41	37	43	TCRBV07,TCRBV23													CASSPTVNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCTTAGACAGGGAGGTGGGGACTAACTATGGCTACACCTTCGGTTCG	CASSLDREVGTNYGYTF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	51	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	6	2	3	0	4	9	20	31	42	35	51	TCRBV07,TCRBV23			TCRBD01,TCRBD02										CASSLDREVGTNYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCTAGTCGACAGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	18	1.9012611699093733E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	3	8	0	18	30	-1	38	45	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCAGCCAAAGCGGGGGTAACTACAATGAGCAGTTCTTCGGGCCA	CASSQSGGNYNEQFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	2	3	4	3	26	37	49	41	52	TCRBV06,TCRBV10													CASSQSGGNYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCGAGGACCCTTCCGGCAGCAATGAGCAGTTCTTCGGGCCA	CASTEDPSGSNEQFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	7	1	7	6	4	11	23	33	41	37	52	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTEDPSGSNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGTGAGACAGGGGGCATTTACACTGAAGCTTTCTTTGGACAA	CSARSETGGIYTEAFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	0	3	5	4	26	38	53	43	57		TCRBV20-01,TCRBV20-or09_02												CSARSETGGIYTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGGTCAGGGGTAGGAAACACCATATATTTTGGAGAG	CASSLGSGVGNTIYF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	2	4	6	2	26	39	51	45	53		TCRBV03-01,TCRBV03-02												CASSLGSGVGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCAGGAGCGGATCAGCCCCAGCATTTTGGTGAT	CASSFSGADQPQHF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	6	5	5	6	0	26	40	-1	46	51		TCRBV12-03,TCRBV12-04				01,02								CASSFSGADQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTTTATCAGGGACTGGCTACACCTTCGGTTCG	CASSLSGTGYTF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	36	unresolved						TCRBJ01	TCRBJ01-02	01	2	0	7	7	3	0	26	41	-1	44	49	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGTGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGTGGGTTTGAACCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSGFEPYNEQFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	48	TCRBV12						TCRBJ02	TCRBJ02-01	01	2	0	9	2	3	7	26	41	47	44	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGFEPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGACAGCCCGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSTARGTGELFF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	5	4	1	7	26	39	45	40	52		TCRBV12-03,TCRBV12-04												CASSSTARGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTACACTCGGGGGATATGGCTACACCTTCGGTTCG	CASSVATLGGYGYTF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	2	5	12	1	26	37	55	49	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVATLGGYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCTGAACTAGCCGCTGAGCAGTTCTTCGGGCCA	CASSPELAAEQFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	7	9	5	3	23	35	46	40	49	TCRBV09,TCRBV21					01,02								CASSPELAAEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGCTGTGTATTTCTGTGCCAGCAGCCCAAAACCTCCGGGACAGGAAGAGGTGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	1.7956355493588524E-4		61	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	4	0	10	8	13	26	44	36	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCCTCAATCGACAGGTCTGTACGAGCAGTACTTCGGGCCG	XASSPQSTGLYEQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	4	8	4	22	34	48	42	52	TCRBV01,TCRBV07,TCRBV17													XASSPQSTGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGCCGGACATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRTYSNQPQHF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	6	0	2	2	26	37	44	39	46	TCRBV06,TCRBV10													CASSRTYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGGCGGACTATACACTACGAGCAGTACTTCGGGCCG	CASRRTIHYEQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	1	9	3	2	4	24	35	43	37	47	TCRBV22,TCRBV24					01,02								CASRRTIHYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGCCTCAACAGGGGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLNRGVTGELFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	1	4	5	2	22	33	46	38	48	TCRBV11,TCRBV12													CASSLNRGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGGGGTTACAATGAAAAACTGTTTTTTGGCAGT	CSARAGGYNEKLFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	1	5	0	4	26	-1	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSARAGGYNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGCGGGGTCTAACTATGGCTACACCTTCGGTTCG	CASAGSNYGYTF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	7	3	0	0	1	26	-1	41	35	42		TCRBV03-01,TCRBV03-02												CASAGSNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACACAGGGGGCGTTTACGATGGCTACACCTTCGGTTCG	CASSHTGGVYDGYTF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	6	1	7	26	40	50	41	57		TCRBV03-01,TCRBV03-02												CASSHTGGVYDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGTACCCGGGGGCAGGCACAGATACGCAGTATTTTGGCCCA	CASSLAYPGAGTDTQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	51	TCRBV12						TCRBJ02	TCRBJ02-03	01	0	6	0	1	6	2	26	43	55	49	57		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAYPGAGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCCGGCCGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSLRPANQPQHF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	9	0	3	4	4	26	38	45	42	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPANQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTATGCTCGGGGAGCTGTTTTTTGGAGAA	CASSVAMLGELFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	7	7	2	6	26	37	43	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVAMLGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGCAGCCAGCTTCTATGGCTACACCTTCGGTTCG	CASSAASFYGYTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	0	4	5	4	0	3	23	-1	43	40	46	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAASFYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTTAGGGGACAGAGCGGCGGGGAGCTGTTTTTTGGAGAA	CASSFRGQSGGELFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	5	7	3	5	19	33	43	36	48	TCRBV07,TCRBV11													CASSFRGQSGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGTCGCAAGGCACCAAGAGACCCAGTACTTCGGGCCA	CASSLVARHQETQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	1	5	4	0	5	1	18	34	42	39	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVARHQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGATAAGACAGGGGTGACTGAAGCTTTCTTTGGACAA	CASSQDKTGVTEAFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	5	3	2	18	35	46	38	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDKTGVTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTTATACAGGGATGAAAAACTGTTTTTTGGCAGT	CASSLYRDEKLFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	3	6	1	0	22	37	-1	38	44	TCRBV12,TCRBV21													CASSLYRDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTAGGTGCCGGGCCCCGTACACCCCTCCACTTTGGGAAC	CASSVGAGPRTPLHF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	1	8	0	11	5	6	22	38	47	43	53	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGAGPRTPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAAAAGAASSMSWCRGCYWTSTATCTCTGTGCCAGCAGCCGGACTAGCGGGGGGCACACAGATACGCAGTATTTTGGCCCA	CASSRTSGGHTDTQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	1	1	2	5	2	27	35	54	40	56	TCRBV11,TCRBV19													CASSRTSGGHTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGACAGGGTATGAAAAACTGTTTTTTGGCAGT	CSARETGYEKLFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	3	6	3	1	26	37	47	40	48		TCRBV20-01,TCRBV20-or09_02												CSARETGYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAGCGAGTGGGGACACTGAAGCTTTCTTTGGACAA	CSAKASGDTEAFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	6	2	3	10	0	26	34	-1	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKASGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGGACAGTTACCTCTATGGCTACACCTTCGGTTCG	CASSQGGDSYLYGYTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	4	3	6	26	42	52	45	58		TCRBV03-01,TCRBV03-02												CASSQGGDSYLYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGGGATCGTACGAGCAGTACTTCGGGCCG	CASSQEGGSYEQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	1	4	0	4	26	-1	49	43	53		TCRBV03-01,TCRBV03-02												CASSQEGGSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAGGGCACTTCGGGGACTGAAGCTTTCTTTGGACAA	CASSEGTSGTEAFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	3	5	10	0	26	38	-1	48	53		TCRBV12-03,TCRBV12-04				01,02								CASSEGTSGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGAACGGGGCCCGAGCGGCTACACCTTCGGTTCG	CASSVERGPSGYTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	42	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	7	0	8	8	6	26	37	50	45	56		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVERGPSGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTTAAGCGGGGAGACTGAAGCTTTCTTTGGACAA	CASSLSGETEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	6	3	5	2	2	22	35	44	37	46	TCRBV07,TCRBV23													CASSLSGETEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTTTATCTTTGCCAGCAGCCAAGATTTAATGTCAGAGTTTTACGGGGAGTTGTTTTTTGGAGAA		Out	VDJ	1	15	1.5843843082578111E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	13	8	3	15	30	3	19	22	57	52	60	TCRBV04,TCRBV05,TCRBV11					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GGACTCGGCCCTCTATCTCTGTGCCAACAGCCCGACAGAGCTGAGCTCTGGAAACACCATATATTTTGGAGAG	CANSPTELSSGNTIYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	5	0	2	7	19	31	38	33	45		TCRBV05-06,TCRBV05-07												CANSPTELSSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTCTGGGCTGGCTACACCTTCGGTTCG	CASSELWAGYTF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	36	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	8	0	7	4	0	23	38	-1	42	46		TCRBV06-01,TCRBV06-08												CASSELWAGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCACTGGGGGGGATTGATACGCAGTATTTTGGCCCA	CASSLGGIDTQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	9	0	6	7	3	24	31	45	38	48		TCRBV24-01,TCRBV24-or09_02												CASSLGGIDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAAAGCAGGGTCAGACACCGGGGAGCTGTTTTTTGGAGAA	CSVKAGSDTGELFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	3	3	6	4	26	33	44	39	48		TCRBV20-01,TCRBV20-or09_02												CSVKAGSDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTCTCAGGGGGCCCCTATAATGAGCAGTTCTTCGGGCCA	CSARDFSGGPYNEQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	7	5	6	26	40	53	45	59		TCRBV20-01,TCRBV20-or09_02												CSARDFSGGPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGTGGTACTAGCACAGATACGCAGTATTTTGGCCCA	CSGGTSTDTQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	3	10	0	7	0	26	31	-1	38	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSGGTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCATCAAAAGCGCGACACTAACCGGGGAGCTGTTTTTTGGAGAA	CAIKSATLTGELFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	7	2	6	5	7	3	24	34	45	41	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIKSATLTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCGGACAGTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGQFSNQPQHF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	0	3	2	24	36	45	39	47	TCRBV06,TCRBV10													CASSPGQFSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACAAAAAAAGAACACTGAAGCTTTCTTTGGACAA	CASSLQKKNTEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	6	1	0	6	26	-1	43	41	49		TCRBV12-03,TCRBV12-04												CASSLQKKNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACCGGTCGGGACAGGGGAAGGTCCTTCGGGCCG	CASSTGRDRGRSF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	15	8	6	26	37	55	45	61		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTGRDRGRSF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGCCAGACCTATCTGTACCACTGTGGCAGTTCTCAACTTAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	4.6475273042229125E-4		50	TCRBV08	TCRBV08-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	5	7	5	9	9	22	30	43	39	52						01,02								X+TCRBV08-02+TCRBJ02-06	TCRBV08-02*01	TCRBD02-01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGCCAGACCTATCTGTACCACTGTGCCAGCAGGGGAGCGGGAGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASRGAGGTYNEQFF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV08	TCRBV08-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	0	4	4	3	22	32	46	36	49														CASRGAGGTYNEQFF+TCRBV08-02+TCRBJ02-01	TCRBV08-02*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGTGGGAGGAGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSQDVGGGGADTQYF	In	VDJ	4	210	0.0022181380315609354	0.0027843704008167487	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	1	4	3	8	23	40	49	43	57													Vb 7.1	CASSQDVGGGGADTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGCAGACTCTGGAAACACCATATATTTTGGAGAG	CASSQEADSGNTIYF	In	VDJ	3	152	0.001605509432367915	0.002015353813924504	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	5	0	2	1	23	40	45	42	46													Vb 7.1	CASSQEADSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATTCTGGACAGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	XASSQDSGQSNTGELFF	In	VDJ	2	138	0.0014576335635971861	0.0018297291205367206	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	5	0	4	1	23	40	50	44	51													Vb 7.1	XASSQDSGQSNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGGGCAGGGAGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDGQGASGANVLTF	In	VDJ	2	104	0.0010985064537254157	0.0013789262937378183	54	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-06	01	0	4	3	0	4	3	23	40	49	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDGQGASGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTCTGGGGTGACACTGAAGCTTTCTTTGGACAA	XASSQVWGDTEAFF	In	VDJ	2	95	0.001003443395229947	0.0012595961337028149	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	1	6	2	3	3	2	23	39	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQVWGDTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCAGCCCTGTATCTCTGCGCCAGCAGCCTCGGGTCCCGCCCGGGACTAGCGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGSRPGLAGAGTGELFF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	63	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	0	2	4	13	4	15	28	55	41	59													Vb 7.1	CASSLGSRPGLAGAGTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGGACGTCCTCTGGAAACACCATATATTTTGGAGAG	YASSQGTSSGNTIYF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-03	01	1	1	7	0	0	3	22	-1	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQGTSSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCCCGACAGAGACTCTGGAAACACCATATATTTTGGAGAG	YASSQDPDRDSGNTIYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	5	0	4	3	22	39	48	43	51													Vb 7.1	YASSQDPDRDSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGAGTTTACTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQDEFTSSYEQYF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	8	0	7	0	23	40	-1	47	52						01,02							Vb 7.1	CASSQDEFTSSYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGCCGTGTATCTCTACGCCAGCAGCCAAGAAGGGGATAAGGGGTAGCGGACGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	38	4.013773580919788E-4		64	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	5	0	13	6	14	31	50	44	56						01,02							Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTATCTGGGAGATCAAACTATGGCTACACCTTCGGTTCG	CASSLSGRSNYGYTF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	2	2	5	4	23	36	46	41	50													Vb 7.1	CASSLSGRSNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGTGGGGGGCAGATAGCTATGGCTACACCTTCGGTTCG	CASSQEWGADSYGYTF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	0	6	0	4	3	6	23	40	49	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQEWGADSYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGCTCTTCATCGAACTATGGCTACACCTTCGGTTCG	CASSQGSSSNYGYTF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	1	4	6	2	6	3	23	39	47	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGSSSNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCCACTAGCCAGGATGAGCAGTTCTTCGGGCCA	CASSQATSQDEQFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	7	8	2	4	23	39	47	41	51						01,02							Vb 7.1	CASSQATSQDEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTCACGCCGGGGAGCTGTTTTTTGGAGAA	CASSHAGELFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	33	TCRBV06	TCRBV06-09	01				TCRBJ02	TCRBJ02-02	01	5	3	7	6	1	1	26	38	41	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSHAGELFF+TCRBV06-09+TCRBJ02-02	TCRBV06-09*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGATAGTGACCCCGGGACTAGCGGGCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	77	8.133172782390097E-4		56	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	4	2	11	3	25	36	59	47	62			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGGTGTACCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	49	5.175655406975516E-4		40	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	5	3	7	0	26	39	-1	46	49			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGAGGTCGGGGCACTGAAGCTTTCTTTGGACAA	CASSGGRGTEAFF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	39	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	3	4	5	0	26	39	-1	44	49			01,02										Vb 12	CASSGGRGTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGTTCCACAGCGTTTACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	2.9575173754145805E-4		47	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-05	01	4	3	5	3	5	6	26	39	48	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ01-05	TCRBV10-01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTCAGGGACGAGGTACTGAAGCTTTCTTTGGACAA	CASSQGRGTEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-01	01	5	0	7	5	2	5	26	38	45	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSQGRGTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGAGGACAGGGTGTCACAGATACGCAGTATTTTGGCCCA	CATSGGQGVTDTQYF	In	VDJ	7	371	0.003918710522424319	0.004919054374776256	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	3	2	0	3	18	-1	41	34	44														CATSGGQGVTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGGGGTAGCCTACAATGAGCAGTTCTTCGGGCCA	CATSRVGVAYNEQFF	In	VDJ	5	269	0.0028413291928090076	0.0035666458943795494	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	1	6	1	2	1	3	18	34	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVGVAYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCACCCATTGGGGAACATACAATGAGCAGTTCTTCGGGCCA	CATTHWGTYNEQFF	In	VDJ	2	109	0.001151319264000676	0.0014452208270905981	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	7	0	8	4	7	3	18	28	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATTHWGTYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGCTTCTAGTTGGGGGCGGCGGGGAGCTGTTTTTTGGAGAA	CATSRLLVGGGGELFF	In	VDJ	2	105	0.0011090690157804677	0.0013921852004083744	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	6	0	7	10	2	18	32	48	42	50														CATSRLLVGGGGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAACTTGGGGACTGGAAACACCATATATTTTGGAGAG	CATSRDNLGTGNTIYF	In	VDJ	2	105	0.0011090690157804677	0.0013921852004083744	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-03	01	0	0	8	2	7	0	18	35	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDNLGTGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCCGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CATSAGQGNTEAFF	In	VDJ	2	97	0.0010245685193400512	0.0012861139470439268	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	1	3	0	18	30	-1	33	41														CATSAGQGNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAACAGCATAGCAATCAGCCCCAGCATTTTGGTGAT	CATSREQHSNQPQHF	In	VDJ	2	95	0.001003443395229947	0.0012595961337028149	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	0	0	2	18	-1	39	35	41														CATSREQHSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGCTCCCCTTAGGGAAATGGCTACACCTTCGGTTCG	CATSREGSP*GNGYTF	Stop	VDJ	2	94	9.92880833174895E-4		48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	0	0	8	6	12	1	18	35	51	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREGSP*GNGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCCGCCGGGGGGGGTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	92	9.717557090647908E-4		47	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	0	3	5	2	18	31	44	36	46														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATACGGTGACGGCGTATGAGCAGTTCTTCGGGCCA	CATSRDTVTAYEQFF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	2	7	8	6	5	18	35	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDTVTAYEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAACAGCGCACAGATACGCAGTATTTTGGCCCA	CATSREQRTDTQYF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	5	1	0	1	18	-1	39	35	40														CATSREQRTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGGGGTTGGGTTGAGAATGGGAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	78	8.238798402940618E-4		59	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	2	6	1	18	18	35	42	36	60														X+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTTTACACACCTTGATCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	26	2.746266134313539E-4		53	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	6	1	4	8	18	35	42	39	50														X+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTCAGCAGGAGGGGGGCGGGGGCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	2.429389272661977E-4		43	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	14	7	2	1	13	1	18	21	41	34	42														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTCGCCGGGACAGGGGAAGGTGAGCAGTTCTTCGGGCCA	CASSFAGTGEGEQFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	9	6	4	18	30	46	36	50														CASSFAGTGEGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCACAGGGGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CATSTTGAGANVLTF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	2	4	2	2	18	31	40	33	42														CATSTTGAGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGTCCCCCCGACAGGGGGCTCTACGAGCAGTACTTCGGGCCG	CASSPPDRGLYEQYF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	0	3	7	1	18	29	46	36	47														CASSPPDRGLYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGAGCCCGGGCAGAACACTGAAGCTTTCTTTGGACAA	CATSEPGQNTEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	1	6	1	18	30	40	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSEPGQNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCTGTGGGGGGACCCCTAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	1.7956355493588524E-4		46	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	1	5	5	8	22	34	45	39	53														X+TCRBV12-01+TCRBJ02-05	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTTCGGGACTCTCTGAAGCTTTCTTTGGACAA	CASSFSGLSEAFF	In	VDJ	1	80	8.450049644041659E-4	0.0010607125336444757	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	0	10	6	3	2	18	32	41	35	43						01,02								CASSFSGLSEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTGCACAGGGGTTAGACAATGAGCAGTTCTTCGGGCCA	CASSFAQGLDNEQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	2	5	3	4	18	32	42	35	46														CASSFAQGLDNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACTAGCGGGCACACAGATACGCAGTATTTTGGCCCA	CASRTSGHTDTQYF	In	VDJ	22	1198	0.012653949341952384	0.015884170191326024	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	4	2	0	2	18	-1	39	29	41						01,02								CASRTSGHTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCGGACAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFADRSSYEQYF	In	VDJ	12	641	0.0067706022772883795	0.00849895917582636	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	0	3	2	18	32	42	35	44														CASSFADRSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACTCTAGCGGAGGCCGAGCAGTTCTTCGGGCCA	CASSLTLAEAEQFF	In	VDJ	11	619	0.006538225912077233	0.00820726322907413	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	5	10	3	5	18	33	43	36	48						01,02								CASSLTLAEAEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGTGCCTTGGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSGALGQNTEAFF	In	VDJ	9	492	0.00519678053108562	0.006523382081913526	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	7	0	1	8	1	18	30	43	38	44														CASSGALGQNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGACAGCCTCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSSGTASLNTEAFF	In	VDJ	4	203	0.0021442000971755707	0.002691558054122857	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	2	6	18	31	40	33	46														CASSSGTASLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCAGGTGGCGGGGCCTTAACCGGGGAGCTGTTTTTTGGAGAA	CASTPGGGALTGELFF	In	VDJ	4	202	0.002133637535120519	0.002678299147452301	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	7	3	5	9	5	18	28	43	37	48														CASTPGGGALTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGTAGCGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSRSGGSYNEQFF	In	VDJ	3	171	0.0018061981114139045	0.0022672730406650666	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	0	4	0	18	31	-1	35	44														CASSSRSGGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGGGACTAGCGGGAGGAGAGAATGAGCAGTTCTTCGGGCCA	CASSGGLAGGENEQFF	In	VDJ	3	167	0.0017639478631936963	0.0022142374139828428	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	1	7	2	4	18	30	47	32	51														CASSGGLAGGENEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCCCAACGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLSPTAGELFF	In	VDJ	3	150	0.001584384308257811	0.0019888360005833917	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	5	6	7	0	18	33	-1	40	43						01,02								CASSLSPTAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACCCCAAGACTAGCGGGGGAATCCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	129	0.0013625705051017174		61	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	4	2	2	0	8	6	18	31	51	39	57														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAACAACTAGGGACAATGAGCAGTTCTTCGGGCCA	CASSQTTRDNEQFF	In	VDJ	2	127	0.0013414453809916134	0.0016838811471606052	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	8	5	6	2	18	30	41	36	43						01,02								CASSQTTRDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGACAGGGCCTAACTATGGCTACACCTTCGGTTCG	CASSQGTGPNYGYTF	In	VDJ	2	106	0.0011196315778355197	0.0014054441070789302	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	0	3	1	18	30	42	33	43														CASSQGTGPNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCACAGGGACGTGGGTGAAAAACTGTTTTTTGGCAGT	CASSSHRDVGEKLFF	In	VDJ	2	97	0.0010245685193400512	0.0012861139470439268	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	7	3	7	18	31	40	34	47														CASSSHRDVGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCTTGGGGGGTACCCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSALGGYPLNTEAFF	In	VDJ	2	97	0.0010245685193400512	0.0012861139470439268	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	0	6	7	18	30	42	36	49														CASSALGGYPLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGCGGGACTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CASSAAGLAGADTQYF	In	VDJ	2	94	9.92880833174895E-4	0.001246337227032259	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	4	5	0	18	30	-1	35	49														CASSAAGLAGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACAGGAGCGCCATGAACACTGAAGCTTTCTTTGGACAA	CASSLDRSAMNTEAFF	In	VDJ	1	83	8.766926505693221E-4	0.0011004892536561435	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	0	4	4	0	0	7	18	-1	39	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDRSAMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGGGGGGAGTAGCGGACCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	81	8.555675264592179E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	3	1	12	18	33	42	34	54														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCCAGGCGGGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	78	8.238798402940618E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	3	7	6	0	18	34	-1	40	46														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTATCGGCTAGCGGCCTATACAATGAGCAGTTCTTCGGGCCA	CASSLLSASGLYNEQFF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	5	4	7	4	18	33	47	40	51						01,02								CASSLLSASGLYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGGGCTGATGGCTACACCTTCGGTTCG	CASSLGQGADGYTF	In	VDJ	1	58	6.126285991930202E-4	7.690165868922448E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	6	0	2	18	-1	44	32	46														CASSLGQGADGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGACATCGCCCGAACTTAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	58	6.126285991930202E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	6	5	1	13	18	31	37	32	50														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCATGGCAATCTCGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	58	6.126285991930202E-4		56	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	15	5	18	30	49	45	54														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAAGGACAGATTCATACAATGAGCAGTTCTTCGGGCCA	CASRRTDSYNEQFF	In	VDJ	1	58	6.126285991930202E-4	7.690165868922448E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	5	4	2	5	18	29	37	31	42														CASRRTDSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCTGGGGTAGCGGGGTACGGTGAGACCCAGTACTTCGGGCCA	CASSPPGVAGYGETQYF	In	VDJ	1	52	5.492532268627079E-4	6.894631468689091E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	3	5	10	6	18	30	48	40	54														CASSPPGVAGYGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGCCTAATAAAAGAGACCCAGTACTTCGGGCCA	CASSPSLIKETQYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	7	3	1	7	18	30	36	31	43						01,02								CASSPSLIKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCAGTTACCGTTCTACGAGCAGTACTTCGGGCCG	CASSSQLPFYEQYF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	5	3	2	8	18	31	36	33	44														CASSSQLPFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCAGAGAGGGTACGACAATGAGCAGTTCTTCGGGCCA	CASTQRGYDNEQFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	11	0	5	6	4	18	28	39	34	43														CASTQRGYDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACGGCGAATCAGCCCCAGCATTTTGGTGAT	CASSPGTANQPQHF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	0	7	4	3	4	18	30	38	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTANQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGTATCTATTCGTCGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSQGIYSSGNEKLFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	5	16	0	18	30	-1	46	51														CASSQGIYSSGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCATAGCGGGAAGGGACGAGCAGTACTTCGGGCCG	CASSLAIAGRDEQYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	3	5	5	4	18	32	45	37	49														CASSLAIAGRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATTGGACAGGGTTTTTCCGAGCAGTACTTCGGGCCG	CASSIGQGFSEQYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	6	3	6	18	30	41	33	47														CASSIGQGFSEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGACAGCCAAACAATGAGCAGTTCTTCGGGCCA	CASSFRQPNNEQFF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	5	2	4	18	32	39	34	43														CASSFRQPNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGTAGAGTACTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	34	3.591271098717705E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	3	10	0	7	0	18	35	-1	42	45						01,02								X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCACAGGGGGCGGTTTAGGCTATGGCTACACCTTCGGTTCG	CASSLSTGGGLGYGYTF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	0	4	3	8	18	33	45	36	53														CASSLSTGGGLGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTAAAGAAAAGAGACCCAGTACTTCGGGCCA	CASSLG*RKETQYF	Stop	VDJ	1	29	3.063142995965101E-4		42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	0	10	3	0	7	18	-1	36	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLG*RKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGGGAGTCCCTACGAGCAGTACTTCGGGCCG	CASSLGQGSPYEQYF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	2	0	4	18	-1	42	34	46														CASSLGQGSPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGCCCCTAGATACGCAGTATTTTGGCCCA	CASSLDGPLDTQYF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	0	8	0	5	1	4	18	35	40	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGPLDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGACTACCCCAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDYPSTDTQYF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	0	4	4	18	30	41	34	45						01,02								CASSPRDYPSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTGGTCGGTCTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	27	2.85189175486406E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	8	5	0	6	4	18	32	41	38	45						01,02								X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTTTGGGCCTAGAGACCCAGTACTTCGGGCCA	CASSLVLGLETQYF	In	VDJ	1	27	2.85189175486406E-4	3.579904801050105E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	4	4	2	18	34	42	38	44														CASSLVLGLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACAGGATGGAGGGAGCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	2.85189175486406E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	6	7	3	18	30	43	37	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGTCAGGGGGCTAATGGCTACACCTTCGGTTCG	CASSFSQGANGYTF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	6	4	2	18	32	44	36	46														CASSFSQGANGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTCCCAATTTATAGAGACCCAGTACTTCGGGCCA	CASSLDSQFIETQYF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	0	4	6	4	4	6	18	35	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDSQFIETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAGCTCCGGGACAGTTTATGGCTACACCTTCGGTTCG	CASSSSSGTVYGYTF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	5	8	2	18	31	46	39	48														CASSSSSGTVYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGTGACAGGGTAACCACTGAAGCTTTCTTTGGACAA	CASSQGDRVTTEAFF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	6	4	18	30	43	36	47														CASSQGDRVTTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATSTCTGTGCCAGCGTCCGGGAAGACCTCTCTGGAAACACCATATATTTTGGAGAG	CASVREDLSGNTIYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	8	8	3	0	3	6	18	27	35	30	41														CASVREDLSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTACAGGACGTAGGGAAAAACTGTTTTTTGGCAGT	CASSLITGRREKLFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	4	8	3	7	18	33	41	36	48														CASSLITGRREKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTGCGGACAGGACAGATACGCAGTATTTTGGCCCA	CASSRADRTDTQYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	3	5	0	18	30	-1	35	42														CASSRADRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCAGGGGCCTCTGGAAACACCATATATTTTGGAGAG	CASSLPGASGNTIYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	2	0	2	1	18	32	40	34	41														CASSLPGASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTAAGGACAGGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	23	2.429389272661977E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	2	7	5	0	18	33	-1	38	47														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGAGGGGCGAGGGGTGGACACTGAAGCTTTCTTTGGACAA	CASSREGRGVDTEAFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	0	3	0	11	18	-1	38	30	49														CASSREGRGVDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACAGATGGAGGGGACGGTAATTCACCCCTCCACTTTGGGAAC	CASTDGGDGNSPLHF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	10	0	6	5	5	18	28	39	33	44														CASTDGGDGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGTTGATAGCGGGTACTACGAGCAGTACTTCGGGCCG	CASSPVDSGYYEQYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	4	3	8	2	18	30	45	38	47						01,02								CASSPVDSGYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGGGGACAAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.3237636521114563E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	6	0	6	3	18	30	42	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCGACAGGGTTGGAGACCCAGTACTTCGGGCCA	CASSPPTGLETQYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	5	3	18	30	42	35	45														CASSPPTGLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCCAATTCCGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASTPNSGNYNEQFF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	3	3	10	1	18	28	43	38	44														CASTPNSGNYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCATCGGGGACACCTCCAAGAGACCCAGTACTTCGGGCCA	CASSHRGHLQETQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	1	6	3	18	29	41	35	44														CASSHRGHLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCGACTAGCGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASRSTSGGQETQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	2	2	3	1	18	29	44	32	45														CASRSTSGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGAGACAGGAAAGTACGAGCAGTACTTCGGGCCG	CASSSETGKYEQYF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	4	4	0	4	18	-1	41	35	45														CASSSETGKYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCCAGGGTTGGAGGAGACCCAGTACTTCGGGCCA	CASSLGPGLEETQYF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	3	5	3	6	18	34	42	37	48														CASSLGPGLEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAATAGCGGGAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSLVIAGVYNEQFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	3	5	1	18	32	46	37	47														CASSLVIAGVYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAGCGGGAGGGACCTACGAGCAGTACTTCGGGCCG	CASSLGLAGGTYEQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	0	0	2	0	1	18	-1	48	32	49														CASSLGLAGGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACAGGGGAGGAGTTCTCTGACCAGTACTTCGGGCCA	CASSLTGEEFSDQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	2	10	0	13	18	-1	40	33	53														CASSLTGEEFSDQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGACAGGGCTATGGAACACTGAAGCTTTCTTTGGACAA	CASSSRTGLWNTEAFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	1	3	5	18	31	42	34	47														CASSSRTGLWNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGTGGGGTCGAGAAACACCATATATTTTGGAGAG	CASSPVGSRNTIYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	6	2	5	5	4	18	30	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPVGSRNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGACAGGGAGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGETGELFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	5	3	4	18	30	41	33	45														CASSPGQGETGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATACTGCCATGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	1.7956355493588524E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	1	8	4	10	5	18	30	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLGGAKNIQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	7	4	1	0	0	18	-1	-1	34	39						01,02								CASSLGGAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCGGGGCTAGGGGGGACCCAGTACTTCGGGCCA	CASSQAGLGGTQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	3	7	2	8	18	30	39	32	47														CASSQAGLGGTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCAAAATGGGGTTCGAAAGAACACTGAAGCTTTCTTTGGACAA	CASQNGVRKNTEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	8	6	2	1	6	7	18	27	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQNGVRKNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCCCCTTATTAATCAGCCCCAGCATTTTGGTGAT	CASSLAPLINQPQHF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	9	0	4	0	10	18	-1	35	32	45														CASSLAPLINQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCGGGACAGGACGTCAGACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	1.5843843082578111E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	7	5	8	18	32	45	37	53														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCTTGGGACAGGAGAGCTATGGCTACACCTTCGGTTCG	CASSLPLGQESYGYTF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	4	6	4	18	32	46	38	50														CASSLPLGQESYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCTGGACCTTACGAGCAGTACTTCGGGCCG	CASSLGSGPYEQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	1	7	4	5	2	18	34	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGAGCAGGGTTTGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	1.5843843082578111E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	4	1	5	18	35	41	36	46														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACGACAGCGGGAGGGTTAGAGACCCAGTACTTCGGGCCA	CASTTAGGLETQYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	6	0	4	4	2	18	28	42	32	44														CASTTAGGLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGGGACAGGGGAGGATTCTGGAAACACCATATATTTTGGAGAG	CASSLGTGEDSGNTIYF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	2	1	1	5	18	32	43	33	48														CASSLGTGEDSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCGGACTAAGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASGLAD*GASTDTQYF	Stop	VDJ	2	94	9.92880833174895E-4		51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	9	0	1	7	26	42	49	43	56						01,02								CASGLAD*GASTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCATTAACCCGCTCTCTGGAAACACCATATATTTTGGAGAG	CASTINPLSGNTIYF	In	VDJ	1	83	8.766926505693221E-4	0.0011004892536561435	45	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	12	4	5	0	0	15	26	-1	34	31	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTINPLSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGGGAACTTATCATTCAGTACTTCGGCGCC	CASGELIIQYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	12	6	3	9	1	7	26	31	39	32	46														CASGELIIQYF+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCCCCCAGGGAGTGGTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	2.9575173754145805E-4		46	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	6	4	3	3	6	8	26	37	48	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTTCAGAGAAACTGAAGCTTTCTTTGGACAA	CASGLFRETEAFF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	2	4	5	5	2	4	26	41	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLFRETEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTGGTGGCAGGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASGGRGGEKLFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	5	4	2	7	2	3	26	38	46	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGGRGGEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCTAACTCCGGGACAGAGAGAACACTGAAGCTTTCTTTGGACAA	CASGS*LRDRENTEAFF	Stop	VDJ	1	19	2.006886790459894E-4		51	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	1	9	3	26	39	55	48	58														CASGS*LRDRENTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCCCAAATTATTGTCCCTGTACTTCTGTGCCAGCAGTAGAAGACGGGACTAGCGGCGAACCGTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.858778545323954E-4		55	TCRBV13	TCRBV13-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	5	3	8	9	26	37	56	45	65						01,02							Vb 23	X+TCRBV13-01+TCRBJ02-07	TCRBV13-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCAGTCTAGCGGGGTACTCCTACGAGCAGTACTTCGGGCCG	CASSSLAGYSYEQYF	In	VDJ	33	1849	0.019530177239791283	0.024515718433857945	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	0	4	2	20	31	44	35	46														CASSSLAGYSYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGTCAAGACGGAGAACACTGAAGCTTTCTTTGGACAA	CASVKTENTEAFF	In	VDJ	18	1018	0.010752688172043012	0.013497566990625954	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	8	1	8	1	8	0	20	29	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVKTENTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAACCCATTAGGACAGGGATTCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTH*DRDSYSNQPQHF	Stop	VDJ	4	206	0.002175887783340727		60	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	0	8	7	20	35	51	43	58														CASSQTH*DRDSYSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAACCTCGAGCCTGTAGTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTSSL*FSNQPQHF	Stop	VDJ	2	117	0.0012358197604410927		54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	5	8	0	12	2	20	35	50	47	52						01,02								CASSQTSSL*FSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATACCCCTCACGACGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	97	0.0010245685193400512		58	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	8	2	0	11	0	20	36	-1	47	53														X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCTACGGGGACAGTAGCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	96	0.001014005957284999		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	2	5	4	20	33	45	38	49														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCTAGCAGTCCCCCGAGGGTCCCTCGGGGCACTGAAGCTTTCTTTGGACAA	CASSPPRVPRGTEAFF	In	VDJ	2	88	9.295054608445825E-4	0.0011667837870089233	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	3	4	14	0	20	33	-1	47	52						01,02								CASSPPRVPRGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGCGCAAAACTAAAACAGGGGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	69	7.288167817985931E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	5	13	1	20	31	51	44	52														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCGGTCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	64	6.760039715233327E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	1	4	0	20	33	-1	37	42														X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCCCCCAGGGCCACTCTTCTATGGCTACGTCGCTACACCTTCGGTTCG		Out	VDJ	1	57	6.020660371379682E-4		59	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	9	7	21	20	35	47	42	68														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTCAGTCAGGCGGCCTACGAGCAGTACTTCGGGCCG	CASSLSQAAYEQYF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	6	4	4	2	7	3	20	31	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSQAAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGAACAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	46	4.858778545323954E-4		40	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	1	2	1	20	34	40	36	41														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCCAGGCCTAAGTCAGCCCCAGCATTTTGGTGAT	CASSQDPGLSQPQHF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	4	6	4	6	20	35	43	39	49														CASSQDPGLSQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCGGACAGGCTAGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	3.063142995965101E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	0	1	5	20	31	39	32	44														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACGGCCCGTAGCTAGCGGAGACCCAGTACTTCGGGCCA	CASSHGP*LAETQYF	Stop	VDJ	1	27	2.85189175486406E-4		45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	6	5	10	0	20	34	-1	44	50						01,02								CASSHGP*LAETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCTGGGACAGAACACCGGAGAAGGGTCCTGTTTTTTGGAGAA	CASSSGTEHRRRVLFF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	14	4	17	20	31	42	35	59														CASSSGTEHRRRVLFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAGGGCAGGCTGGAAACACCATATATTTTGGAGAG	CASSLGQAGNTIYF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	6	4	4	2	7	0	20	31	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQAGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGGGGCAGGGGTCCGAACACTGAAGCTTTCTTTGGACAA	CASSWGRGPNTEAFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	1	6	3	20	31	43	37	46														CASSWGRGPNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTGGGGGGCCTTGGGGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	2.2181380315609354E-4		41	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	5	6	0	6	1	8	20	32	39	33	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATTGGGCACCTGGTTCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	1.9012611699093733E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	8	0	6	1	9	20	36	41	37	50														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCGACAAGATGAACACTGAAGCTTTCTTTGGACAA	CASSDKMNTEAFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	0	1	3	20	31	36	32	39														CASSDKMNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATTTGGGTACGACAGGCTGGGAAGGCTACACCTTCGGTTCG	CASSQDLGTTGWEGYTF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	4	8	11	7	20	35	52	46	59														CASSQDLGTTGWEGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAGGGATACAATGAGCAGTTCTTCGGGCCA	CASSQEGYNEQFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	4	0	1	20	-1	40	35	41														CASSQEGYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGACTAGCGGAGGGCATACGCAGTATTTTGGCCCA	CASSYRTSGGHTQYF	In	VDJ	13	701	0.007404356000591503	0.009294493576059718	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	5	7	1	5	23	38	49	39	54						01,02								CASSYRTSGGHTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAGAGTCAGGGACCACTGAAGCTTTCTTTGGACAA	CASGESGTTEAFF	In	VDJ	12	647	0.006833977649618692	0.008578512615849698	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	0	7	4	9	0	23	32	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGESGTTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGAGCGGGAGCAGAGACCCAGTACTTCGGGCCA	CASSYSGAGAETQYF	In	VDJ	7	394	0.0041616494496905165	0.005224009228199043	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	6	2	4	3	1	23	40	51	43	52														CASSYSGAGAETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCAGGGCTGGAAACACCATATATTTTGGAGAG	CASSYGRAGNTIYF	In	VDJ	6	358	0.0037813972157086425	0.004746688588059028	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	3	2	2	0	23	38	-1	40	45														CASSYGRAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGAACGCCGTGTTTCCTTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	308	0.0032532691129560387		49	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	2	8	3	2	16	23	36	40	38	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCCCTCTCATTGAAGCTTTCTTTGGACAA	CASSYSGPLIEAFF	In	VDJ	5	284	0.0029997676236347887	0.0037655294944378887	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	8	0	7	0	8	23	-1	44	40	52														CASSYSGPLIEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTACCGGGACAGGGACTGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSYLPGQGLPSYEQYF	In	VDJ	5	274	0.0028941420030842682	0.003632940427732329	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	0	4	6	23	39	52	43	58														CASSYLPGQGLPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGCGGGTGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVAGGSYNEQFF	In	VDJ	4	240	0.002535014893212498	0.003182137600933427	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	4	0	1	3	23	35	43	36	46						01,02								CASSVAGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSEMNTEAFF	In	VDJ	4	215	0.0022709508418361957	0.0028506649341695283	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	2	0	0	1	23	-1	38	35	39														CASSEMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACACCCGGACTAGCGAGCGATTCAAATGAGCAGTTCTTCGGGCCA	CASSYTPGLASDSNEQFF	In	VDJ	4	212	0.0022392631556710394	0.0028108882141578604	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	6	7	6	9	23	38	53	44	62						01,02								CASSYTPGLASDSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSYSSSSYEQYF	In	VDJ	3	165	0.001742822739083592	0.002187719600641731	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	7	0	0	2	23	-1	44	40	46						01,02								CASSYSSSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGPGANVLTF	In	VDJ	3	165	0.001742822739083592	0.002187719600641731	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	6	0	7	2	3	0	23	34	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCTGGGAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSWEGGTEAFF	In	VDJ	2	134	0.0014153833153769779	0.0017766934938544968	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	9	0	4	4	3	23	32	43	36	46														CASSWEGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAACCGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSTENTGELFF	In	VDJ	2	119	0.0012569448845511967	0.0015778098937961576	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	2	8	2	4	1	23	40	46	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSTENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGGACAGGGGACGCAGATACGCAGTATTTTGGCCCA	CASSAGTGDADTQYF	In	VDJ	2	113	0.0011935695122208842	0.001498256453772822	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	4	3	3	23	35	48	38	51														CASSAGTGDADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGCTATTACGAGGAGCGGGACAACTGATGCAGATACGCAGTATTTTGGCCCA	CASSWAITRSGTTDADTQYF	In	VDJ	2	111	0.0011724443881107802	0.00147173864043171	60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	3	4	14	9	21	34	55	48	64														CASSWAITRSGTTDADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAGGACTAGCGGTAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	106	0.0011196315778355197		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	5	4	3	4	23	34	47	37	51						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGCAGGGGTGAAGCTTTCTTTGGACAA	CASSYSGRGEAFF	In	VDJ	2	102	0.0010773813296153115	0.0013524084803967064	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	7	3	0	23	40	-1	43	49														CASSYSGRGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASSYEGWNTEAFF	In	VDJ	2	100	0.0010562562055052072	0.0013258906670555945	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	5	2	1	1	2	23	38	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEGWNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCCCCCTTAGCGGGGGGGCCGTCGATGAGCAGTTCTTCGGGCCA	CASSYGPLSGGAVDEQFF	In	VDJ	2	99	0.0010456936434501552	0.0013126317603850387	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	8	8	6	23	38	57	46	63														CASSYGPLSGGAVDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGCGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSYERGKETQYF	In	VDJ	2	90	9.506305849546866E-4	0.0011933016003500352	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	2	3	1	1	23	38	47	39	48														CASSYERGKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCAGGGAGGGGGCGCGAGTGGCTACACCTTCGGTTCG	CASSPQGGGASGYTF	In	VDJ	2	90	9.506305849546866E-4	0.0011933016003500352	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	5	0	7	8	5	23	35	50	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQGGGASGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAACCGACAGGGGGTACGAGCAGTACTTCGGGCCG	CASSPTDRGYEQYF	In	VDJ	2	90	9.506305849546866E-4	0.0011933016003500352	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	4	6	0	23	35	-1	41	50														CASSPTDRGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCATCAGGGCCCCAATCAGCCCCAGCATTTTGGTGAT	CASSYHQGPNQPQHF	In	VDJ	2	86	9.083803367344783E-4	0.0011402659736678114	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	3	4	3	23	37	46	41	49														CASSYHQGPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGTGGGGACAGGGCACTATGGCTACACCTTCGGTTCG	CASSSVGTGHYGYTF	In	VDJ	1	83	8.766926505693221E-4	0.0011004892536561435	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	3	5	1	23	36	50	41	51														CASSSVGTGHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTAGGGGGGCTTTCCTACGAGCAGTACTTCGGGCCG	CASSYLGGLSYEQYF	In	VDJ	1	82	8.6613008851427E-4	0.0010872303469855876	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	1	5	1	1	1	4	23	39	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGGLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCCCGGACAGGGCCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	82	8.6613008851427E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	3	0	6	2	23	34	48	40	50														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCTCGATAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	80	8.450049644041659E-4		37	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	5	8	6	7	0	23	36	-1	43	46						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCGGGAGGGGCCTTCCTACGAGCAGTACTTCGGGCCG	CASSPREGPSYEQYF	In	VDJ	1	67	7.076916576884889E-4	8.883467469272484E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	0	1	4	4	23	34	46	38	50														CASSPREGPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCATTACAGGGGAACGAACCCCCGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	67	7.076916576884889E-4		61	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	0	5	15	20	32	44	37	59														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAATCCTTCCCAGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSNPSQGDTGELFF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	3	9	0	23	35	-1	44	51														CASSNPSQGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCGAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSEGNTGELFF	In	VDJ	1	64	6.760039715233327E-4	8.485700269155805E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	11	0	1	1	0	23	40	-1	41	46														CASSDSEGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGTAGCGGGGGGGCCTCCACAGATACGCAGTATTTTGGCCCA	CASRSGGASTDTQYF	In	VDJ	1	57	6.020660371379682E-4	7.557576802216889E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	5	0	2	2	4	23	32	45	34	49														CASRSGGASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTTCGGGTGATGGGGTCGAGCAGTACTTCGGGCCG	CASSFSGDGVEQYF	In	VDJ	1	56	5.915034750829161E-4	7.424987735511329E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	6	2	6	11	1	23	36	51	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGDGVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAACACCCGGGACTAGCGGGAAGCGAGCAGTACTTCGGGCCG	CASSYQHPGLAGSEQYF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	6	8	2	23	38	59	46	61														CASSYQHPGLAGSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCACAGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSAQGSGANVLTF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	2	1	2	0	23	35	-1	37	44														CASSAQGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAAGGGACTAGCGGAAAAGAGACCCAGTACTTCGGGCCA	CASSKGTSGKETQYF	In	VDJ	1	54	5.70378350972812E-4	7.15980960210021E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	3	3	2	23	35	49	38	51						01,02								CASSKGTSGKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCGTATGGGATGAGCAGTTCTTCGGGCCA	CASSTVWDEQFF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	0	9	8	7	0	23	35	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTVWDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGCGGCAACTCAAGAGACCCAGTACTTCGGGCCA	CASSYWAATQETQYF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	1	8	0	2	0	7	23	-1	43	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWAATQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGCAGGAGGGTGATGAGCAGTTCTTCGGGCCA	CASSDGQEGDEQFF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	0	8	8	2	23	35	49	43	51														CASSDGQEGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACACCTTAACGGACCGGTTTACGAGCAGTACTTCGGGCCG	CASRHLNGPVYEQYF	In	VDJ	1	50	5.281281027526036E-4	6.629453335277972E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	1	7	4	10	5	23	34	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRHLNGPVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACAGGGGCATAAATGAAAAACTGTTTTTTGGCAGT	CASRDRGINEKLFF	In	VDJ	1	49	5.175655406975516E-4	6.496864268572413E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	2	5	0	4	23	-1	43	34	47														CASRDRGINEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACGGGACAGGGGTTCAATGAGCAGTTCTTCGGGCCA	CASTTGQGFNEQFF	In	VDJ	1	49	5.175655406975516E-4	6.496864268572413E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	2	6	4	2	23	33	47	37	49														CASTTGQGFNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TCTGTGTACTTGTGTGCCAGCAGTTCCCTACGGGGGTCGGGCCCCACGAGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSLRGSGPTRLAKNIQYF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	63	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	4	8	2	0	5	17	12	25	36	30	53														CASSSLRGSGPTRLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGGAGAGAGCTAAATGGCTACACCTTCGGTTCG	CASSYSRRELNGYTF	In	VDJ	1	46	4.858778545323954E-4	6.099097068455736E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	5	6	0	10	23	-1	44	40	54						01,02								CASSYSRRELNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCAGCGGGGGTTACGAGCAGTACTTCGGGCCG	CASSYSTSGGYEQYF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	6	2	4	4	1	23	40	52	44	53														CASSYSTSGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACCCCAATACTGAAGCTTTCTTTGGACAA	CASSYDPNTEAFF	In	VDJ	1	45	4.753152924773433E-4	5.966508001750176E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	2	7	5	0	6	23	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACTAGCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSTSDTGELFF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	6	3	0	0	23	-1	-1	40	48						01,02								CASSDSTSDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACTAGCGGGAGAGAGACCCAGTACTTCGGGCCA	CASSSGTSGRETQYF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	0	2	4	2	0	23	36	-1	38	52														CASSSGTSGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCAGAGAGCACTGAAGCTTTCTTTGGACAA	CASSYAESTEAFF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	4	5	4	1	4	23	38	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYAESTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACACTCCCGGGACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CASSTLPGQLNEKLFF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	4	9	2	23	34	50	43	52														CASSTLPGQLNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCGCGGGAGGGGTAAATGAGCAGTTCTTCGGGCCA	CASSYGAGGVNEQFF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	0	7	3	3	23	38	50	41	53														CASSYGAGGVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGTGCTCAGGGGGCCGGAAGGCTACACCTTCGGTTCG	CAVLRGPEGYTF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	4	0	8	5	5	23	29	42	34	47														CAVLRGPEGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGACAGAGGGAGCTATGGCTACACCTTCGGTTCG	CASSYWDRGSYGYTF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	4	0	6	23	-1	46	39	52														CASSYWDRGSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAACTCACGACAAACACCTATGGCTACACCTTCGGTTCG	CASSQLTTNTYGYTF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	6	4	8	5	23	35	47	43	52														CASSQLTTNTYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGCAGAGTAGTTTTCGAGACACCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	4.119399201470309E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	2	6	5	17	4	23	32	53	49	57														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGAGAGCAGTACTTCGGGCCG	CASSYGTGEQYF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	4	7	0	1	23	-1	46	38	47														CASSYGTGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGGCCTGGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSYQGAWGGTEAFF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	4	0	9	23	-1	46	38	55														CASSYQGAWGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAAAACAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQNRGNQPQHF	In	VDJ	1	39	4.119399201470309E-4	5.170973601516819E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	2	4	0	23	35	-1	39	45														CASSQNRGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGGCAGGAGTCTCGGTCTGGTCCGGGTCTTCGGGCCA	CASSFGRSLGLVRVF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	4	4	4	17	4	19	23	36	44	40	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGRSLGLVRVF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTTCCGGGGGGGAAAATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	4.013773580919788E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	7	5	3	23	34	47	39	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCGAGTCCCCGTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	3.908147960369267E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	2	2	2	8	23	40	45	42	53														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCTCTCGCGAGCAGTACTTCGGGCCG	CASSDSSREQYF	In	VDJ	1	37	3.908147960369267E-4	4.9057954681057E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	10	6	0	4	23	-1	42	40	46						01,02								CASSDSSREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGAAGGGACAAAACTCCTACGAGCAGTACTTCGGGCCG	CAIRKGQNSYEQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	0	3	3	23	34	43	37	46														CAIRKGQNSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCATTTACCGGGACAGGGAGGTATGGCTACACCTTCGGTTCG	CASSPFTGTGRYGYTF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	5	9	3	23	35	53	44	56														CASSPFTGTGRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACTTCGTTACTACACCTTCGGTTCG	CASSYSLRYYTF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	3	10	10	0	6	23	-1	43	40	49						01,02								CASSYSLRYYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCGGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSDRGSYEQYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	1	3	1	23	35	43	38	44														CASSDRGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCTTTCGGGGCCCCGAAGGTGACACAGGGGCGATCCTATGGCTACACCTTCGGTTCG	CASFGAPKVTQGRSYGYTF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	2	4	23	5	23	29	59	52	64														CASFGAPKVTQGRSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGAGAGACTAGCGGGGGAATACAAGAGACCCAGTACTTCGGGCCA	CASS*ETSGGIQETQYF	Stop	VDJ	1	33	3.485645478167184E-4		51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	2	4	4	23	36	52	40	56														CASS*ETSGGIQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTAGGCGGCAACCCAAGAGACCCAGTACTTCGGGCCA	CASSY*AATQETQYF	Stop	VDJ	1	33	3.485645478167184E-4		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	7	5	1	2	4	23	39	45	41	49						01,02								CASSY*AATQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACAGGGTCCGAGCAGTACTTCGGGCCG	CASSYTGSEQYF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	6	1	2	23	37	44	38	46														CASSYTGSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACCGGAGTGTATGGCTACACCTTCGGTTCG	CASSPTGVYGYTF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	2	5	6	2	23	35	45	41	47														CASSPTGVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGACAGGGGGTAATACTGAAGCTTTCTTTGGACAA	CASRGTGGNTEAFF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	5	1	4	23	34	46	35	50														CASRGTGGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGACAGGGATGTTTACCACTGAAGCTTTCTTTGGACAA	CASSYLTGMFTTEAFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	4	1	8	23	39	47	40	55														CASSYLTGMFTTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGCGGGAGATCGTGGCGAGCAGTACTTCGGGCCG	CASSYSGAGDRGEQYF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	6	4	7	23	40	51	44	58														CASSYSGAGDRGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACTACAGGGGGCTTTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	30	3.1687686165156223E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	0	3	4	3	23	34	47	38	50														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGGCATAGCGGCGGGAGGGCCCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSFGIAAGGPGYNEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	3	11	5	23	36	56	47	61														CASSFGIAAGGPGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTAGCGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSSGGSYNEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	1	0	0	23	-1	-1	36	47														CASSSSGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGGGGGAGAGACTGGCTACACCTTCGGTTCG	CASSYLGGETGYTF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	9	1	7	1	6	23	39	46	40	52														CASSYLGGETGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAGGATCCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDPSSYNEQFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	4	4	0	1	7	23	34	39	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACTGGACTCTCCAGCACTGAAGCTTTCTTTGGACAA	CASRTGLSSTEAFF	In	VDJ	1	29	3.063142995965101E-4	3.845082934461224E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	10	4	4	6	23	34	43	38	49						01,02								CASRTGLSSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAGACAGGGACAAGAGACCCAGTACTTCGGGCCA	CASTRQGQETQYF	In	VDJ	1	28	2.9575173754145805E-4	3.7124938677556647E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	3	2	3	1	23	33	43	36	44														CASTRQGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACCAAAGACAGGGGTAAGGGTTTAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	2.9575173754145805E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	2	2	7	6	13	23	30	44	36	57														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGACATTTATGGCTACACCTTCGGTTCG	CASSYGDIYGYTF	In	VDJ	1	26	2.746266134313539E-4	3.447315734344546E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	5	1	2	23	38	45	39	47														CASSYGDIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTAGGACGGGGAGCTAACTATGGCTACACCTTCGGTTCG	CAISVGRGANYGYTF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	3	0	6	2	23	35	46	41	48						01,02								CAISVGRGANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTATCTCCTACGAGCAGTACTTCGGGCCG	CASSYSISYEQYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	9	0	0	1	23	-1	42	40	43						01,02								CASSYSISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCCTCCCGGGGGGGCAGCCCCAGCATTTTGGTGAT	CASALPGGQPQHF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	8	8	0	7	7	0	23	32	-1	39	47														CASALPGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
TGTGTGCCAGCAGTTACGCTTAACTCTTTTCGGGACTATATAAAGAAGGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	2.429389272661977E-4		68	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	0	9	0	14	12	2	17	38	31	50						01,02								X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTGGAGTGELFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	0	4	1	4	23	33	42	34	46														CASTGGAGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCCCCACCCCTCTGGAAACACCATATATTTTGGAGAG	CAIPHPSGNTIYF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	10	3	7	0	6	2	23	30	38	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIPHPSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCCGGGACAGGGGTCGAAAAACTGTTTTTTGGCAGT	CAISSGTGVEKLFF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	2	2	23	36	48	38	50														CAISSGTGVEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGGAACCTGAGCCCCAGCATTTTGGTGAT	CASSYSGEPEPQHF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	8	0	6	23	-1	45	40	51														CASSYSGEPEPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCCGACAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASNPTGSNQPQHF	In	VDJ	1	22	2.3237636521114563E-4	2.9169594675223083E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	4	0	4	0	23	33	-1	37	43														CASNPTGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATATTACGCTTCTGGAAACACCATATATTTTGGAGAG	CASSLYYASGNTIYF	In	VDJ	1	21	2.2181380315609354E-4	2.784370400816749E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	4	3	7	1	6	3	23	36	44	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYYASGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTTACATATCAGTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	21	2.2181380315609354E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	6	0	4	7	23	33	40	37	47														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGACCGAGAAATATGGCTACACCTTCGGTTCG	CAISGTEKYGYTF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	0	7	5	1	7	23	34	40	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGTEKYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSETGGTEAFF	In	VDJ	1	20	2.1125124110104148E-4	2.6517813341111893E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	4	2	0	23	35	-1	37	46														CASSETGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATAGGGCCGGGACAGAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	2.1125124110104148E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	8	2	23	35	50	43	52														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTCGCGGACTTCACTATGGCTACACCTTCGGTTCG	CAIRGLHYGYTF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	1	10	3	5	2	23	30	40	35	42						01,02								CAIRGLHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAGGACAGGGCACGCACAGATACGCAGTATTTTGGCCCA	CASQDRARTDTQYF	In	VDJ	1	19	2.006886790459894E-4	2.51919226740563E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	3	1	2	3	23	32	42	34	45														CASQDRARTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGACTAGCGGGAAGCGCCCAAGAGACCCAGTACTTCGGGCCA	CASSPGLAGSAQETQYF	In	VDJ	1	18	1.9012611699093733E-4	2.3866032007000703E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	0	3	1	3	5	23	34	50	37	55														CASSPGLAGSAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTACGGGGAGAGACCGGGGAGCTGTTTTTTGGAGAA	CASSLRGETGELFF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	3	5	4	4	23	34	43	38	47						01,02								CASSLRGETGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCGGCCTATCTAACTATGGCTACACCTTCGGTTCG	CASSYRGLSNYGYTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	5	0	1	5	23	38	43	39	48						01,02								CASSYRGLSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGTTACACAGATACGCAGTATTTTGGCCCA	CASSDGYTDTQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	2	7	2	0	5	23	-1	38	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGYTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGAGGGCACATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPEGTSGANVLTF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	0	1	3	4	23	35	43	38	47														CASSPEGTSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATCTACAGGGGAGTCGAGCAGTACTTCGGGCCG	CASRIYRGVEQYF	In	VDJ	1	16	1.6900099288083318E-4	2.1214250672889513E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	6	5	3	23	34	46	39	49														CASRIYRGVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGGTATCTGTTCTTCGGGCCA	CASSYSRGYLFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	15	1	5	23	40	47	41	52														CASSYSRGYLFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATATGCAGGGGGAGTATGGCTACACCTTCGGTTCG	CASSDMQGEYGYTF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	5	6	2	23	35	48	41	50														CASSDMQGEYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACAAACCTGGAACTGAAGCTTTCTTTGGACAA	CASSHKPGTEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	1	8	5	9	0	23	35	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHKPGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAACCTAGCGGGAGAGGAATACAATGAGCAGTTCTTCGGGCCA	CASSNLAGEEYNEQFF	In	VDJ	7	411	0.004341213004626403	0.005449410641598494	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	4	4	5	24	35	49	39	54													Vb 18	CASSNLAGEEYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGATGACAAATACTGAAGCTTTCTTTGGACAA	CASSPMTNTEAFF	In	VDJ	7	369	0.0038975853983142152	0.004892536561435144	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	6	5	3	3	24	38	45	41	48													Vb 18	CASSPMTNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGTAACTTCGCGGGAAGAGGCGGGTCCTACGAGCAGTACTTCGGGCCG	CASNFAGRGGSYEQYF	In	VDJ	3	193	0.0020385744766250502	0.0025589689874172977	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	7	3	1	7	9	24	32	45	39	54													Vb 18	CASNFAGRGGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTTAGGGACGTACGAGCAGTACTTCGGGCCG	CASSPLGTYEQYF	In	VDJ	3	172	0.0018167606734689565	0.002280531947335623	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	0	7	4	4	1	24	38	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLGTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCACTCATACCGGGACAGCCATCCAAGAGACCCAGTACTTCGGGCCA	CATHTGTAIQETQYF	In	VDJ	3	167	0.0017639478631936963	0.0022142374139828428	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	5	1	8	4	24	31	46	39	50													Vb 18	CATHTGTAIQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTCTCTGATAGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSSLIGTGELFF	In	VDJ	3	157	0.0016583222426431756	0.0020816483472772835	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	6	5	4	5	9	1	24	35	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSLIGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTAGGCCAACCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLRPTATNEKLFF	In	VDJ	2	133	0.0014048207533219259	0.0017634345871839407	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	4	5	4	0	2	7	24	37	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLRPTATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGGGGGGAACTGAAGCTTTCTTTGGACAA	CASSPSGGTEAFF	In	VDJ	2	121	0.001278070008661301	0.0016043277071372695	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	5	1	1	24	39	47	40	48													Vb 18	CASSPSGGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQTATNEKLFF	In	VDJ	2	114	0.0012041320742759364	0.0015115153604433778	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	5	0	2	0	24	37	-1	39	43													Vb 18	CASSQTATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSPEGDTEAFF	In	VDJ	2	103	0.0010879438916703635	0.0013656673870672625	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	1	3	1	0	24	39	-1	40	46													Vb 18	CASSPEGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCCAGGGGGGAGGGAGAAAAACTGTTTTTTGGCAGT	CASSPSRGEGEKLFF	In	VDJ	2	86	9.083803367344783E-4	0.0011402659736678114	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	3	4	1	8	3	6	24	38	48	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSRGEGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGCCAGGCCTCGGAACACCATATATTTTGGAGAG		Out	VDJ	1	82	8.6613008851427E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	4	7	2	6	24	40	46	42	52													Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTAGAGTAGAGGTAGGGGAGCAGTTCTTCGGGCCA	CASSRVEVGEQFF	In	VDJ	1	81	8.555675264592179E-4	0.0010739714403150316	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	6	5	3	10	12	0	24	35	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRVEVGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGGACTGGGGACAATGAGCAGTTCTTCGGGCCA	CASSPRTGDNEQFF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	10	5	2	4	24	38	45	40	49						01,02							Vb 18	CASSPRTGDNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGAGGGAACGAGCCCTGAAGCTTTCTTTGGACAA	CASSPREGTSPEAFF	In	VDJ	1	78	8.238798402940618E-4	0.0010341947203033638	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	0	6	0	8	24	-1	47	40	55													Vb 18	CASSPREGTSPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCGGAACGGACACTGAACACTGAAGCTTTCTTTGGACAA	CASSPPERTLNTEAFF	In	VDJ	1	75	7.921921541289055E-4	9.944180002916959E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	0	8	1	24	38	51	46	52													Vb 18	CASSPPERTLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTTGTCAGATACGCAGTATTTTGGCCCA	CASSPPLSDTQYF	In	VJ	1	73	7.710670300188013E-4	9.679001869505841E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	0	0	4	0	5	24	-1	41	-1	46													Vb 18	CASSPPLSDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCAGGACAGCCGAACACTGAAGCTTTCTTTGGACAA	CASSPGQPNTEAFF	In	VDJ	1	69	7.288167817985931E-4	9.148645602683603E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	1	0	2	24	-1	45	39	47													Vb 18	CASSPGQPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGGNQPQHF	In	VDJ	1	68	7.18254219743541E-4	9.016056535978043E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	1	2	0	0	24	-1	-1	37	43													Vb 18	CASSQGGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGACAGGGGAAACTATGGCTACACCTTCGGTTCG	CASSPLDRGNYGYTF	In	VDJ	1	66	6.971290956334368E-4	8.750878402566924E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	2	2	1	1	24	40	50	41	51													Vb 18	CASSPLDRGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTTGAGGCAGGGGTGGGTCAGCCCCAGCATTTTGGTGAT	CASSPVEAGVGQPQHF	In	VDJ	1	65	6.865665335783848E-4	8.618289335861365E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	6	7	4	24	39	52	46	56													Vb 18	CASSPVEAGVGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGCTGGATTGGCAGCCCCAGCATTTTGGTGAT	CASSPGLDWQPQHF	In	VDJ	1	60	6.337537233031245E-4	7.955344002333567E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	8	0	7	0	8	24	-1	43	39	51													Vb 18	CASSPGLDWQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTGGGATGCAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPWDASSGNTIYF	In	VDJ	1	55	5.809409130278641E-4	7.29239866880577E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	0	8	0	2	6	24	38	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPWDASSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCCGGGACAGGTTCGTCGAGAAAAACTGTTTTTTGGCAGT	CASSPPGQVRREKLFF	In	VDJ	1	53	5.598157889177599E-4	7.027220535394651E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	4	8	3	8	24	38	49	41	57													Vb 18	CASSPPGQVRREKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATGACCGGGACCCAAGCTGAAGCTTTCTTTGGACAA	CASSPMTGTQAEAFF	In	VDJ	1	51	5.386906648076557E-4	6.762042401983532E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	7	6	7	5	24	38	50	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPMTGTQAEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGACAGGGCACATTGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRGQGTLGGANVLTF	In	VDJ	1	48	5.070029786424995E-4	6.364275201866855E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	3	4	1	10	24	37	47	38	57													Vb 18	CASSRGQGTLGGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTTAGCGGGGGGGCCCATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLSGGAHSYNEQFF	In	VDJ	1	47	4.964404165874475E-4	6.231686135161295E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	1	3	5	24	38	52	41	57													Vb 18	CASSPLSGGAHSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGGCCAAGAGACCCAGTACTTCGGGCCA	CASSPTGQETQYF	In	VDJ	1	44	4.6475273042229125E-4	5.833918935044617E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	4	1	0	0	24	-1	-1	39	44													Vb 18	CASSPTGQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGTGGATGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSPRGWGSYEQYF	In	VDJ	1	43	4.5419016836723914E-4	5.701329868339057E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	6	2	0	6	0	24	40	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRGWGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCAGCGGGAGATACGCAGTATTTTGGCCCA	CASSPSAGDTQYF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	4	5	3	0	24	38	-1	41	47						01,02							Vb 18	CASSPSAGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACAGCCGGGACCAGCCCCAGCATTTTGGTGAT	CASSPDSRDQPQHF	In	VDJ	1	42	4.436276063121871E-4	5.568740801633498E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	5	7	0	7	24	-1	44	38	51													Vb 18	CASSPDSRDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTTTCTCCCTGACCGGGACGGTGAACACTGAAGCTTTCTTTGGACAA	CASSFSLTGTVNTEAFF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	0	7	0	13	2	24	35	53	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSFSLTGTVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGAAACTGAAGCTTTCTTTGGACAA	CASSPRETEAFF	In	VDJ	1	41	4.33065044257135E-4	5.436151734927938E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	0	8	5	0	1	24	-1	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRETEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGGCAGGCAGATCGGCCCCAGCATTTTGGTGAT	CASSRGQADRPQHF	In	VDJ	1	38	4.013773580919788E-4	5.03838453481126E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	6	0	9	0	10	24	-1	43	37	53													Vb 18	CASSRGQADRPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTAGCCTTGGAAACACCATATATTTTGGAGAG	CASSLSLGNTIYF	In	VDJ	1	36	3.8025223398187465E-4	4.7732064014001407E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	5	7	3	1	2	24	37	42	38	44						01,02							Vb 18	CASSLSLGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGCCAGGTAGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSPRPGSLNTEAFF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	0	4	5	24	39	47	43	52													Vb 18	CASSPRPGSLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACGTCGGAGGGGACCCAGTACTTCGGGCCA	CASSTSEGTQYF	In	VDJ	1	35	3.696896719268226E-4	4.640617334694581E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	7	5	0	24	36	-1	41	47													Vb 18	CASSTSEGTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCAGGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSPPGLSGNTIYF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	4	0	2	3	24	38	44	40	47													Vb 18	CASSPPGLSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGGGGGCAAGGCGATGGGACTGAAGCTTTCTTTGGACAA	CASSRGQGDGTEAFF	In	VDJ	1	34	3.591271098717705E-4	4.5080282679890217E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	5	0	11	24	-1	43	36	54													Vb 18	CASSRGQGDGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPMGGNQPQHF	In	VDJ	1	33	3.485645478167184E-4	4.375439201283462E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	2	2	2	0	24	39	-1	41	46													Vb 18	CASSPMGGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAGGACGAGAACACTGAAGCTTTCTTTGGACAA	CASSKDENTEAFF	In	VDJ	1	32	3.3800198576166635E-4	4.2428501345779027E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	1	7	1	2	2	24	36	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSKDENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGGGACAGGGGACTGGAGCAGCCCCAGCATTTTGGTGAT	CASSRDRGLEQPQHF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	2	7	2	7	24	35	47	37	54													Vb 18	CASSRDRGLEQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGTAGCTGACACTGAAGCTTTCTTTGGACAA	CASSPTVADTEAFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	7	3	4	2	24	39	47	43	49						01,02							Vb 18	CASSPTVADTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCGGGGGACTAACCCAGGACAATGAGCAGTTCTTCGGGCCA	CASGGLTQDNEQFF	In	VDJ	1	31	3.274394237066143E-4	4.110261067872343E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	9	5	2	7	24	33	42	35	49						01,02							Vb 18	CASGGLTQDNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACAGGGATGTCCTACGAGCAGTACTTCGGGCCG	CASSPGTGMSYEQYF	In	VDJ	1	30	3.1687686165156223E-4	3.9776720011667837E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	1	0	3	24	-1	48	39	51													Vb 18	CASSPGTGMSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGACAGGGGGTCTACGAGCAGTACTTCGGGCCG	CASSPRQGVYEQYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	1	3	2	1	24	38	49	40	50													Vb 18	CASSPRQGVYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCAGGGGGTTTAACTACGAGCAGTACTTCGGGCCG	CASSPPRGFNYEQYF	In	VDJ	1	25	2.640640513763018E-4	3.314726667638986E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	3	0	5	24	-1	48	41	53													Vb 18	CASSPPRGFNYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCAAATACAGGGGGTTTTGGAAACACCATATATTTTGGAGAG	CASSPSNTGGFGNTIYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	1	3	6	3	24	39	53	45	56													Vb 18	CASSPSNTGGFGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGAGCGGGGGGGACTCTGAGACCCAGTACTTCGGGCCA	CASSPQSGGDSETQYF	In	VDJ	1	24	2.5350148932124975E-4	3.1821376009334273E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	6	0	5	2	5	24	40	52	42	57													Vb 18	CASSPQSGGDSETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCTCCCCAGCAGGGGGAGTCACTGAAGCTTTCTTTGGACAA	CASSRSPAGGVTEAFF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	4	9	3	24	37	53	46	56													Vb 18	CASSRSPAGGVTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATGATCGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPMIGSNQPQHF	In	VDJ	1	23	2.429389272661977E-4	3.049548534227868E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	3	1	8	1	7	0	24	38	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPMIGSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGTTAGGGACAGGGTGCGGCTACACCTTCGGTTCG		Out	VDJ	1	23	2.429389272661977E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	8	8	3	24	38	55	46	58													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTGGGCACAGATACGTAGTATTTTGGCCCA	CASSPLGTDT*YF	Stop	VDJ	1	17	1.7956355493588524E-4		39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	5	13	7	6	24	38	49	45	55													Vb 18	CASSPLGTDT*YF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGAGTTGGGACTCCGGAGGGGGAGCAGTACTTCGGGCCG	CASSPRVGTPEGEQYF	In	VDJ	1	17	1.7956355493588524E-4	2.2540141339945108E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	7	7	9	24	38	51	45	60						01,02							Vb 18	CASSPRVGTPEGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAACTCGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLNSGENTEAFF	In	VDJ	1	15	1.5843843082578111E-4	1.9888360005833919E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	1	6	1	24	37	49	43	50													Vb 18	CASSLNSGENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3397B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2069	1648	350	70	0	1255	1040	189	26	0	94674	75421	16039	3214	0	0.104553498	8.97449398	0.104522839	9.2175684				19843	0.0846073329	0.0341284275	0.0271880347	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:42	Age (Range):45-65 Years (Late Adulthood),Age:62 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 665,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 342,type of chemo:carbo/taxol	0.7965200362887468	MSKCC- Snyder- P01-02		1679.0	
